REGULATIONOF1INTEGRINTRAFFICANDARF6GTPASEBY AMP-ACTIVATEDPROTEINKINASE   
by RehmanAta,BScRyersonUniversity2014   Athesis presentedtoRyersonUniversity inpartialfulfillmentofthe requirementsforthedegreeof MasterofScience intheProgramof MolecularScience      Toronto,Ontario,Canada,2016 ©RehmanAta2016

AUTHOR'S DECLARATION FOR ELECTRONIC SUBMISSION OF A THESIS I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I authorize Ryerson University to lend this thesis to other institutions or individuals for the purpose of scholarly research. I further authorize Ryerson University to reproduce this thesis by photocopying or by other means, in total or in part, at the request of other institutions or individuals for the purpose of scholarly research. I understand that my thesis may be made electronically available to the public.





ii

Abstract
Regulationof1IntegrinTrafficandArf6GTPaseby AMP-activatedProteinKinase
RehmanAta  MasterofScience,MolecularScience,RyersonUniversity2016   Integrinsarecellsurfacereceptorsthatphysicallybridgetheextracellularmatrixtothe cytoskeletonandresponsibleforadhesion,migration,andsignaling.Integrinfunctionis intimatelycontrolledbytheirmembranetraffic.Forexample,integrinsaredynamically internalizedfromthecellposteriorandrecycledtothecellanteriorduringcellmigration. Misregulationofintegrinsisintimatelylinkedwithcancerprogression,including metastasisandcellproliferationandsurvival.Wehaverecentlyuncoveredthatintegrin membranetrafficiscontrolledbyAMP-activatedproteinkinase(AMPK),anenergystress sensingkinasewithincellsatbecomesactivateduponenergystresssuchasbyanincrease incellAMP:ATPratio.IconfirmedthatAMPKactivationresultedinareductionofcell surface1-integrin.Usingassaysthatselectivelymeasureintegrinexocytosisand endocytosis,IfoundthatAMPKactivationregulates1-integrinrecyclingandpossibly endocytosis.IdemonstratedthatAMPKregulatesArf6localization,akeyproteinwhich regulates1-integrinmembranetraffic.IconfirmedthatArf6andclathrinareinvolvedin reciprocalregulation,thushighlightingthepossiblepathwayfor1-integrinregulationby AMPK. 





iii

Acknowledgements
I would like to thank Dr. Costin N. Antonescu for his excellence as a mentor and a professor. Without his guidance and support throughout this arduous degree, this journey would have been much more difficult. It has been an honour taking up the mantle of AMPK research from my predecessor, and I look forward to passing on the project to capable hands. I would also like to thank my supervisory committee members Dr. Andras Kapus and Dr. Sarah Sabatinos, for they continually offered their support and challenged me throughout this degree. It is with utmost sincerity that I would like to thank my colleagues and friends in Molecular Science who have supported me throughout the last two years. I simply would not have been able to accomplish this without their patience, guidance and heart. You all are truly special for sticking by me - you know who you are. I would not be standing here, had the two bravest individuals I know, decided not to make the incredible sacrifice of leaving their friends and family behind, and immigrating to Canada in 1998. To my parents, Atta Ullah and Nyla Ata, I am forever in debt for your selflessness, bravery and heart. Lastly, I would like to thank my best friend and brother, Marco Cirone. Without your support and presence, I'm not sure where I would be. I am truly fortunate to be able to surround myself with incredible people.

iv

Table of Contents
ABSTRACT ACKNOWLEDGEMENTS LISTOFTABLES LISTOFFIGURES LISTOFABBREVIATIONS INTRODUCTION EXECUTIVESUMMARYOFINTRODUCTION 1CELLHOMEOSTASISANDCELLSTRESS 1.1HOMEOSTASIS 1.2ATPSYNTHESIS 1.3METABOLICSTRESS 2AMP-ACTIVATEDPROTEINKINASE 2.1AMPKREGULATION 2.2SUBSTRATES&TARGETSOFAMPK 2.3PHYSIOLOGICALSIGNIFICANCEOFAMPK 3MEMBRANETRAFFIC 3.1CLATHRINMEDIATEDENDOCYTOSIS 3.2CLATHRINCOATVESICLEFORMATION 3.3SMALLGTPASES:RAB&ARF 3.4ROUTESOFINTERNALIZATIONANDRECYCLINGUSINGARFANDRABGTPASES 4INTEGRINS 4.1STRUCTUREANDFUNCTION 4.2INTEGRINTRAFFICKING 4.3CELLMIGRATION 5CONTROLOFCELLMIGRATIONDURINGMETABOLICSTRESS 5.1AMPK&CONTROLOF1-INTEGRIN RATIONALE&HYPOTHESIS MATERIALS&METHODS RPECELLCULTUREANDPHARMACOLOGICALTREATMENTS CDNATRANSFECTION SIRNATRANSFECTION TOTALANDCELLSURFACEIMMUNOFLUORESCENCEASSAY ENDOCYTOSISASSAY ANTIBODYRECYCLINGASSAY WIDEFIELDEPIFLUORESCENCEIMAGING CELLSURFACEANDTOTALSTAININGABUNDANCEQUANTIFICATION CELLMIGRATIONASSAY CELLVIABILITYASSAY III IV VII VIII IX 1 1 3 3 4 8 9 10 13 16 20 20 23 25 29 29 30 30 32 35 36 39 41 41 42 42 43 44 45 45 46 47 47

v

IMMUNOBLOTTING TIRFMICROSCOPYANDSPINNINGDISKCONFOCALMICROSCOPYIMAGING TIRFMICROCOPYANDSPINNINGDISKCONFOCALMICROSCOPYANALYSIS RESULTS RESULTSPARTI:AMPKREGULATES1-INTEGRINONTHECELLSURFACE&CELLMIGRATION AMPKISREQUIREDFOR1-INTEGRINCELLSURFACEREDUCTION AMPKACTIVATIONBYA-769662HINDERSMIGRATIONOFRPE-WTCELLS LONGTERMAMPKACTIVATIONBYA-769662DOESNOTAFFECTCELLVIABILITY  RESULTSPARTII:AMPKACTIVATIONCONTROLSSPECIFICSTAGESOF1-INTEGRINMEMBRANETRAFFIC ACUTEAMPKACTIVATIONDOESNOTAPPRECIABLYALTERTHERATEOF1-INTEGRINENDOCYTOSIS 1-INTEGRINRECYCLINGISREGULATEDBYAMPKACTIVATION TRANSFERRINRECEPTORRECYCLINGISNOTREGULATEDBYAMPKACTIVATION  RESULTSPARTIII:REGULATIONOFARF6GTPASEBYAMPK A-769662REGULATESARF6GTPBINDINGANDSUBSEQUENTLYITSCELLULARLOCALIZATION ACUTEPERTURBATIONOFARF6GTP/GDPCYCLINGREGULATES1-INTEGRINENDOCYTOSIS A-769662REGULATESARF6RECRUITMENTTOCLATHRINCOATEDPITS ARF6CONTROLSCLATHRINASSEMBLY DISCUSSION REGULATIONOF1-INTEGRINBYAMP-ACTIVATEDPROTEINKINASE(AMPK) AMPKREGULATIONOF1-INTEGRINENDOCYTOSIS AMPKREGULATES1-INTEGRINRECYCLINGBUTNOTTRANSFERRINRECEPTORRECYCLING AMPKREGULATIONOFARF6TOCONTROL1-INTEGRINTRAFFICKING AMPKANDARFSREGULATIONOFCCPSANDENDOCYTOSIS CONCLUSION REFERENCES

48 48 49 51 52 52 55 58 59 59 59 61 62 67 68 69 70 77 80 81 84 86 88 93 97 99

vi

List of tables
Table 1 ­ ArfGAPsremovedfromthecellsurfaceupontreatmentwithA-769662.............66

vii

List of figures
 Figure 1 ­ Glycolysis,Krebscycle&Oxidativephosphorylation................................................5 Figure 2 ­ AMPKallostericregulationbyAMPADP&ATPbinding.......................................12 Figure 3 ­ Membranetrafficof1-integrinsbyArf&Rabs.....................................................28 Figure 4 ­ Cellmigrationrequiresintegrintrafficking.............................................................33 Figure 5 ­ InhibitionofAMPKbysiRNAgenesilencingpreventsthereductionincell surface1-integrinelicitedbyA-769662treatment...................................................................54 Figure 6 ­ ActivationorinhibitionofAMPKdoesnotleadto1-integrindegradation......55 Figure 7 ­ A-769662treatmentdoesnotaffectcellarea..........................................................56 Figure 8 ­TreatmentwithA-769662reducescellmigration..................................................57 Figure 9 ­TreatmentwithAMPKactivatorsdoesnotaltercellviability...............................59 Figure 10 ­AcuteAMPKactivation(15min)doesnotaffect1-integrinendocytosis........64 Figure 11 ­ 1-integrinrecyclingishinderedbyAMPKactivation..........................................65 Figure 12 ­TransferrinreceptorrecyclingisunaffectedbyAMPKactivation......................66 Figure 13 ­ AMPKactivationbyA-769662regulatesArf6-GTPbinding................................72 Figure 14 ­ QS11treatmentreducestheabundanceofcellsurface1-integrin..................73 Figure 15 ­QS11treatmenthinders1-integrinendocytosis.................................................74 Figure 16 ­AMPKactivationbyA-769662treatmentdecreasesGFP-Arf6-WTrecruitment toCCPs................................................................................................................................................75 Figure 17 ­AMPKactivationdoesnotaffectGFP-Arf6-GTP-lockedmutantrecruitmentto CCPs.....................................................................................................................................................76 Figure 18 ­ Arf6regulatesclathrinassemblyinclathrincoatedpits......................................79 Figure 19 ­ ProposedmodelforAMPKandArf6on1-integrinregulation..........................96

viii

List of abbreviations
ACC­Acetyl-CoAcarboxylase ADP­Adenosinediphosphate AgRP­Agouti-relatedprotein-expressingneuron AICAR­5-Aminoimidazole-4-carboxamideribonucleotide;AICAribonucleotide;Acadesine AMP­Adenosinemonophosphate AMPK­AMP-activatedproteinkinase ANOVA­Analysisofvariance ANTH­AP180amino-terminalhomology AP-2­Adaptorcomplex2 Arf­ADP-ribosylationfactor Arp2/3­Actinrelatedprotein2/3 ATP­Adenosinetriphosphate BSA­BovineSerumAlbumin CaMKK­Ca2+/calmodulin-dependentkinasekinase CBM­Carbohydratebindingdomain CBS­Cystathioninebetasynthase CCP­Clathrincoatedpit CCV­Clathrincoatedvesicle CD36­Fattyacidtranslocase CHC­Clathrinheavychain CLC­Clathrinlightchain CLIC3­Chlorideintracellularchannelprotein3 CME­Clathrinmediatedendocytosis CPT1­Carnitinepalmitoyltransferase1 CTD­C-terminaldomain DTT­Dithiothreitol ECM­Extracellularmatrix eEF2­Eukaryoticelongationfactor2kinase EGF­Epidermalgrowthfactor ix

EGFR­Epidermalgrowthfactorreceptor ENTH­EpsinN-terminalhomology EPS15­EGFRpathwaysubstrate15 ETC­Electrontransportchain FCHo­FCHdomainonlyprotein FAD/FADH2­Flavinadeninedinucleotide FAT4­FATtumoursuppressorhomolog4 FAK­Focaladhesionkinase FBS­Fetalbovineserum G-clathrin­Gyratingclathrin GAP­GTPaseactivatingprotein GEF­Guanylexchangefactor GDI­GDP-dissociationinhibitors GFS­GDIdisplacementfactors GDP­Guanosinediphosphate GFP­Greenfluorescentprotein GHSR­Growthhormonesecretagoguereceptortype1 GLUT-1­Glucosetransporter1 GLUT-4­Glucosetransporter4 GTP­Guanosinetriphosphate HSC70­Heatshockcognate90 IMAC­Immobilixedmetalionchromatography LKB1­LiverkinaseB1 LSB­LaemmliSampleBuffer MHC­MajorHistocompatibilityComplex MO25­Mouseprotein25 MS­Massspectrometry mTOR­Mammaliantargetofrapamycin NA­NumericalAperture NAD+/NADH­Nicotinamideadeninedinucleotide NPY­NeuropeptideY x

NT­Non-targetting PBS­Phosphatebufferedsaline Pdlim5­PDZandLIMdomain5 PFA­Paraformaldehyde PI­Propidiumiodide PI4P­Phosphatidylinositol-(4)-bisphosphate PI(4,5)P2­Phosphatidylinositol-(4,5)-bisphosphate PIP5K­Phosphatidylinositol-4-phosphate-5-kinasexii PKA­ProteinkinaseA PM­Plasmamembrane POMC­pro-opiomelanocortin-expressingneurons PNRC­Perinuclearrecyclingcompartments PSF­Point-spreadfunction Q-Ubiquinone QH2­Ubiquinol RFP­Redfluorescentprotein RPE­Retinalpigmentepithelialcells SDS­Sodiumdodecylsulfate SDSPAGE­SDSPolyacrylamidegelelectrophoresis SH3­Srchomology3 siRNA­SilencingRNA SNX9­Sortingnexin9 STRAD­STE20-relatedkinaseadaptorprotein TBC1D1­TBC1domainfamilymember1 TBC1D4­TBC1domainfamilymember4 TfR­Transferrinreceptor TIRFM­Totalinternalreflectionfluorescencemicroscopy TXNIP­Thioredoxin-interactingprotein WT­Wildtype VALAP­Vaseline,Lanolin,Parafinwax





xi

Introduction
Executive Summary of introduction
Inthisstudy,Iwilldiscusscellularstressanditsimplicationsforwholecellphysiology.A majortypeofphysiologicallysignificantcellularstressisenergeticstress,inwhichthereis asignificantdecreaseinATPconcentration.ATPisgeneratedbyglycolysisandoxidative phosphorylation,butcanalsobesynthesizedbyoxidationoffattyacids.Foracellto regulatelevelsofATP,itrequiresanATPsensor.Inalleukaryoticcells,thisisAMPactivatedproteinkinase(AMPK).AMPKisactivatedwhencellsareexperiencingenergetic (orothertypesof)stress,torectifytheenergeticstressandestablishhomeostasis.It performsthisbylimitingprocesseswhichareenergyconsuming(anabolic)andincreasing pathwaysinvolvedinenergycreation(catabolic).Asignificant,butnotwellunderstood, roleofAMPKinlimitinganabolicandincreasingcatabolicprocesses,istheregulationofthe cellsurfaceproteome.Inshort,ourunderstandingofhowcellmetabolismandmetabolic signalingaffectsmembranetrafficiscurrentlyquitelimited.Afewnotableexamplesofthe AMPKregulationofmembranetrafficaretheincreaseofGLUTtransportersonthecell surface,andthedecreaseofNa+/K+ATPaseuponAMPKactivation.Amajorregulatorofcell surfacemembranetrafficisclathrin-mediatedendocytosis,andthesmallGTPasesADPribosylationfactors(Arfs)andRabs.Theseregulatethemembranetrafficofavarietyof proteins,suchastransferrinreceptors(TfR)andintegrins.Interestingly,integrinswere showntoberegulatedbymetabolism(specifically,AMPKactivation)throughanunknown pathway(Rossetal.,2015).Integrinsareinvolvedincelladhesion,migration,signalingbut canalsobeinvolvedintumourigenesiswhenmisregulated.HowAMPKregulatesintegrins isnotknownandisexploredinthisstudy. 1

Theproteinsfoundonthecellsurface(collectivelytermedthecellsurfaceproteome)are involvedinnumerousprocessessuchasnutrienttransport,signaling,andcelladhesion. Availabilityoftheseproteinsatthecellsurfacecontrolstheirfunction,asmanyofthese proteinshaveaprimaryfunctionthattheyarenolongerabletoperformifinternalizedinto thecell.Forexample,nutrienttransportersrequireaccesstosubstratesintheextracellular milieu,andadhesionmoleculesrequireaccesstoextracellularmatrix(ECM)contactsites (Shawetal.2004;Caswelletal.2009).  Thecellsurfaceproteomeisadynamicallyregulatedcompartment,whichallowsit toberegulatedbyavarietyofcellularprocessesandcuesduringchangingcellular conditions.Forexample,remodellingthecellsurfaceproteomeisrequiredduring mammalianerythropoiesis­theproductionofredbloodcells(Wraith&Chesterton1982). Duringmammalianerythropoiesis,erythroblasts(immatureredbloodcellscontaininga nucleus)giverisetoreticulocytes(immatureredbloodcellslackinganucleus),whichleave thebonemarrowandmatureintocirculatingerythrocytes(Wraith&Chesterton1982). Leavingthebonemarrowandenteringcirculationispairedwithtwomajorplasma membraneeventsforerythrocytes:1)formingthediscshapeviachangesinthe cytoskeletonand2)lossoferythroblast-specificproteinsfromthecellsurface.Thelossof erythroblastproteinsoccursthroughendocyticeventsbetweenthereticulocyteand circulatingerythrocytestage(Wraith&Chesterton1982).Thisflexibilityofthecellsurface proteomehasmanyotherfunctionsduringdevelopment(Artavanis-tsakonasetal.1999; Yanetal.2010).Importantly,theplasticityoftheplasmamembranewithregardsto proteincontentandregulationisveryimportantinadultorganisms,asthisphenomenon

2

allowscellstosurviveavarietyofdifferingmetabolicandenvironmentalconditionssuch asischemia,hypoxiaandenergystress.Understandinghowthecellsurfaceproteomeis dynamicallyregulatedbycellularcues,suchasmetabolismandenergystressisa fundamentallyimportantquestioninbiology.

1 Cell Homeostasis and Cell Stress


1.1 Homeostasis
Withineverycell,abalanceofATPADP+Piexists.Thisreactionexistsinastatethatis farawayfromequilibrium,asthecellmaintainsahighconcentrationofATPtoADPat10:1 (Hardieetal.2012).FavouringofATPinequilibriumisnecessarytomaintaincell homeostasisanddriveenergy-requiringprocesses.Inalleukaryoticcells,adenylatekinase ishighlyexpressed,whichcatalysesthereversiblereaction2ADPATP+AMPcloseto equilibrium(separatefromtheATPADP+Pireaction)(Hardieetal.2012).Ifthe concentrationofADPrises(meaningATPlevelsaredecreasing)theadenylatekinase reactionshiftsawayfromequilibriumandnowfavourstheproductionofATP+AMPata 1:1ratio(Hardieetal.2012).TherateofATPproductionthroughthisreactionisnotable tooffsettheenergydeficiencyincells.Therefore,whenacellbeginstoloseenergy,AMP andADPconcentrationsrise,signalingmetabolicstress.    

3

1.2 ATP synthesis

1.2.1 Glycolysis ATPgenerationstartswiththeconsumptionofglucosebyglycolysistogenerate ATPandNADH(Lietal.2015).Briefly,intheenergyinvestmentstage,glucoseisconverted tofructose-1,6-bisphosphatewhileconsuming2ATPmoleculesintheprocess.Inthenext fewreactions,dubbedtheenergyharvestingstage,2moleculesofNADHand4molecules ATParegenerated(Lietal.2015).Thisgivesanetgainof2moleculesofATP,NADHand pyruvateforglycolysis.ThisproductionofATPfromglucoseasaresultofglycolysisis limited,andcellsmusteitherhaveamassiverateoftransportofglucosefromthe extracellularmilieu,ormustuseadditionalmetabolicpathwaystofurthermetabolize pyruvate(Lietal.2015).Mosthealthycellsinadultorganismsdothelatter,wherethebulk ofATPcomesfromAcetyl-CoAmetabolisminthemitochondria,throughtheactionofthe Kreb'scycleandoxidativephosphorylation(Akram2014).PyruvateisoxidizedtoAcetylCoA,generatinganothermoleculeofNADH.Acetyl-CoAthenenterstheKreb'scycle,in whichacetyl-CoAundergoes8differentreactionstoultimatelygenerate3moleculesof NADH,1moleculeofFADH2and1moleculeofATPpercycle(Fig1A)(Akram2014).In total,theKrebscyclegenerates6NADH,2FADH2,and2ATP­as2acetyl-CoAmolecules enterstheKrebscycleperglucose(Akram2014).Fromhere,theNADHandFADH2made fromglycolysis(2NADH),theconversionofpyruvatetoacetyl-CoA(2NADH)andthe Krebscycle(6NADHand2FADH2)areusedintheelectrontransportchain(ETC)(Sazanov 2015). 

4

Fig 1. Glycolysis, Krebs cycle & Oxidative phosphorylation Glycolysis reactions take place in the cytoplasm and it produce 2 molecules of pyruvate, 2 NADH and 2 ATP. The pyruvate then enters the mitochondria where it is converted to acetyl-CoA and undergoes the 8 step Krebs cycle. This produces 3 NADH, 2 FADH2 and 1 ATP per molecule of pyruvate. NADH and FADH2 then enter the Electron Transport Chain. The ETC consists of 5 membrane protein complexes: Complex I, II, III, IV, and ATPase synthase. Two transport proteins ubiquinone (Q) and cytochrome c are also involved. The ETC carries the electrons from NADH and FADH2 throughout the complexes to pair proton movement across the inner mitochondrial membrane to establish a proton gradient. This gradient is used by ATPase synthase to create ATP at the end of the chain. Oxygen is also required for the ETC (thus the name, oxidative phosphorylation), as it acts as the inal electron acceptor on complex IV. When oxygen is not suficient in a cell, the ETC shuts down as it can no longer carry electrons throughout the ETC.
Cytoplasm
Glycolysis glucose + 2 NAD+ + 2 ADP + 2 Pi 2 pyruvate + 2 NADH + 2 ATP + 2 H2O Krebs Cycle 2 x (acetyl-CoA+ 3 NAD+ + FAD + ADP + Pi+ 3 H2O) 2 x (3 NADH + H+ + FADH2 + 2 CO2 + ATP)

Mitochondrial Matrix

Inner Mitochondrial Space

4 H+

4 H+
Cytochrome c
2e-

2 H+ 2.7 H+

Q

Q

2Q
2QH2

Complex I

QH2

Complex II

QH2

Complex III
1

Complex IV
/ 2 O2 H2O

ATP synthase
ADP+ Pi

Succinate NADH NAD+ + H+

6 H+

Fumurate + 2 H+

2 H+

4 H+

ATP

Proton

Matrix
5

1.2.2 Oxidative phosphorylation TheETC(Fig1B)iscomposedofaseriesofproteincomplexesembeddedinthe mitochondrialinnermembranethatmakeupoxidativephosphorylation(Sazanov2015). Electronsarecapturedfromdonormoleculesandaretransferredthroughthesecomplexes. Coupledwiththistransferisthepumpingprotonsfromthematrixtotheintermembrane space,generatingaprotongradientthatsubsequentlydrivesATPproduction(Sazanov 2015).ThecomplexesintheETCareasfollows:NADHdehydrogenase(complexI), succinatedehydrogenase(complexII),cytochrome-bC1(complexIII),cytochromecoxidase (complexIV),andATPsynthase(Sazanov2015).ATPsynthaseisresponsiblefor generatingATPattheendoftheETC.Inadditiontothesecomplexes,twomobilecarriers areinvolved:ubiquinone(Q)andcytochromec(Sazanov2015).Qisresponsiblefor carryingelectronsfromcomplexItocomplexIIIandfloatswithinthemembrane. Cytochromecisamobileproteinintheintermembranespaceandtransportselectrons fromcomplexIIItocomplexIV(Sazanov2015).AtthestartoftheETC,NADHisoxidized anditselectronsarepassedinsideComplexI,toreduceQtoubiquinol(QH2).Atthesame time,4protonsarepumpedviacomplexItotheintermembranespace.QH2isusedby complexIIItoreducecytochromecintheintermembranespace(Sazanov2015).As complexIIIreducescytochromec,4moreprotonsarepumpedacrosstheintermembrane space.ComplexIVusescytochromec(2e-)toreducemolecularoxygen(O2)toH2O,while pumpingout2protonsintotheintermembranespace.Oxygenisknownasthefinal electronacceptor­ifoxygenisnotavailable,theETCshutstoahaltaselectronsarenot abletobefreedupfromcomplexIV(Sazanov2015).Assuch,hypoxiaexertsmetabolic stressasaresultofreducedATPproductionbytheETC.EachNADHmoleculepumps10

6

protonsacrosstotheintermembranespace,andthiscreatesaprotongradient.The potentialenergyinthisgradientisusedbyATPsynthasetocreateATPusingADPand inorganicphosphate(Sazanov2015).  IntheKrebscycle,theconversionofsuccinatetofumarateusestheenzyme succinatedehydrogenasetoreduceFADtoFADH2.Asmentionedabove,succinate dehydrogenaseiscomplexII,andholdstheelectronsinFADH2­transferoftheseelectrons arealsousedtopumpprotonsacrosstheinnermembrane.ComplexIIreducesQtoQH2, whichtravelstocomplexIIItoreducecytochromec(2e-).Cytochromec(2e-)reductionis coupledwith4protonspumpedacrosscomplexIII.Cytochromec(2e-)thentravelsto complexIVwhereoxygenisreducedtoH2Oand2moreprotonsarepumpedacrossthe membrane.EachFADH2moleculepumps6protonsintotheintermembranespace.2.7 protonsareneededtocreate1moleculeofATP.Attheendofoxidativephosphorylation, totalATPproducedfrom1glucosemoleculeis30-32ATP(Sazanov2015).  Whenoxidativephosphorylationisnotenough,fattyacidscanalsobeshuttledinto ATPproduction.Thisiscalledfattyacidoxidation(-oxidation).Theoverallpurposeof fattyacidoxidationistobreakdownlongcarbonchainsinto2carbonsubunitsgroupsand oxidizingthemintheprocess(Houten&Wanders2010).Theelectronsfromoxidationare usedtoreduceNAD+andFAD­thesearecapableofproducingATPintheETC.The2 carbonsubunitsarealsoconvertedtoacetyl-CoA,whichcanentertheKrebscycletocreate moreATP.Fromasingle16-carbonfattyacidchain,107ATPcanbegeneratedwhichis significantlyhigherthanwhat1moleculeofglucosegenerates(Houten&Wanders2010).

7

ThenetconsequenceofthesecatabolicpathwaysistoconvergeonATPproduction,in ordertofuelthelargerangeofchemicalreactionsintherestofthecellthatareotherwise energeticallyunfavourable. 

1.3 Metabolic Stress
Thevastmajorityofcellculturemodelsgrowcellsunderoptimalconditionsto ensurerapidandconsistentgrowth.Optimalinthiscasereferstonutrientandserum availability.Thisisunlikelytocorrespondtothephysiologicalsituationformostcells, whichexperienceongoingmetabolicchallenges,arisingfromchangesinbloodflow, nutrientavailabilityandoxidativedamage.Thisisevidentwiththebehaviourof Mammaliantargetofrapamycin(mTOR),theserine/threoninekinasethatregulatescell growth,cellproliferation,andproteinsynthesisamongothers.mTORbecomesinactivated inmanydiversetypesofcells3-4hourspostfeeding,astheaminoacidlevelsdrop(Kim 2009;Demetriadesetal.2014).Althoughglucoseconcentrationremainrelativelystable, theyalsoattimesfluctuate,particularlyaslargespikes1hourafterameal(Giuglianoetal. 2008).Thesearethephysiologicallyrelevantconditionsthatcellsencounterwithregardto cellmetabolismsupplyandstress,whichcandiffersubstantiallyfromtheconditions typicallyusedinmostcurrentcellculturegrowthmodels.  Thereareavarietyofphysiologicalmetaboliccellstressors,suchashypoxia(lackof oxygen),ischemia(lowbloodflow),andothermechanismsthatleadtometabolicstress (notenoughenergy)(Hardieetal.2012).Metabolicstressoccurswhenthereisalackof ATPavailableforcellstomaintainitshomeostaticfunctions,whichcausesareductionin

8

theATP:AMPorATP:ADPratioincells.Withoutcellularresponsemechanismstometabolic stress,thiscanleadtoreductionsinATPsufficienttoimpairkeycellularprocesses requiredforsurvival,suchastranscription,translationandDNAreplication(Uni1981; Conaway&Conaway1988;Harmsetal.2014).Toallowcellstomaintainhomeostasisand tosurviveshort-termmetabolicchallengesandstressors,cellsundergocalculatedchanges initssignalingandprocesses,shiftingpriorityawayfrommacromoleculebiosynthesisand otherenergy-consumingprocesses(broadly,anabolism)toenergysynthesisand autophagy(broadly,catabolism). 

2 AMP-activated Protein Kinase
Itisevidentthenthatacellenergysensormustmonitorandreacttoincreasing concentrationsoftheratioofAMPandADPinordertomaintaincellularhomeostasis. Whenacellisputunderconditionsofmetabolicstress,adecreaseintheATP:AMPratio resultsinactivationofAMP-activatedproteinkinase(AMPK),akeyproteinthatinitiates signallingpathwaysthatleadtoenergyconservation,increasedenergyproductionand intake.AMPKistheprincipalenergysensorinmosteukaryoticcells(Hardieetal.2012). Thisisevincedbymanyapproaches,includingstudieswithmiceinwhichAMPKorits activatingkinaseliverkinaseB1(LKB1)aregeneticallyknockedout.Intheseanimalsthe ATP:AMPratioissignificantlylowerduringstressinducingconditionsinmusclecells (contraction)andcardiacmuscle(ischemia)(Sakamotoetal.2005;Sakamotoetal.2006), demonstratingthatAMPKsignalingisrequiredforcellstodetectmetabolicstress,and subsequentlytoengageinprocessestorestoreATP:AMPratio,thusmaintainingcellular

9

homeostasis.HowdoesAMPKsenseATP:AMPrationsandsubsequently,howdoesAMPK controlcellphysiologicalprocessestomaintainhomeostasis? 

2.1 AMPK Regulation
AMPKisaheterotrimerthatisactivatedbydirectbindingofAMPorADP.The heterotrimeriscomposedofan(catalytic),and(regulatory)subunit.Genesencoding AMPKsubunitsarefoundinalleukaryotes(Hardieetal.2012).Theandthesubunits canexistsintwoisoforms:1or2and1or2.Thegammasubunithasthreeisoforms: 1,2and3.The2isoformsarepredominantlyfoundinskeletalandcardiactissue, whereashepatictissueconsistsofequaldistributionof1and2(Pinteretal.2013; Violletetal.2006).Also,AMPKcomplexescontaining2and2arestimulatedtoagreater extentthanthosewith1and1andAMPKcontaining3aretheleastsensitivetoAMP (Saltetal.1998;FCheungetal.2000;Oakhilletal.2011;Scottetal.2004).Hence,while AMPKhasageneralroleinsensingmetabolicstress,specificaspectsofAMPKfunctionare distinctlyregulatedindifferenttissuesbasedontheisoformsexpressed.  AMP,ADP,andATPdirectlybindtothesubunittoallostericallyactivateor deactivateAMPK(Hardieetal.2012),bychangingtheconformationofAMPK.The subunitcontainsaSer/Thrkinasedomainattheaminoterminus;thekinaseactivityinthis domainisactivatedwhentheconservedThreonine-172(T172)residue­locatedinthe activationloop­isphosphorylated(Hardieetal.2012;Suteretal.2006).T172 phosphorylationismediatedbyupstreamkinases:LKB1-STRAD-MO25complex(Hawleyet al.2003;Woodsetal.2003;Shawetal.2004)andtheCalcium/Calmodulinactivated 10

proteinkinasekinases(CAMKK)(Hurleyetal.2005;Woodsetal.2005;Hawleyetal. 2005).LKB1-STRAD-MO25isaheterotrimericcomplexcomposedoftheproteinliver kinaseB1(LKB1),alongwithitsaccessorysubunitsSTE20-relatedkinaseadaptorprotein (STRAD)andmouseprotein25(MO25).TheAMPKsubunitcontainsacarbohydrate bindingdomain(CBM),whichallowsmammalianAMPKtobindglycogenparticles; however,thephysiologicalsignificanceofAMPKbindingtoglycogenisstillyetunknown. ThesubunitC-terminaldomain(CTD)bindsboththe-CTDandthe-subunit,forming thecoreofAMPKprotein.  LKB1-STRAD-MO25phosphorylationofT172onAMPKisinitiatedbybindingof AMPtothesubunit,whichpromotesphosphorylationandinhibitsdephosphorylation (Daviesetal.1995;Hawleyetal.1995).Thesubunitcontains4regulatorybindingsites forAMP,ADP,andATP(undertheconditionswithinthecell,site2ispredominantlyempty andsite4ispredominantlyboundwithanAMPmolecule)(Fig2)(Hardieetal.2012).The bindingsitesarecomposedoftwoBatemandomains,whichareformedbytwotandem repeatsofCBSrepeats(fourCBSrepeatstotal)(Xiaoetal.2011).TheCBSrepeatsassociate togethertoformacentralcleftabletobindadenosinederivatives.AMPbindingonsite1 causesallostericactivationofAMPK,whilebindingofAMPorADPtosite3allowsforT172 phosphorylation(Xiaoetal.2011).WhenAMPorADPbindssite3,aregionofthe subunit,termedthe-hookinteractswiththesubunit(Xiaoetal.2011).Thisinteraction stabilizestheactiveconformationofAMPKbynotallowingphosphataseaccesstoT172, therebyprotectingitfromdephosphorylation(Xiaoetal.2011).Theactivationloopis protectedbytheCTDoftheandsubunitsintheactiveconformation.WhenATPis

11

AMPK

Fig 2. AMPK allosteric regulation by AMP ADP & ATP binding AMPK activation by AMP & ADP. The -kinase domain is phosphorylated by LKB1 or CamKK at Thr172 upon AMP or ADP binding to site 3 on the  subunit. This protects dephosphorylation of Thr172 from phosphatases. Phosphorylation of Thr172 site increases AMPK activity 100-fold. As ATP levels rise, it replaces ADP/AMP on sites 1 and 3, which eventually allows for dephosphorylation at Thr172 by a protein phosphatase.






ATP

ADP 1 2 4 3 ATP

ATP

T172

T172

1 1 2 2 4 4

3 3

ADP

AMP ATP

AMP

LKB1 Phosphatases CaMKK

ATP ATP ATP 1 2 4 3 ATP
P P

T172

T172
ADP

1 1 2 2 4 4

3 3

ADP

AMP

AMP

12

boundtosite3,the-hookinteractionisnotfavourableduetoastericclash,andT172is leftunprotectedandsusceptibletodephosphorylation(Xiaoetal.2011).Asenergylevels decreaseinacell,thenetresultofAMPbindingandprotectionfromphosphatasesisT172 phosphorylation,whichinturnresultsina100-foldincreaseinAMPKactivity(Fig2)(Xiao etal.2011).

2.2 Substrates & Targets of AMPK

2.2.1 Role of AMPK in Glucose uptake Onceactivated,AMPKactsonahostofdifferenttargets,eitherdirectlyorindirectly, andphosphorylationofthesesubstratesfunctionstolimitenergyexpenditureandincrease energyproduction.AclassicmechanismaffectedbyAMPKisglucoseuptakeviaglucose transporter4(GLUT4)inskeletalmusclecells.Duringmusclecontraction,AMPKis activatedasaresultofasubstantialdropinATP:AMPratio,whichresultsfromthe energeticrequirementsofmusclecontraction.AMPKactivationinskeletalmusclecells allowsenhancementofcatabolismofglucosetoATP(Sheareretal.2004).Thisincreased catabolismofglucoseinexercisingskeletalmusclecellsoccursasaresultofthe translocationofvesiclescontainingtheGLUT4transportertotheplasmamembrane(Chen etal.2008;Pehmolleretal.2009).ForGLUT4carryingvesiclestofusewiththeplasma membrane,GproteinsfromtheRabfamilymustbeintheGTP-boundstate(Sakamoto& Holman2008).However,intheabsenceofmusclestimuli,thesespecificRabproteinsare predominantlyintheGDP-boundstate(andthereforeinactive);thisisensuredbythehigh activityoftheRabGAPsTBC1domainfamilymember4(TBC1D4)andTBC1D1(Chenetal.

13

2008;Pehmolleretal.2009).Inacontractingmuscle,AMPKactivationleadstothe phosphorylationofTBC1D1,whichallowsforTBC1D1tobindwith14-3-3proteinsand ultimatelydissociatefromtheGLUT4vesicles(Chenetal.2008;Pehmolleretal.2009). ThiseventallowsforconversionofRabtoitsactiveGTP-boundform,enablingtheGLUT4 carryingvesiclestofusetotheplasmamembraneandreleaseGLUT4transporters.  Similarly,AMPKparticipatesinmodulatingglucoseuptakebyglucosetransporter1 (GLUT1)uptakeaswell.GLUT1istheglucosetransporterresponsibleforglucosetransport intoawiderangeoftissuesthroughoutthebody(Wuetal.2013).Underconditionsof energeticsufficiency,Thioredoxin-interactingprotein(TXNIP)bindstoGLUT1tomediate GLUT1internalizationbyclathrinmediatedendocytosis,thuslimitingtheglucose transportactivityofGLUT1.TXNIPexhibitshighlevelsofexpressionwhencellsare culturedinhighglucoselevels.Byaseparatemechanism,TXNIPalsoimpairsexpressionof GLUT1mRNA,therebyfunctioningasanegativefeedbackloop.AMPKactivationbyenergy stressphosphorylatesTXNIP,resultinginrapidTXNIPdegradation(Wuetal.2013).The degradationofTNXIPbothincreasestheamountofGLUT1mRNAandimpairsGLUT1 endocytosis,thusenhancingthecontentofGLUT1atthecellsurface,thusincreasingthe uptakeofglucosemolecules(Wuetal.2013).Oncetheenergystresshasbeenrelieved, TXNIPbeginsonceagaintonegativelyregulateGLUT1(Wuetal.2013).AMPKthus controlsthemembranetrafficofGLUT4andGLUT1bydifferentmechanisms.AMPKalso controlstheinternalizationofthetightjunctionproteinoccludin,theNa+K+-ATPasepump, andfattyacidtranslocase(CD36)(Antonescuetal.2014).Themechanismsforthe regulationofthemembranetrafficofthesemembraneproteinsdiffersthanwhathasbeen

14

describedforGLUT1andGLUT4,orinsomecasesarecurrentlynotknown(Zheng& Cantley2007;Samovskietal.2012;Gusarovaetal.2009;Antonescuetal.2014).Hence,a numberofseparatestudieshavefoundthatAMPKcontrolsthecellsurfacemembrane trafficofmultipleproteins,whichraisesthequestionoftheextenttowhichAMPKmay morebroadlycontrolthecellsurfaceproteome(Rossetal.2015).  2.2.2 Regulation of lipid metabolism Duringperiodoffastingorlowcarbohydratenutrientavailability,fattyacid metabolismisanimportantaspectofmaintainingwholebodyenergymetabolism(Kiens 2006).Theregulationoffattyacidmetabolismoccursthroughtranscriptionalcontrolof specificgenesbyAMPK.Fattyaciduptakehasbeenshowntobehigherincellsinwhich AMPKisactivated,suggestingAMPKalsohasaroleinregulatingfattyaciduptake(Shearer etal.2004;Sheareretal.2005;Steinbergetal.2004;Luikenetal.2003).Themechanismis thoughttooccurbyAMPKincreasingtranslocationoffattyacidtranslocase(CD36)tothe plasmamembrane,althoughthereisstillsomedebatetothisidea(Bonenetal.1999).After fattyaciduptake,theycaneitherbeshuttledstraighttooxidation,orkeptasstorageto meetthemetabolicdemandsofcellslateron.Goingforwardwiththeoxidationpathway beginswithAcetyl-CoAcarboxylase(ACC).ACCisanenzymethatexistsintwoisoforms: ACC1andACC2.ACC2butnotACC1containsa146aminoacidstretchonitsNH2-terminal whichlocalizesittothemitochondria(Abu-Elheigaetal.2000).ACCcatalyzesthe carboxylationofacetyl-CoAtomalonyl-CoA,whichiseitherincorporatedintofattyacids viafattyacidsynthaseduringsynthesisoractstoallostericallyinhibitcarnitine palmitoyltransferase1(CPT1).CPT1isfoundontheoutermitochondrialmembraneand

15

inhibitstranslocationoffattyacidstothemitochondria,wherefattyoxidationoccurs (Bianchietal.1990;Munday2002).ACC2localizationtomitochondriaisthoughttobe importantasmalonyl-CoAproductionoccursincloseproximitytoCPT1,whereitcan easilyinhibitit.LiverandbraintissuecontainequalamountsofACC1andACC2,whereas skeletalandcardiacmusclecontainACC2predominantly(Iversonetal.1990;Abu-Elheiga etal.1995).DeletionofwholebodyACCisembryonicallylethal,whichdemonstratesits importanceindevelopment(Abu-Elheigaetal.2005).  ACCregulationoccursbyphosphorylationbyAMPK.InACC1,phosphorylationat S79byAMPKinhibitsit,whiletheequivalentsiteonACC2isS221(Abu-elheigaetal.1997; Cortonetal.1995).InmostAMPKstudies,phosphorylationofACC1andACC2atthose serineresiduesisusedasthemeasurementofAMPKactivationinvivo.TheAMPKACC interplayisamajorsignalingpathwaywhichdetermineswhetherfattyacidsare undergoingsynthesisoroxidation,andatalargerscalerepresentstheswitchbetween anabolismandcatabolismincells. 

2.3 Physiological Significance of AMPK
 2.3.1 Role of AMPK in whole body metabolism AMPKattemptstorestorehomeostasisbyinhibitinganabolicprocessessuchas gluconeogenesis,fattyacidsynthesisandproteinsynthesis,whileincreasingglucoseintake andglycolysis(Hardieetal.2012).OnewayAMPKregulatesproteinsynthesisisby inhibitingpeptideelongation,byactingoneukaryoticelongationfactor2kinase(eEF2).

16

AMPKphosphorylateseEF2onS398,whichinturninhibitsproteinelongation(Browneet al.2004).  Throughitsactionsinthehypothalamusofthebrain,AMPKisabletoinfluence wholebodymetabolismandenergybalance.Thearcuatenucleusofthehypothalamusis theappetitecontrolcentre,whereinincreasedactivityofneuropeptideYandagoutirelatedprotein-expressingneurons(NPY/AgRPneurons)increasesappetiteand subsequentfeeding(Aponteetal.2011).Ontheoppositespectrum,activityinproopiomelanocortin-expressingneurons(POMC)inhibitsappetite(Aponteetal.2011). Ghrelinisahormonereleasedfromthestomachthatpromotesfeedingwhenthebodyisin afastedstate.Ghrelinbindstothegrowthhormonesecretagoguereceptortype1(GHSR) inpresynapticneuronsupstreamNPY/AgRPneurons,toactivateAMPK(Yangetal.2011). ItsactivationbeginsduetoupstreamactivationofheterotrimericGproteinGqviaGHSR, whichtriggersintracellularCa2+release(Yangetal.2011).TheincreasedintracellularCa2+ activatesAMPKviatheCaMKKpathway(Andrews2011).AMPKactivationalsoinducesa positivefeedbackcycle,whereCa2+releasefromryanodinereceptorssustainsAMPK activation.AlthoughthedownstreamtargetsofAMPKarestillunclear,itisevidentthatits activationresultsinneurotransmitterreleaseontotheNPY/AgRPneurons.Thispromotes sustainedfeeding,whichpersistsevenafterghrelinisnolongeractivatingGHSR,duetothe positivefeedbackloop(Andrews2011).Inaccordancetothismodel,feedingstopswhen leptinisreleasedtoPOMCneuronsthatreleaseopioidstoinhibitAMPK(Claretetal.2007; Yangetal.2011).Hence,AMPKhasmultiplerolesthatmanifestinwhole-bodycontrolof humanphysiology.

17

2.3.2 Role of AMPK in tumourigenesis GeneticmutationsinthetumoursuppressorLKB1,theupstreamactivatorofAMPK,leads toPeutz-Jegherssyndrome,whichischaracterizedbynoncancerousgrowthsinthe gastrointestinaltract,calledhamartomatouspolyps(Shawetal.2016).Thegeneticdisease alsocomeswithagreaterriskofdevelopingothertypesofcancers.Severalstudieshave shownthatAMPKmediatesmanyofthetumoursuppressoreffectsofLKB1.Supportofthis comesintheformofAMPKactivators(e.g.A-769662,metformin,phenformin)whichdelay theonsetoftumourigenesisinvivo(Huangetal.2008;Evansetal.2005).Onemechanism bywhichAMPKmaycontroltumorgrowthcomesfromtheobservationthatAMPKcontrols mTORC1andRNApolymerasetranscriptionfactorTIF-1A,bothofwhichareneededfor rapidcellproliferation(Gwinnetal.2008;Inokietal.2003;Hoppeetal.2009).Inaddition, AMPKactivationalsocausesG1cellcyclearrest,whichoccursbyactivationofp53and subsequentlyp21,thecellcycleinhibitorprotein(Jonesetal.2005;Imamuraetal.2001). Assuch,lowglucoseconditionsresultinactivationofp53viaphosphorylationonS15by AMPK.Interestingly,inp53-deficientcells,AMPKactivationwasnotabletoarrestcells, showingthatp53iscriticalforinductionofcellcyclearrestviaAMPK(Jonesetal.2005). Collectively,thesestudiesindicatethatAMPKmaynegativelyregulatethegrowthofsome tumorsundersomecircumstances.However,thefunctionsofAMPKintumourgrowthis complex,asAMPKactivationinlaterstagesoftumorgrowthmayenhancetumorsurvival andgrowth,byprotectingthesetumorsfromsomeofeffectsofhypoxiaandnutrient limitation(Faubertetal.2015).  Inthelattersituationsoflate-stagetumorgrowth,lossofAMPKmightcooperate

18

withoncogenestopromotetumourigenesis.OneofthewaysAMPKlossmightpromote tumourprogressionisthepropensityforthecellmetabolismtoswitchtoaerobic glycolysis,commonlyreferredtoastheWarburgeffect.TheWarburgeffectisphenotypeof manytumours,inwhichthereisdeliberateshiftofATPgenerationviaoxidative phosphorylationtoATPgenerationthroughglycolysis,evenunderoxidativeconditions (Warburg1956).Althoughthereismuchdebateastowhytumourcellsdefaulttoaerobic glycolysis,thelatesthypothesisdescribesthattheneedsofrapidlyproliferatingcellsgofar beyondATPgeneration:theyrequiremassiveamountsofmacromolecularbuildingblocks (lipids,aminoacids,nucleotides)toincorporateintobiomass(VanderHeidenetal.2009; Newsholmeetal.1985).Acellundergoingdivisionneedsavarietyofmacromolecular buildingblockstoreplicateallofitscellularcontentforthetwodaughtercells.Knockoutof AMPKinmousemodelshasdemonstratedaWarburg-likemetabolicshift(Faubertetal. 2013).Further,lossofLKB1,theAMPKupstreamkinase,promotedtheWarburgeffectin tumours(Faubertetal.2014).AnotherconsequenceofAMPKlossisunregulatedmTOR activity(Shawetal.2016;Inokietal.2003).Thiscanhavewide-spreadingeffectsthat promotetumourprogression,aslossofAMPKwithmTORactivationleadstoanunchecked cellularmetabolism.  Thus,AMPKcontrolsanumberofcellularprocessesthathavefundamentalrolesin normalcellphysiologyandincertaindiseasessuchascancer.Someofthesefunctions involvecontrolofcellcycleandmetabolicenzymes,butAMPKalsohasemergingfunctions inthecontrolofmembranetraffic,inparticularinthecontrolofcellsurfaceabundanceof specificproteins.Understandingthemechanism,extentandsignificanceofcontrolofcell

19

surfacemembranetrafficbyAMPKthusrepresentsanimportantobjectiveto understandinghowcellmetabolismcontrolscellphysiology. 

3 Membrane traffic
Theplasmamembraneharborsproteinsinvolvedinprocessessuchascellsignaling, celladhesion,andmembranetrafficking.Theproteinsandlipidsoftheplasmamembrane areindynamicexchangewithintracellularcompartments(endosomes),asaresultof constitutiveendocytosisandrecycling.Thevastmajorityofproteinsundergoturnover betweentheplasmamembraneandintracellularcompartmentswithat1/2ontheorderof minutesorten'sofminutes(Swiatecka-Urban2013).Hence,therelativeratesof endocytosisandrecyclingeffectivelycontrolthecellsurfacecontentofeachspecific protein(Antonescuetal.2014). Thistypicallyoccursthroughclathrinornonclathrin mediatedendocytosis.Subsequently,theformationoftransportvesiclesandtheirdelivery tospecificcompartmentsiscontrolledbytwomainfamiliesofsmallGTPases:ADPribosylationfactors(Arfs)andRabs. 

3.1 Clathrin mediated endocytosis
Clathrinmediatedendocytosis(CME)isthemaininternalizationmechanismfor integralmembraneproteinsfromthecellsurface,resultingintheformationofclathrin coatedvesicles(CCVs).CMErequiresrecruitmentoftheproteinclathrin,theadaptor proteinAP-2andotherproteinsandcargotosmallregionsontheinnerleafletplasma membranetoformclathrin-coatedpits(CCPs).Effectorproteins,someofwhichfacilitate membranecurvature,contributetoassemblyandmaturationofCCPs,afterwhichsome

20

CCPsundergoscissionfromtheplasmamembranebytheGTPasedynamin,leadingto productionofanintracellularCCVlefttobetraffickedtoendosomes.Althoughthereare severalproteinsfoundinaCCP,therearefivekeymoleculesneededforCCPtotransition toCCV:clathrin,AP-2adaptorprotein,phosphatidyl-inositol-4,5-bisphosphate(PI(4,5)P2), cargoproteins,anddynamin(Antonescuetal.2011).  Clathrinformsastabletrimermadeupofa3heavychain,eachassociatedwitha lightchain,termedatriskelion(Kirchhausenetal.2014).Purifiedclathrinself-assembles toformcage-likestructures(Kirchhausenetal.2014).ThepresenceofAP-2enhancesthe assemblyofclathrinintothecage-likestructureofCCPs(Kirchhausenetal.2014).CCPs andCCVsvaryinsize,averaginganywherefrom50­200nmindiameter(Stevenetal. 1983)andcontain35-40triskelions.Onaverage,thereare25-30moleculesofAP-2found inaCCV(Kirchhausenetal.2014).  AP-2istheprototypicalclathrinadaptorprotein,asitistheprinciplenon-clathrin componentofpurifiedclathrincoatedvesicles(Jacksonetal.2010).AP-2isa heterotetramericproteincomposedofa100kDa-subunit,100kDa2-subunit,a50kDa µ2-subunitanda17kDa2 subunit.TheAP-2µ2subunitinteractsdirectlywith cytoplasmictailsoftransmembranereceptorsthroughatyrosinesortingmotif(YXX)and theacidicdileucinemotif[ED]XXXL[LI](Traub2009).AP-2alsobindsclathrinviathe clathrinbox(LX[DE])found onthe2hingetoactasthecentralhubinthematuring clathrincoatedpit(Traub2009).AP-2isfoundintwostates:closedandopen(Jacksonet al.2010).Initsclosedstate,thetwocargobindingsitesareburied;intheopenstate,at

21

leastoneofthecargobindingsitesisaccessibleandisstabilizedbybindingtoPI(4,5)P2 (Kirchhausenetal.2014;Jacksonetal.2010).Further,intheclosedstate,theclathrinbox issequesteredwithinthecoreofAP-2(Kellyetal.2014).AP-2membraneandcargo bindingenhancesformationoftheopenstructurefromtheclosedstate,whichreleasesthe clathrinboxtorecruitclathrin.Thus,thisallowscouplingofcargoandmembrane recognitionbyAP-2toclathrinassembly.However,AP-2haslowaffinityforbiological membranesandassuch,itrequirestheenrichedpresenceofPI(4,5)P2ontheplasma membranetoontheplasmamembrane(Traub2009).  PI(4,5)P2isfoundinalleukaryoticorganismsandfunctionsandregulatesmany importantcellprocessessuchorganizationofthecytoskeleton,andvesiculartrafficking. PI(4,5)P2alsoregulatesCCPinitiation,stabilization,andsize(Antonescuetal.2011).It mustalsobepresentandenrichedontheinnerleafletoftheplasmamembraneforAP-2to functionasanadaptorinCME(Honingetal.2005).AP-2interactswithPI(4,5)P2attwo basicsitesontheandµ2subunits.PI(4,5)P2issynthesizedbyPI4-kinases phosphorylatingPIonthe4sitetoproducePI(4)P,followedbyPI5-kinase phosphorylationonthe5sitetoproducePI(4,5)P2(Toker1998).Ithasbeendemonstrated thatPI(4,5)P2synthesisisrequiredforCCPinitiationandforCCPmaturation(Antonescu etal.2011).Further,clathrinstabilizationisdependentontherateofAP-2andPI(4,5)P2 presenceontheplasmamembrane(Mcmahon&Boucrot2011).  DynaminproteinsarelargemultidomainGTPaseswhichpinchofftheCCVsatthe plasmamembrane.Theyfunctionthroughcyclesofoligomerizationdrivenbyself-

22

assemblyandGTPhydrolysis,whichdrivesscissionbetweendynaminsGTPasedomain andits-helicalstalktocreateCCVfromCCPs(Kirchhausenetal.2014). 

3.2 Clathrin coat vesicle formation
Clathrincoatvesicleformationoccursin5mainsteps:nucleation,cargoselection, clathrincoatassembly,vesiclescission,&uncoatingandclathrincomponentrecycling (Mcmahon&Boucrot2011).  3.2.1 Nucleation Thefirststepofvesicleformationistheinvaginationoftheplasmamembrane.This iscalledthenucleationmoduleanddefineswhereontheplasmamembraneclathrincoat formationwilloccur.TheproteinsinvolvedinthenucleationmoduleareAP-2,PI(4,5)P2 andclathrin(Cocuccietal.2012).NearlyconcomitantlywithCCPinitiation,specific proteinssuchasFCHdomainonly(FCHo)proteins,EGFRpathwaysubstrate15(EPS15), andintersectinsarerecruitedandfacilitateassemblyattheearlystagesofCCPs(Cocucciet al.2012).IncellsinwhichEPS15andintersectinsareperturbed,theassemblyofCCPsis dramaticallyimpaired.ConsistentwitharoleforFCHoinearlystagesofCCPassembly (priortoCCPinvagination),theF-BARdomainofFCHobindstolowcurvatureareason membranesandinducesmembranecurvature.Thissuggeststhatmembranecurvature occursattheearlieststagesofCCPformation(Mcmahon&Boucrot2011).  3.2.2 Cargo selection ThenucleationmoduleproteinsdescribedabovearethoughttorecruitAP-2,

23

alongsideotheradaptorproteins,tobegincargoselection.AP180amino-terminal homology(ANTH)isamembranebindingproteinandepsinN-terminalhomology(ENTH) isamembranebendingprotein,bothofwhichareoftenfoundalongsideAP-2duringthis step(Fordetal.2001;Fordetal.2002).ANTHandENTHarethoughttobeinvolvedin cargoselectionaswell(Dittman&Kaplan2006;Chidambarametal.2008).FCHoproteins alsocontainligandbindingdomainswhichsuggeststhatcargoselectionmightoccurinthe nucleationstageaswell.IfAP-2recruitmentisdisrupted,clathrindoesnotbindtheplasma membrane­thishighlightstheimportanceofAP-2inCME(Mcmahon&Boucrot2011).  3.3.3 Clathrin coat assembly Clathrintriskeliaarerecruitedfromthecytosoltotheplasmamembraneatsitesofadaptor proteinenrichmenttobegincoatassembly.Clathrinassemblystabilizesmembrane curvatureandrelocatesmembranebendingadaptorproteinstotheedgeofthevesicle, wheretheycanworkmoreefficiently(Mcmahon&Boucrot2011).Theclathrinlattice formsascaffoldtowhichmanyproteinsarerecruitedviabindingtheN-terminalproteinproteininteractionplatformformedbya7-bladedbeta-propellerdomain(terHaaretal. 2000;terHaaretal.1998).Manyofthe~50cytosolicproteinsrecruitedtoCCPsareasa resultofbindingtotheN-terminaldomain.  3.3.4 Vesicle scission DynaminisrecruitedbyproteinscontainingBARdomains(Mim&Unger2012)­ theseproteinshavepreferencetolocalizeatcurvedmembranelocation,andlikelyassistin creationofthevesicleneck.Endophillin,amphiphysinandsortingnexin9(SNX9)are

24

examplesofBARcontainingproteins­theseproteinsallhaveSrchomology3(SH3) domains,whichbindthepro-richsitesofdynamin.GTPhydrolysisdependent conformationalchangeofdynaminallowsformembranescission(Mcmahon&Boucrot 2011).  3.2.5 Uncoating and clathrin component recycling Followingscissionfromtheplasmamembrane,ATPaseheatshockcognate90 (HSC70)andauxilindissembleclathrinfromitslatticestructuretoitstriskelia,allowing thevesicletotraveltoandsubsequentlyfusewithitstargetendosome.Hydrolysisof PI(4,5)P2tophosphatidylinositol-(4)-bisphosphate(PI4P),whichisinitiatedbythe phosphatasesynaptojanin,isrequiredforuncoatingaswell(Cremonaetal.1999).Auxilin bindstheterminaldomainsofclathrintriskeliaduringthecoatassemblyandbudding stage,anditthenrecruitsHSC70toaspecificmotifbelowtheclathrinhub(Rapoportetal. 2008;Xingetal.2010).Thatiswhereuncoatingisinitiated.Onceuncoated,theclathrin moleculesarereleasedbackintothecytoplasm,wheretheycanparticipateinadditional roundsofvesicleformation. 

3.3 Small GTPases: Rab & Arf
SmallGTPasesaresignallingmoleculesthatareoverseemembraneprotein trafficking.ThesemoleculesareabletoswitchbetweenanactiveGTP-loadedform,andan inactiveGDP-loadedform.Guanine-exchancefactors(GEFs)andGTPase-activating proteins(GAPs)controltheloadingofGTPandGDPtoregulatesmallGTPaseactivation. SpontaneousreleaseofGDPisveryslowandthereforeGEFsmustcatalyzetheremoval

25

GDPfortheadditionofGTPtoactivesmallGTPases(Behnia&Munro2005).  3.1.1 ADP-ribosylation factor proteins (Arfs) Arfsareagroupof6smallGTPbindingproteins20kDainsizeresponsiblefor intracellulartransport.TheArfproteinofinteresthereisArf6,theleastconservedofthe6 (Chavrier&Goud1999).Itmediatestransportfromtheplasmamembraneandalsohelps regulatetheactincytoskeleton(Chavrier&Goud1999).  ArfscontainanN-terminalamphipathichelixwhichisboundtoamyristoylgroup. InitsGDPform,thehydrophobicresiduesoftheamphipathichelixareburiedinsidea hydrophobicpocketontheGTPase(Antonnyetal.1997).Themyristoylgroupmediates rapidandreversibleassociationwithmembranes;associationwithmembranesallowGEFs toactontheArftoactivateit.GTPbindinginducesaconformationalchangeinregionson Arfs(andsmallGTPasesingeneral)termedswitch1andswitch2(Behnia&Munro2005). InArfshowever,thereisalsoan"interswitch"region(Pasqualatoetal.2002).OnceaGEF removesGDPinplaceforGTP,itinducesaconformationalchangenotonlyinswitch1and switch2regions,butalsotheinterswitchregion(Pasqualatoetal.2002).Aconformational changeintheinterswitchregiondisplacestheN-terminalamphipathichelixfromits hydrophobiccompartmentinthecoreoftheArfGTPase,andallowsfortheArftoassociate withthemembraneviathehydrophobicresiduesandthemyristoylgroup(Behnia& Munro2005).Thisinterswitchmechanismallowsforcouplingofmembranerecruitmentto GTPbinding.Now,themembrane-associated,GTP-boundArfisreadytorecruitits effectors.

26

3.3.2 Rab GTPases RabGTPasesfunctioninthemovementofperipheralmembraneproteinsto organelles,overseeingthetimingandlocationoftheirrecruitment.Thereare approximately60differenthumanRabproteins,andeachexhibitsspecificenrichment withinspecificmembranecompartments,functioningtocontrolspecificmembranetraffic events(Kannoetal.2010).ToensureRabsarepresentatthecorrectmembranes,theyare modifiedbytwoprenylgroupsontheirC-terminals.Aprenylgroupisalipidanchorwhich allowsassociationwithmembranes,howeverthisisnotenoughforspecificityto subcellularcompartments,asmanyRabssharethesamelipidgroups.Evidencepoints towardsGEFsandGAPsprovidingcorrectlocalizationandspecificitytomembranesfor Rabs(Blümeretal.2013).AnexampleofthisistheRabGEFRabex-5whichspecifically targetsandlocalizesRab5atoendomembranes(Blümeretal.2013).Inthecytosol,Rabs bindtoGDP-dissociationinhibitors(GDIs),whichmasktheprenylgroups,tolimitrandom associationswiththeplasmamembrane.GDIdisplacementfactors(GDFs)whicharefound embeddedinmembranes,catalysetheremovalofGDIsallowingtheprenylgroupstobind withthemembrane.WiththeRabrecruitedtothemembrane,GEFsremovetheGDPfor GTPwhichactivatestheproteinandcausesaconformationalchangeinswitch1andswitch 2regionsthatallowsittobindeffectors(Behnia&Munro2005).    

27

Fig 3. Membrane Trafic of integrins by Arfs and Rabs 1 integrins recycling occurs through Rab & Arf proteins. (1) Rab 5 and rab 21 are responsible for initial internalization, which locates them to the APPL early endosome or the EEA 1 early endosome. (2) RASA1 (p120RasGAP) competes for rab21 for the same site and quickly recycles integrin back to the membrane if it binds. (3) Rab25 sorts integrins via activation states ­ inactive integrins are quickly recycling back to the membrane. (4) Rab4 is also involved in quick integrin recycling, while rab11 is involved in slower recycling. (5) Arf6 activity on integrin depends on the GAPs bound to them: ARAP2 recycles integrins to EEA1 from APPL early endosomes, while ACAP1 recycles integrins from rab11 endosomes.
Active integrin Heterodimer Inactive integrin Heterodimer

Rab21

or

Rab5

1

3
Rab25

4
Rab4

Arf6
ARAP2

APPL Early Endosome

5
Rab11

2
RASA1
EEA1 Early Endosome

Arf6
ACAP1

Rab21

Recycling Endosome

28

3.4 Routes of internalization and recycling using Arf and Rab GTPases
ManydifferentreceptorsuseArfsandRabstomediatetheirendocytosisand recyclingfromtheplasmamembrane.Transferrinreceptor(TfR),aconstitutively internalizingandrecyclingintegralmembraneproteinthatfunctionsinthecellularuptake ofiron,usesbothArf6andRabproteinsinitsrecyclingmechanisms(Grant&Donaldson 2009).Epidermalgrowthfactor(EGF)receptor(EGFR),animportantreceptortyrosine kinasethatinternalizesuponbindingitshormoneligand(EGF),canundergoendocytic traffickingleadingtorecyclingbacktotheplasmamembrane,aphenomenonrequiringRab proteins,primarilyRab5and11(Ceresa2006).Aswillbediscussedindetailbelow, integrinreceptorsundergointernalizationandmembranetrafficleadingtorecyclingwhich involvesbothArf6andmanydifferentRabproteins.Hence,thedistinctmembranetrafficof variousintegralmembraneproteinssuchasTfR,EGFRandintegrinsiscontrolledbysome commonRabsandArfproteins,aswellasuniqueGTPases;thelatterprovidenodes controllingmembranetrafficthatallowuniqueanddistinctregulationofasubsetof membraneproteincargobyspecificstimuliandconditions,suchasthoseelicitedduring metabolicstress.

4 Integrins
Integrinsareafamilyoftransmembranecellsurfaceproteinsthatmediate attachmenttotheECM(DeFranceschietal.2015).Integrinsarecriticalregulatorsofcell migration,anddynamicmembranetraffic(endocytosisandrecycling)ofintegrinsis requiredforthemovementofcelladhesionstotheextracellularmatrixandassemblyofthe actincytoskeletonduringcellmigration.

29

4.1 Structure and Function
Integrinsarepresentonthecellsurfaceasheterodimersconsistingofaanda subunit(Caswelletal.2009).Inmammals,thereexist19-integrinsand8-integrin subunits,comprisingatotalof25heterodimers(Caswelletal.2009).Originallythought toonlylinktheECMtotheactincytoskeleton,integrinsarepartofavarietyofintracellular signallingpathways,includingoutside-insignallingthatcontrolactivationofactin nucleation,polymerizationandcross-linkingproteins,aswellaspro-survivaland mitogenicsignaling(Caswelletal.2009);thesesignalscanhavecancerousconsequencesif theirappropriateregulationislost(DeFranceschietal.2015).Integrinscanexistonthe cellsurfaceinoneofthreeconformations:inactiveandbentwithlowaffinityforECM ligands,extendedandprimedwithaclosedhead-pieceandthereforelowaffinityforits ligand,orextendedwithanopenhead-piecewithhighaffinityforECMligands.Theinactive integrinconformationisstabilizedbyasaltbridgebetweentheinthecytoplasmictail regionsandhelixpackinginthetransmembranedomain(Partridgeetal.2005).Integrin activationcanoccurthroughtwomechanisms:inside-outsignaling,wherebindingof proteinstothecytoplasmictailsinducesconformationalchangesintheintegrin heterodimer,oroutside-insignaling,wherebindingontheextracellularportioninduces activation(Partridgeetal.2005).Inbothcases,talinbinding1integrinisacommonfinal stepofactivation.Talinaproteinthatlinksthecytoskeletontothecellmembrane,(Shattil etal.2010). 

4.2 Integrin Trafficking
TheRabandArffamilyhaveadirectroleinintegrinmembranetrafficregulation.

30

Rab21directlyinteractswith-tailsoftheintegrinheterodimer,viatheWKLGFFKR sequencethatiscommontomany-subunit(Pellinen2006;Hynes2002).The 1integrin heterodimerpairisinternalizedviaclathrinanddynamintoRab5orRab21-positiveEEA1containingearlyendosomes(Maietal.2011).IntheEEA1endosome,p120RasGAP competeswithRab21forthesamecytoplasmicbindingsite(DeFranceschietal.2015). ThedisplacementofRab21byp120RasGAPresultsintheshuttlingof1integrin heterodimersbacktotheplasmamembrane(Maietal.2011).Rab25caninteractwith 51integrinsthroughthe1cytoplasmicdomainonendosomes,andsortthembasedon theiractivationstate(DeFranceschietal.2015).Rab25isalsoabletoshuttleactive51 tothelysosome,whereinsteadofdegradation,theyaretransportedtotheplasma membraneattherearofcancercells,inachlorideintracellularchannelprotein3(CLIC3)dependentmanner(Dozynkiewiczetal.2012).Asofyet,theparticularGEFs&GAPs involvedinRab21andRab25regulationarenotyetcertain.  TheothermajorfamilyinvolvedinintegrintraffickingistheArffamily.Arf6are involvedinclathrindependent&independentintegrinendocytosis(Sakuraietal.2011; Yueetal.2014),andshuttlingintegrinstotheplasmamembraneaspartofcellmigration regulation(Arjonenetal.2012).Arf6hasalsobeenshowntolocalizetoCCPsandArfGAPs andArfs(includingpossiblyArf6)havebeenshowntoenhancemembranebindingofAP-2 andpromoteformationofCCPs(Hymanetal.2006;Baietal.2011).Arf6isabletobind GAPs,whichfurtherregulateArf6activity.Forinstance,theArf6GAPsARAP2&ACAP1 bothlocalizetoArf6-positiveendosomalcompartmentstoperformcontrastingfunctions. ARAP2allowsforintegrinreceptorstomovefromearlyAPPLendosomestoEEA1-

31

containingearlyendosomes,whichshuttlesthemtowardsrecyclingordegradation(Daiet al.2004).APPLendosomesareRab5-positive,earlyendosomeswhichcontaineitheroneor bothAPPL1andAPPL2(Erdmannetal.2007;Miaczynskaetal.2004;Zoncuetal.2009). APPLendosomesexhibitsome,albeitlimitedcolocalizationwithEEA1-endosomes,andas suchareconsideredadistinctpopulationofearlyendosomes(Urbanskaetal.2011).In contrast,ACAP1isinvolvedinrapid1integrinrecyclingfromRab11-containing endosomes(Daietal.2004).Interestingly,Arf5hasalsobeenimplicatedin1-integrin trafficking.BRAG2,aGEF,recruitstoCCPsviadirectinteractionwithclathrinandAP-2,and interactswithPI(4,5)P2(Sakuraietal.2011).BRAG2thenactivatesArf5attheplasma membranetointernalize51toearlyendosomes. 

4.3 Cell Migration
Cellmigrationisaprocessthatbeginswithdynamicpolarizationandformationof thelamellipodia­protrusionsattheleadingedgeofthecellsurface.Here,Rac1­asmall GTPase­activationisneededfortheformationofthelamellipodiumwhichleadstocell migration(Ballestremetal.2000).Rac1isanupstreamregulatorofactindynamics& organization,andonceitisactivatedbyGEFs,itrecruitsacomplexwhichactivatesthe actin-relatedprotein2/3(Arp2/3)complex(Koronakisetal.2011).Arp2/3functionsas anactinnucleatorandtoorganizetheactinfilamentinvolvedinlamellipodiaformation (Yanetal.2015).  Duringcellmigration,regulatedintegrintraffickingandactinpolymerizationdrives theformationofprotrusionsoffilopodiaandlamellipodiaattheleadingedgeofacell.Actin

32

Integrin heterodimer
Nucleus PNRC

2
Early endosome

1

Extracellular Matrix

Fig 4. Cell migration requires integrin traficking Coordinated integrin membrane trafic is required for cell migration. Integrins are continuously recycled from the cell surface, to internal compartments and back to the plasma membrane for cell migration. Integrins trafics through two main pathways: (1) the short-loop pathway and 2) the long loop pathway. (1) In the short-loop pathway, recycling is dependent on Rab4 and promotes, like its name suggests, rapid integrin recycling back to the membrane. The short-loop pathway converges at the early endosome, and also recycles inactive 1-integrin heterodimers. (2) The long-loop pathway locates integrsin to the perinuclear recycling comparment (PNRC), and is Rab11 dependent. It is a longer recyling pathway for integrins, and is the pathway active 1-integrin heterodimers take. This recycling ensures a fresh pool of integrins are available at the cell surface to engage the matrix and create new adhesions for traction in cell migration.

33

assemblyattheplasmamembraneallowsfortractionrequiredformigratingcells,asthe actinfiberslinkthecytoskeletonofthecelltotheECMproteinssuchasfibronectinvia integrinheterodimers.Ligandbindingonintegrinsactivatesthem,thatwhichinduces clusteringtoallowforintracellularlinkageproteinstobindtothecytoplasmictail.The proteinswhichmediatelinkageofintegrinstotheactincytoskeletonaretalin,vinculin,and -actinin(Huttenlocher&Horwitz2011).Variouscombinationofbindingoftheseproteins tothecytoplasmictailsofintegrins,andalsolinkageofintegrinstotheECMmediates formationoffocaladhesions.Focaladhesionsareclustersofintegrinsfoundatcentraland peripheryregionsofthecell,andareimportantinprovidingtractionforcesrequiredfor migration(Huttenlocher&Horwitz2011).Focaladhesionsalsoserveassignalingcentres thatpromotecellmigration.TheseinvolveRhoGTPases,whichusethefocaladhesionsasa dockingpointtoregulateactinpolymerizationandcelladhesion(Abram&Lowell2009; Huveneers&Danen2009).Celladhesionviaintegrinsitselfservesasasignalformigration aswell,inaformofoutside-insignaling.Here,proteinkinaseA(PKA)activationbyintegrin adhesionisanearlysignalindirectedcellmigration(Limetal.2008).51integrinsare particularlypertinentincellmigration,astheyarefoundinmanycellstypes,butalsoserve asthereceptorfortheECMproteinfibronectinwhichaidsintraction(Caswell&Norman 2008;Jonesetal.2006;Pellinen&Ivaska2006).  Cellmigrationrequiresthecoordinatedreleaseofadhesionfromtheposteriorof themigratingcell.Thereleaseofintegrinsispartlyduetocontractileforces,whichsevers theconnectionofintegrinswiththeactincytoskeleton,leavingtheintegrinboundtothe substratumasintegrinfootprints(Regen&Horwitz1992;Smilenovetal.1999).Theother

34

aspectinvolvescoordinatedintegrinendocytosisattherearofthecell,howeverthisdoes notoccurinallcelltypes(Caswelletal.2009).Somesignalingimplicatedincellretraction atthetrailingedgeandcelladhesiondetachmentistheRho/ROCKsignalingpathway (Webbetal.2004). 

5 Control of cell migration during metabolic stress
AMPKactivationhasbeenshowntohavealleviatingrolesinavarietyofdiseases, includingatherosclerosis,tumourinvasionandmetastasis(Steinberg&Kemp2009).Inall ofthesediseases,dysregulatedcellmigrationisneededfortheirdevelopmentand progression.ThepreventionofthesediseasesbyAMPKactivationmayoccurduetothecell migrationinhibitionuponAMPKactivation. Giventhatcellmigrationinvolvesmassive levelsofATPconsumption,duetoactindynamicsandmembranetraffic,the downregulationofthisprocessunderconditionsofmetabolicstressisconsistentwiththe otherdescribedrolesofAMPKtoallowcellstomaintainhomeostasisandensuresurvival underconditionsoflimitedenergyavailability.Hence,AMPKmightbeexpectedtocontrol cellmigration,anditispossiblethatthisoccursbyseveralparallelmolecularmechanisms.  ThereareseveralpossiblemechanismsbywhichAMPKmayregulatecellmigration, whichtodatehavelargelyfocusedonthecontroloftheactinandmicrotubulecytoskeleton involvedincellmigrationbyAMPK.OneoftheseinvolvesaroleofAMPKtoinhibitcell migrationthroughPDZandLIMdomain5(Pdlim5)(Yanetal.2015).AMPKactivation phosphorylatesPdlim5whichassociateswithRhoGEF6(Arhgef6)todisplaceitfromthe leadingedgeofthemigratingcell.DisplacingArhgef6interruptsRac1activity,whichcanno

35

longerrecruitArp2/3tothelamellipodium.Thisleadstodisruptionoftheactinnetwork andultimatelyinhibitscellmigration(Yanetal.2015).  Furthermore,AMPKphosphorylatesCLIP-170tocontrolthespeedofmicrotubule polymerizationanddirectionalcellmigration(Nakanoetal.2010).CLIP-170isa microtubuleplusendproteinthatlinksendocyticvesiclestomicrotubules.Itbindsto newlypolymerizeddistalendsofgrowingmicrotubules,whiledissociatingfromolder microtubules.InhibitionofAMPKresultsinslowertubulinpolymerizationandprolonged CLIP-170associationatoldermicrotubuletips.AMPKinhibitionalsodestabilizes microtubulesandperturbsdirectionalcellmigration(Nakanoetal.2010).  ItisclearthatbothactivationandinhibitionofAMPKhasthepropensitytoperturb cellmigration,andAMPKregulationofcellmigrationisnotanon-offswitch,butlikelya veryspecificandpreciseregulation.MassivelyactivatingAMPKwithpharmacological activatorssuchas5-Aminoimidazole-4-carboxamideribonucleotide(AICAR)andA-769662 orinhibitingwithCompoundCbothyieldperturbedandinhibitedcellmigration(Nakano etal.2010;Rossetal.2015). 

5.1 AMPK & control of 1-integrin
 Asdescribedabove,AMPKisanemergingregulatorofthemembranetrafficofa

numberofproteinsincludingGLUTs,Na+/K+-ATPase,andothers,suggestingthatAMPK mayhavepreviouslyunappreciated,broaderrolesinregulatingthecellsurfacemembrane trafficofanumberofadditionalproteins.TodeterminehowAMPKmaybroadlycontrolthe

36

cellsurfaceproteome,theAntonesculabpreviouslyusedastreptavidin/biotinylation approachtoselectivelylabelproteinsonthecellsurface(Rossetal.2015).Whencoupled withtreatmentofcellswiththeAMPKactivatorA-769662andmassspectrometry,this approachallowedtheidentificationofproteinsthatexhibitedalteredcellsurface abundanceinAMPK-activatedcells.ThisworkrevealedthatAMPKactivationresultedin alterationofcellsurfaceabundanceofmanyproteins.Geneontologyanalysisrevealedthat regulatorsofcelladhesionandmigrationaredepletedfromthecellsurfaceuponactivation ofAMPK,including1-integrin,4integrin,11-integrin,FATtumoursuppressorhomolog 4(FAT4)andprotocadherin-7(Rossetal.2015).Usingseveraladditionalmethods,AMPK indeedreducedthelevelofcellsurface1-integrin,butdidnotchangethetotallevelsof 1-integrin(Rossetal.2015).Assuch,thispreviousworkidentified1-integrinasa proteinthatundergoesalterationinmembranetrafficupontreatmentwiththeAMPK activatorA-769662,resultinginreducedcellsurfacelevelsof1-integrin(Rossetal.2015). As1-integrindoesnotcontainaconsensusAMPKphosprylationsite,directinteraction withAMPKtomediatethisregulationisnotlikely.  However,itisimportanttoconsiderthepossibilityofofftargeteffectsofmost drugs,ofwhichAMPKactivatorsarenoexception(Vincentetal.2014).AMPKactivators suchasAICAR,2-deoxy-D-glucose,salicylate,metforminandphenformindisplayAMPKindependenteffectsoncellproliferationandmetabolismwithonlyA-769662exerting AMPK-dependenteffects(Vincentetal.2014).Thus,itiswithcarethatresultsshouldbe interpreted,whenonlypharmacologicalactivatorsareused.Basedontheprevious findings,itispossiblethatAMPKhasaroleinregulating1-integrinmembranetrafficasa

37

paradigmtoregulatemigration.However,itisnotknownwhetherAMPKisinvolved directlyandwhatthemechanismbywhichAMPKmayregulateintegrinmembranetraffic. ObtainingabetterunderstandingofwhetherandhowAMPKcontrols1-integrin membranetrafficiscriticalinordertounderstandhowcellmetabolismandmetabolic stresssignalsbroadlycontrolendomembranetrafficandcellmigration.                  

38

Rationale & Hypothesis
Previousfindingsinourlabhasusedasystematicapproachtodemonstrate coordinatedremodelingofthecellsurfaceuponinresponsetocellstress.Thisis highlightedinRossetal.(2015),whereproteinsdepletedfromthecellsurfaceuponAMPK activationwereidentified.1-integrinwasofparticularinterestduetoitsmanyintegrin bindingpartners(themostamong-integrins),aswellastheroleofintegrinsinmany physiologicalprocesses,includingangiogenesisandmetastasis(Desgrosellier&Cheresh 2010;DeFranceschietal.2015;Caswell&Norman2006).1-integrinwasshowntobe reducedfromthecellsurfaceupontreatmentwiththeAMPKactivatorA-769662(Rosset al.2015).Importantly,thiseffectofA-769662treatmentwaspartlyspecificforfor1integrin,asthisdrughadnoeffectoncellsurfacetransferrinreceptorlevels,However, whetherA-769662controls1-integrinasaresultofactivationofAMPKorasa consequenceofanoff-targeteffectofthepharmacologicalactivatorsofAMPK,AICARand A-769662remainstobedetermined.Further,elucidatingthemechanismbehindthe interactionof1-integrinandAMPKwillleadtogreaterunderstandingofanewpathway, butalsoimprovedpotentialtherapeuticsforcancerandmetastasis.  ItisnotknownhowAMPKregulates1-integrinonthecellsurface.Ihypothesize thatAMPKeffectsatleastonecomponentof1-integrinendocytosisandrecycling,tocause amassivereductionof1-integrinonthecellsurface.UsingsilencingRNA(siRNA)against AMPK,IdeterminedthattheeffectofA-769662oncellsurface1-integrinwasAMPK specificandnotanofftargetconsequence.Iexaminedthemechanismof1-integrincell

39

surfacereduction,determiningwhetherAMPKactstoreducetherecyclingorendocytosis of1-integrin,thusrevealingthemechanismbywhichAMPKcontrolscellsurface1integrtinlevels.AMPKmayalsocontrolspecificaspectsofCME.Further,Ifoundevidence suggestingthatAMPKmayregulateArf6tocontrolmembranetraffic.Arf6GAPs,suchas ArfGAP3,werefoundtobereducedfromthecellsurfaceuponAMPKactivation(Rossetal. 2015).AnalysisofArfGAP3revealedthatitcontainsaconsensusAMPKphosphorylation site(Table1).AMPKactivationalsoinducesrelocalizationofArf6fromtheplasma membranetocytoplasmiccompartmentsinaArf6GTPase-dependentmanner.Therefore, AMPKregulates1-integrininresponsetometabolicstress,potentiallybyactingonArf6 oritseffectors.             

40

Materials & Methods
A-769662andQS11wasobtainedfromAbcam(Cambridge,MA),AICARwas obtainedfromCellSignalingTechnology(Danvers,MA),Antibodiesforimmunoblotting were:anti-pACC,anti-AMPK(1/2),anti-actinandfromCellSignalingTechnology (Danvers,MA),andanti-1-integrin(Calbiochem,Billerica,MA).Antibodiesusedfor immunofluorescenceassaywere:anti-1-integrinfromEMDMillipore,(Darmstadt, Germany),andanti-TfRfromSantaCruzBiotechnology(SantaCruz,CA).GFP-Arf6-WT& GFP-Arf6-Q67LweregenerouslygiftedbySergioGrinstein(TheHospitalforSickChildren, Toronto,ON). 

RPE cell culture and pharmacological treatments
Humannon-immortalizedRetinalPigmentEpithelial(ARPE-19,henceforthRPE) wereobtainedfromATCC.RPEcellsstablyexpressingclathrinlightchainfusedto enhancedRFP(RPE-RFP-CLC,henceforthRPE-RFP)werepreviouslygenerated(Aguet, Antonescu,Mettlen,Schmid&Danuser,2013).AllRPEcellsweremaintainedinT75flasks inDMEMF12supplementedwith10%fetalbovineserum(FBS)and5% streptomycin/penicillininahumidifiedincubatorat37°Cand5%CO2.Forexperiments requiringAMPKactivation,RPEcellswerewashedwithPBSandincubatedinlowserum media(0.1%FBSinDMEMF12)for1hour,afterwhichtheyweretreatedwith100MA769662or2mMAICARasindicated(whileremaininginthe0.1%FBSDMEMF12media) toactivateAMPK.Aftertreatmentfor15,30,60minutesor24hours,cellswerewashed andharvested.ForexperimentsrequiringArfGAPinhibition,RPEcellswereincubatedin lowserummediafor30minutesandtreatedwith5µMQS11for15minutesforendocytic 41

assay,or30minutesforcellsurfaceexperiments.Insomeexperiments(Fig6),cellswere alsotreatedwith40McompoundCfor1hour. 

cDNA transfection
TransfectionofRPEcellswithGFP-Arf6-WTandGFP-Arf6-Q67LoronlyeGFP (control)wasperformedwithLipofectamine2000(ThermoFisher,Waltham,MA)asper themanufacturers'instructions.Briefly,RPEandRPE-RFPcellsweretransfectedusing1µg DNAand3µLLipofectamine2000reagentinavolumeof1mLofserum-freemedia(per wellofa12wellplate)for4hours. 

siRNA transfection
RPEcellsweretransfectedwithsiRNAusingcustom-synthesizedsiRNAsusingRNAiMAX transfectionreagent(LifeTechnologies,Carlsbad,CA),aspermanufacturer'sinstructions. Briefly,eachsiRNAwastransfectedataconcentrationof220pmol/Lwiththetransfection reagentinOpti-MEMmedia(LifeTechnologies,Carlsbad,CA)for4hours,followedby washingandreplacementwithregulargrowthmedia.siRNAtransfectionswereperformed twice(72hand48h)priortoeachexperiment.Sequencesusedwereasfollows:nontargeting(NT)control:(sense)CGUACUGCUUCGGAUACGGUU, (antisense)CCGUCUCGCAAGCAGUACGUUandAMPK1/2: (sense)GCACCUUCGGCAAAGUGAAUU,(antisense)UUCACUUUGCCGAAGGUGCUU (Dharmacon,GEHealthcare,Lafayette,CO).   42

Total and cell surface immunofluorescence assay
Toselectivelydetectcell-surfaceproteins,intactcellswerewashedwithPBS (supplementedwith1mMCaCl2andMgCl2(PBS2+))andblockedinasolutionofPBS2+with 3%bovineserumalbumin(BSA)for15minutesat4°C.Cellswerethenincubatedwith primaryantibodytoanexofacialepitoperecognizingTransferrinreceptoror1-integrin for1hourat4°C.CoverslipswerewashedinPBS2+beforefixationwith4%PFA(inPBS2+) for20minutesat4°C.AfterquenchingwithPBS2+containing100mMglycine,cellswere washedwithPBS2+andincubatedwithgoatanti-mousecy3secondaryantibodyfor1hour atroomtemperature.Afterseveralwashes,coverslipsweremountedinDakofluorescent mountingmedia(Dako,Carpinteria,CA).  Fortotalproteindetection(i.e.ofbothcellsurfaceandintracellularproteins),cells wereinitiallyfixedin4%PFAfor20minutesat4°C,followingbyquenchingwithsolution of100mMglycineand0.1%TritonX-100inPBS2+for10minutesatroomtemperature. CellswerethenwashedinPBS2+andblockedwith3%BSA(inPBS2+)for15minutesat roomtemperature,followedbyadditionofprimaryantibodyatroomtemperaturefor1 hour.CellswerewashedwithPBSfollowedbyadditionofgoatanti-mousecy3secondary antibodyfor1hour.Afterseveralwashes,coverslipsweremountedinDakofluorescent mountingmedia(Dako,Carpinteria,CA).  

43

Endocytosis assay
Cellswereincubatedwithlowserumconditions(0.1%DMEMF12)for1hourat 37°C.Followingthat,theintactcellswereblockedwith3%BSA,andsubsequently incubatedwithanti-1-integrinantibodyfor1hourat4°Ctolabelonlycellsurface1integrin.AfterseveralwasheswithPBS2+,cellswereincubatedat37°Cinmediawithor without100µMA-769662for15minutes.Time=0coverslipswerenotsubsequently incubatedat37°Candleftat4°Cduringthe15-minuteincubationoftheexperimental conditions.Allconditionswerethensubjectedtogoatanti-mousecy3secondaryantibody for1hour;fortheconditionsthatunderwentrewarmingafterlabelingwithprimary antibodylabeling,thisalloweddetectionofonlythoseantibody-1-integrincomplexes remainingatthecellsurface(andnotthosethatunderwentinternalization).Following washeswithPBS2+,cellswerefixedwith4%PFA(inPBS2+)andquenchedwith100mM glycinesolutioninPBS2+.AfterseveralPBS2+washes,coverslipsweremountedinDako fluorescentmountingmedia(Dako,Carpinteria,CA).  ForArfGAP1inhibitionendocyticexperiments,protocolwasasdescribedabove exceptthefollowingchanges:cellswereincubatedinlowserumconditionsfor1hourat 37°C,followedby30-minutetreatmentwith5µMQS11.Afterprimaryantibodylabelling, cellswereincubatedwith5µMQS11for15minutes. 

44

Antibody recycling assay
Cellswereincubatedfor1houratlowserumconditions.Followingthat,0.1%FBS DMEMF12mediasupplementedwithanti-1-integrinoranti-TfRantibody(1:400)and 100µMA-769662orwithout(control)wasaddedtocellsfor15,30and60minutesat37°C toallowforreceptorrecycling.Afterincubationforindicatedtimes,cellswereplacedat 4°Candfixedwith4%PFAandquenchedwith100mMglycine+0.1%TritonX-100 solutioninPBS2+.AfterwashingwithPBS2+,cellswerelabelledwithgoatanti-mousecy3 secondaryantibodyfor1hour.AfterseveralwasheswithPBS2+,coverslipsweremounted inDakofluorescentmountingmedia(Dako,Carpinteria,CA).1-integrinandTfRtotal proteinlabellingwasperformedasdescribedabove.Eachtimedrecyclingconditionwas dividedbytotalreceptortomeasurerecyclingrate(timedconditionfluorescence/total fluorescence). 

Widefield epifluorescence imaging
ImmunofluorescencemicroscopypresentedinFigures5B,7and8wasperformed usinga63x(NA1.49)oilobjectiveonaLeicaDM5000Bepifluorescencemicroscopeusing aDFC350FXcamera(LeicaMicrosystems,Wetzlar,Germany).Imageswereacquiredusing AdobePhotoshop(SanJose,CA)andallexposuretimesandimagescalingwereequal withinanexperiment.Wide-fieldepifluorescencemicroscopyexperimentspresentedin Figures10,11,12,14and15wereobtainedusinga60×(NA1.4)oilimmersionobjective onaZeissAxiovert200MepifluorescencemicroscopeusinganORCA-Flash4.0camera (HamamatsuCorporation,Bridgewater,NJ).  45

Cell surface and total staining abundance quantification
Surfaceandtotal1-integrinorTfRineachcellwasquantifiedusingImageJ software(NationalInstitutesofHealth,Bethesda,MD).Meanpixelintensityoffluorescence wasmeasuredforregionsofinterestcorrespondingtocellcontour(wholecell)via manuallydelineationinImageJ(Fig7,redtraces).Averagebackgroundfluorescencewas determinedbymeasuringpixelintensityofaregionofinterestoutsideofthecellareaand subtractedfromthemeanpixelintensityofaregionofinterestasindicatedinFig7(yellow traces).Similarmeasurementswereperformedoncellssubjectedtoasimilar immunofluorescencemethodbutwithoutincubationwithspecificprimaryantibodies.Cell surfacesecondaryantibodylabelingincellsnotincubatedwithprimaryantibodywas ~10%ofthatofcontrolcellsincubatedwitheitheranti-1-integrinor-TfRantibodies;the meanno-primaryfluorescenceintensityvaluewassubtractedfromallconditionsineach experiment.  Imageswere16-bitandtypicalintensityrangeswerebetween10­30000units ensuringpixelintensitysaturationdidnotoccur.Measurementsof1-integrincellsurface abundanceundereachsetofconditionsweresubjecttoone-wayanalysisofvariance (ANOVA)withNewman-Keulspost-test,withp<0.05asathresholdforsignificant differenceamongconditions.Measurementsof1-integrincellsurfaceundertwo conditions(Control,A-769662orControl,QS11)andTfRcellsurfaceabundanceundertwo conditions(Control,A-769662)weresubjecttoaStudent'st-test,withap<0.05asa thresholdforsignificantdifferenceamongconditions. 

46

Cell Migration Assay
RPEcellsgrowntoconfluenceina35mmdishwithagrid(SarstedtCanada, Montreal,QC)forcellmigrationexperiments.Plateswithconfluentcellswerewoundedby asinglepassageofap10micropipettetip.Cellswerethenimmediatelywashedandplaced inmediacontaining0.1%FBS(tominimizecellproliferation),andtreatedwith100MA769662ornot(control).Imageswereacquiredat0and24hoursfollowingwounding. ImagesofcellswereacquiredusingaLeicaDMILmicroscopeequippedwithaSkylight cameraphonemicroscopemount,usingaSamsungGalaxyS4smartphonedigitalcamera. Imagesweremanuallyalignedusingdishgrid.Cellmigrationwasquantifiedbymeasuring theareaofthewoundcoveredbycellsafter24h(usingmanualdelineationofcellcoverage areausingImageJ),andexpressedasapercentoftheinitialwoundarea.Atleast20 individualwoundedareaswereexaminedforeachconditionineachexperiment. 

Cell viability assay
Cellviabilitydeterminationbypropidiumiodidestainingintheabsenceof detergentpermeabilization.FollowingcellularwithA-769662for24hours,intactRPEcells wereincubatedwith500nMpropidiumiodidefor15minat4°C,followedbywashing, fixationandmountinginDakofluorescentmountingmediaasdescribedabove.Asa positivecontrolforpropidiumiodidestaining,anadditional,parallelexperimentwas performedbyfirstsubjectingcellstofixation(4%PFAfor30min)andpermeabilization (0.1%TX-100for20min)priortolabelingwith500nMpropidiumiodide. 

47

Immunoblotting
Whole-celllysateswerepreparedinLaemmliSampleBuffer(LSB,0.5MTrispH6.8, Glycerol,10%SDS,10%-mercaptoethanol,and5%bromophenolblue,allfromBioShop, Burlington,ON)supplementedwithaproteaseandphosphatasecocktail(1mMsodium orthovanadate,10nMokadaicacid,and20nMProteaseinhibitorcocktail(BioShop, Burlington,ON).Lysateswerethenheatedat65Cfor15minandpassedthrougha27.5 gagesyringe.  Lysatesfromwhole-cellextractswereprobedbyWesternblotting.Sampleswere subjectedtoglycine-TrisSDS-PAGEtoresolveproteinsandfollowedbytransferto polyvinylidenefluoridemembrane(Bio-Rad,Burlington,ON).Themembraneswere blockedinasolutionofTBS-Tcontaining4%BSAor3%milkfor30minutesatroom temperaturewithprimaryantibodyfor1hour.Appropriatesecondaryantibodieswere usedtoprobetheprimaryantibodies.Themeasurementsofanti-1-integrinwere normalizedtotheloadingcontrolsignal(actin).QuantificationofAMPK1/2 knockdownsviaimmunoblottingwasperformedbynormalizinganti-AMPKsignaltothe loadingcontrol(actin),followedbycomparisontocontrol(NT)siRNAanti-AMPKsignal. 

TIRF microscopy and spinning disk confocal microscopy imaging
Fixedcellson22mmby22mmcoverslipsweremountedontwodouble-stripsof double-sidedtapeonaglassslidewithPBSsupplementedandsealedwithVALAP (Antonescuetal.,2011)forTIRFmicroscopy(TIRFM).TIRFMexperimentspresented inFig16and17werevisualizedusinga150×(NA1.45)objectiveonanOlympusIX81 48

instrument(Olympus,Tokyo,Japan)equippedwithCellTIRFmodules(OlympusCanada, RichmondHill,Canada)using491-(50mW)and561-nm(50mW)laserilluminationand 520/30and624/50emissionfilters.ImageswererecordedusingaC9100-13EM-CCD camera(Hamamatsu).ImageswereacquiredusingVolocity(PerkinElmer,Waltham,MA). Allexposuretimeswereconsistentwithinanexperiment.  SpinningdiskconfocalmicroscopyexperimentspresentedinFig13obtainedusing aNikonOlympusIX81equippedwithaYokogawaCSUX1scanheadanda100×(NA1.4)oil objectiveusingaHamamatsuC9100-13electron-multiplyingcharge-coupleddevice(EMCCD)camera.Excitationlightwasprovidedby488-(100mV),andemittedlightwas collectedafterpassagethrough525/50. 

TIRF microcopy and spinning disk confocal microscopy analysis
Diffractionlimitedobjectslightexhibitapoint-spreadfunction(PSF)asaresultof diffractionfromasmallpoint-emitteroflight(Aguetetal.2013).CCPsarediffraction limitedobjects.TodetectCCPs,aGaussianmodelapproachwasusedasperAguetetal. (2013)toapproximatethePSFofthediffraction-limitedCCPs.ThepositionofCCPsand intensityofRFP-CLCandofGFP-Arf6wasmeasuredateachCCP(Aguetetal.,2013).For thelatter,theamplitudeoftheGaussianmodelforeachCCP(inoneofmanyfluorescence channels)isanindicationofthefluorescenceintensityofclathrin(orotherproteins) withinCCPs,measuredrelativetoalocalbackgroundfluorescence,withouttheneedfor globalimagethresh-holding(Aguetetal.2013).Thefluorescenceintensityofaparticular proteinwithinCCPsthusreflectsthenumberofsuchmoleculeswithineachstructure.

49

MeasurementsofclathrinorotherproteinswithinindividualCCPsbythismethodwere usedtoobtainacellularaverageofrelativeproteinrecruitmenttoCCPsunderspecific conditions.   

50

Results
 UsingsiRNAgenesilencingincombinationwithtreatmentwiththeAMPKactivator

A-769662,IuncoveredthatAMPKactivationreducescellsurface1-integrin.Thiswasan importantconsideration,aspharmacologicalactivatorsofAMPKexhibitagrowinglistof off-targetandAMPKindependenteffectswhichmayresultinmisinterpretationofresults basedonlyonA-769662(Vincentetal.2014).IestablishedAMPKsilencinginRPEcells,to establishthattheregulatorycontrolof1-integrinbyAMPKisarealphenomenon.Ifound thattotalcellular1-integrinlevelsdonotchangeupontreatmentwithA-769662,showing thatAMPKdoesnotleadtodegradationofinternalized1-integrin.Tostudyphysiological consequencesofAMPKregulating1-integrin,Iestablishedascratchwoundassay, measuringcellmigration.IfoundthatAMPKactivationimpairscellmigration,consistent witharoleforAMPKincontrolling1-integrinmembranetraffic.IuncoveredthatAMPK activationresultsinalterationintherateof1-integrinrecycling,aswellasinthe propertiesofclathrin-coatedpits,showingthatAMPKmaycontrolmembranetrafficat severaldistinctstages.Lastly,IuncoveredevidencethatAMPKregulatesArf6inamanner thatrequiresArf6GTPaseactivity.    

51

Results Part I: AMPK regulates 1-integrin on the cell surface & cell migration
AMPK is required for 1-integrin cell surface reduction
InordertodetermineifAMPKisrequiredfor1-integrincellsurfacereduction elicitedbyA-76962treatment,IestablishedAMPKsilencinginRPEcells.ItransfectedRPE cellswithsiRNAtargetingAMPK1/2andnon-targeting(NT,control)siRNA.Toconfirm andmeasurethelevelofAMPK1/2knockdown,Ipreparedwhole-celllysatesand subjectedthesetoimmunoblottingwithanti-AMPK1/2&anti-actinantibodies(loading control)(Fig.5A).AMPK1/2siRNAcellsshoweda69.6±2.6%reductionintotalAMPK -subunitexpression,indicatingeffectivesilencingofAMPK.  TodeterminehowAMPKsilencingimpactsthecontrolofcellsurface1-integrin uponA-769662treatment,Ithenfluorescentlylabelledcellsurface1-integrininintact controlsiRNAcells(controlandA-769662treatedconditions)andAMPK 1/2silenced cells(controlandA-769662treatedconditions).Theantibodyrecognizesanexofacial epitopeon1-integrin,anddoesnotbinddifferentlytoactivateandinactive1-integrin, makingthisasuitablereporteroftotalcellsurface1-integrin(Jimenez-Sotoetal.2009). NTsiRNAcellsdisplayedthesamereductionofcellsurface1-integrinuponAMPK activationbyA-769662seenpreviously(Fig5B,C).However,theAMPK1/2siRNAcells nolongerdisplayedreductionincellsurface1-integrin(Fig5B,C).Boththecontroland theA-769662treatedconditionsofAMPK1/2deficientcellsshowedcomparablelevelsof 1-integrintotheNTsiRNAcondition.Theseresultsindicatethatthereductionofcell

52

surface1-integrinbyA-769662requireAMPK,suggestingthatAMPKdoesindeedcontrol 1-integrinmembranetraffic.  Todeterminewhetherthereducedlevelsof1-integrinonthecellsurfaceinAMPK activatedcellsisduetotranslocationofcellsurface1-integrintoaninternalmembrane compartmentorinsteaddueto1-integrindegradation,Ipreparedwholecelllysatesof RPEcellstreatedwithA-769662,AICAR,andCompoundC(AMPKinhibitor)for60 minutes,andsubjectedthesetoimmunoblottingwithanti-1-integrinandanti-actin antibodies(loadingcontrol).Nodifferencewasseenintotal1-integrininallthree conditionscomparedtocontrol,confirmingthatthereductionofcellsurface1-integrinis duetointernalizationintocellularcompartmentsandnotmerelyreflectingareductionin wholecell1-integrin(Fig6).  Toensurethatthedifferenceseenincellsurface1-integrinwasduetochangesin abundanceandnotchangesincellarea,ImeasuredthecellareaincontrolandA-769662 treatedcells.TherewasnoapparentdifferenceincellsizeintheA-769962treated conditioncomparedtothecontrol(Fig7),highlightingthatthechangesincellsurface1integrinwasindeedduetoadifferencein1-integrincellsurfaceabundance.   

53

A B C

Fig 5. Inhibition of AMPK by siRNA gene silencing prevents the reduction in cell surface 1-integrin elicited by A-769662 treatment. (A-C) RPE cells were transfected with siRNA targeting AMPK 1/2 or non-targeting (NT, control) siRNA. (A) Whole cell lysates were prepared and resolved by immunoblotting and probed with anti-AMPK 1/2 or anti-actin antibodies. Shown are immunoblots representative of at least 3 independent experiments. (B) Following siRNA transfection, cells were treated with 100 M A-769662 for 60 min as indicated. Intact cells were labeled with an antibody speciic for an exofacial epitope on 1-integrin. Shown are representative luorescence micrographs depicting cell surface 1-integrin luorescence. Scale = 5 m (C) Cell surface  1-integrin levels obtained by luorescence microscopy were quantiied. Shown are the cell surface 1-integrin measurements in individual cells (diamonds) as well as the median ± interquartile range of these values in each treatment condition (n = 3 independent experiments) 54

   

Fig6.ActivationorinhibitionofAMPKdoesnotleadto1-integrindegradation. RPEcellsweretreatedwithA-769662&AICARtoactivateAMPK,andCompoundCtoinhibit AMPK.Wholecelllysateswerepreparedandresolvedbyimmunoblottingandprobedwithanti1-integrinoranti-actinantibodies.Shownareimmunoblotsfortotal1-integrin.

AMPK activation by A-769662 hinders migration of RPE-WT cells
Next,Iexaminedwhethertherearecellphysiologicalconsequencesofthe regulationof1-integrinbyAMPK.Cellmigrationrequiresconstitutive,directed membranecyclingof1-integrin,fromthebackofthecelltothefront.Todetermine whetherA-769662treatmentaffectedcellmigration,Iemployedawoundscratchingassay, whichallowsmeasurementoftherateofcellmigrationtocloseagapformedinacell monolayer.RPEcellsweregrowntoconfluenceon35mmplateswithagridandwounded withasinglepassofp10pipettetip.ThecellsweresubjectedtoA-769662ortheuntreated condition.Cellmigrationwasquantifiedbypercentofwoundareacoveredin24hours(Fig 8A).Cellsinthecontrolconditioncovered80%ofthewoundafter24hours,whereasA769662treatedcellsonlycovered17%ofthewoundafterthesameamountoftime(Fig 8B). 

55

A

Cell surface 1-integrin Raw image Manual cell delineation 1 2 3

B
Cell Area (pixels x 105)

n.s.
30 25 20 15 10 5 0
control A-769662

Fig 7. A-769662 treatment does not affect cell area Manual cell delineation is shown in (A), which involves subtracting the cell luorescence intensity (1) by the background luorescence intensity (3) Scale = 5 m (B) The area of cells quantiied for cell surface 1-integrin experiments is shown. In both control and A-769662, there is no difference in cell size which shows that the decrease 1 integrin on the cell surface is not due to a change in cell size, but due to abundance.

56

A
Control

0H

24H

B

A-769662

Fig 8. Treatment with A-769662 reduces cell migration RPE cells were subjected to an epithelial wounding cell migration assay, either under conditions of continuous stimulation with 100 M A-769662 or unstimulated (control) (A) Shown are representative micrographs of cells immediately after wounding (0 h) or 24 h after wounding, as indicated, with the region of the wound indicated by dashed white lines. (B) The coverage of the wounded area by cells 24 hours after wounding was quantiied; shown are the means ± SE of the percent of wounded area covered by migrating cells in 24h in control and A-769662 treated cells (n = 3, p < 0.05).

Ctrl A-769662
57

Long term AMPK activation by A-769662 does not affect cell viability
ToensurethatthereductionofcellmigrationincellstreatedwithA-769662for24 hourswasaconsequenceofsignalsactivatedasaresultofAMPKactivation,andnotthe resultofdecreasedcellviability,Iperformedaviabilityassaywithpropidiumiodide(PI) staining.PIfluorescentlylabelsfornucleicacidsindeadcells,butisunabletodosoin livingcellswithanintactplasmamembrane,assuch,livingcellsareimpermeabletoPI (Yehetal.1981).IgrewRPEcellstoconfluenceinandsubjectedthemtothesame conditionsusedforthecellmigrationassay:untreated(control)andA-769662treatment for24hours.ToobtainapositivecontrolforPIstaining,Iexaminedaseparateconditionin whichIpermeabilizeduntreatedcellsandstainedwithPI;thismimicsthePIstaining observeduponcelldeath.A-769662treatedcellsremainedintact,asevincedbythelackof PIlabelingofA-769662treatedcells(Fig9).Hence,A-769662treatmentfor24hoursdoes notcausecelldeath,andthereductionincellmigrationisaconsequenceofAMPKsignaling withinviablecells.

58

Fig9.TreatmentwithAMPKactivatorsdoesnotaltercellviabilityyetregulatescell surface1-integrinlevels. RPEcellsweretreatedusingidenticalconditionsasusedforthecellmigrationassay(Fig8, 0.1%FBSinDMEMwith100MA-769662).Followingthistreatment,intactcellswere subjectedtostainingusingpropidiumiodide(PI);cellspreparedinparallelthatwerefirstfixed andpermeabilizedpriortotreatmentwithPIprovideaneffectivepositivecontrolforPI stainingtodetectpermeabilized(non-viable)cells.pixel intensity display range is different between the left panel and the right two panels. In the right two panels, the fluorescence labeling with PI does not produce a signal within cells above the background outside of cells. Scale=5m.

  Results Part II: AMPK activation controls specific stages of 1-integrin membrane traffic

Acute AMPK activation does not appreciably alter the rate of 1-integrin endocytosis
Todeterminewhichcomponentofcellsurface1-integrintrafficissubjectto regulationbyAMPKactivation,Ifirstexaminedtherateof1-integrinendocytosis.I performedanendocyticassaytomeasureendocytosisof1-integrinincellstreatedwith A-769662andincontrolcells.Thisassayinvolveslabellingallcellsurface1-integrinin intactcellswithananti-1-integrinprimaryantibodyat4°C,atemperatureatwhichcell surfacemembranetrafficisreversiblyarrested.Followingwashingtoremoveexcess 59

antibody,thecellswerethenrapidlyreturnedto37°Ctoallowmembranetraffic(including endocytosis)for15minutes,andthenimmediatelyreturnedtoiceandlabelledwith secondaryantibody.Ofnote,thesecondaryantibodymayonlyaccessthe1-integrin antibodyremainingatthecellsurface,butnottheantibodyinternalizedduringthe15min incubationat37°C.Assuch,comparingthefluorescenceintensityof1-integrinremaining atthecellsurface(asafunctionofinitialcellsurface1-integrinlabelingat4°C)allows measurementoftherateof1-integrininternalization.  Thekeycomparisoninthisexperimentisthatofthefractionofcellsurface1integrinremainingatthecellsurfaceafter15-minuteinternalizationincontrolvsA769662-treatedcells.Importantly,theseexperimentsrevealthatthereisnodifferencein theamountof1-integrininternalizedinuntreatedandA-769662conditions(Fig10). However,therearetwokeyexperimentallimitationshere:1)thattheA-769662cannotbe addedpriortothe4°Clabelingstage,ascoolingtemperaturesaltercertainsignal transductionpathways(Al-Fageeh&Smales2006)and2)themeasurementof1-integrin internalization,andthusA-769662treatment,islimitedto15minutes.Anylongertimepointsallowtherecyclingof1-integrinbacktotheplasmamembranefollowing internalization,whichthenincludesrecycled1-integrinandconvolutestheparameters beingmeasured(Teckchandanietal.2009).Hence,thatIdidnotobserveaneffectA769662treatmenton1-integrinendocytosismayreflectthatAMPKdoesnotregulate1integrinendocytosis,ormayinsteadbetheresultofthefactthattheexperimentalassay doesnotallowsufficienttimeforactivationofAMPKandregulationofinternalizationin

60

the15minutesoftheassay. 

1-integrin recycling is regulated by AMPK activation
Next,Ilookedat1-integrinrecyclingtoseeifA-769662treatmenteffectedthis portionoftrafficking.Forthis,Iperformedarecyclingassaywhichrequiresincubating cellsat37°Cwiththeanti-1-integrinantibodypresentinthecellularmedia(DMEMF12). Cellsareincubatedfor15,30and60minuteswiththeantibodysolutiontolabelthe1integrinrecyclingthroughtheplasmamembrane.Afterthisstageandsubsequentfixation andpermeabilization,the1-integrinwhichboundanti-1-integrinantibodiesareprobed withfluorescently-conjugatedsecondaryantibodies.Thepercentageof1-integrin recyclingthroughthecellsurfaceineachconditionandtimepointisdeterminedby (recycling-1-integrin/total-1-integrin).TheconditionsItestedwereuntreatedandA769662treatedforthethreetimepoints:15,30and60minutes.Thereisasignificant differencein1-integrinrecyclinginA-769662treatedconditions(Fig11).Hence, activationofAMPKsignificantlyreduces1-integrinrecyclingthroughtheplasma membrane.Thedifferenceinrecyclingispresent,butmodest,atthe30-minutetimepoint (Fig11).At60minutes,thefullextentof1-integrinrecyclingreductionduetoA-769662 treatmentisevident.Thereisa40%reductioninrecyclinginA-769662treatedcells comparedtocontrol.Hence,uponAMPKactivationbyA-769662,1-integrinrecyclingis reduced.Thisresultisconsistentwiththereductionofcellsurface1-integrinincells treatedwithA-769662. 

61

Transferrin receptor recycling is not regulated by AMPK activation
Notably,theeffectofA-769662on1-integrinwasatleastpartlyspecific,asthis treatmenthadnoeffectonthecellsurfacelevelsofanotherconstitutivelyinternalizingand recyclingmembraneprotein,transferrinreceptor(TfR)(Fig12).TodetermineifAMPK activationbyA-769662treatmentcontrolsTfRrecycling,ImeasuredTfRrecyclingwithan analogousprotocoldescribedaboveusingantibodiesthatrecognizeanexofacialepitopeon TfR.Strikingly,IfoundthatmuchlikewhatwasobservedwhenmeasuringcellsurfaceTfR, A-769662treatmentdoesnotaffecttherateofTfRrecycling.Hence,althoughboth1integrinandTfRbothtrafficthroughpartlyoverlappingearlyandrecyclingendosomes,the activationofAMPKtriggersanunderlyingsignalingmechanismwhichhinders1-integrin recyclingbutleavesthatofTfRunaffected.   Overall,A-769662specificallyregulates1-integrinrecycling(>40minuteofA769662treatment),butitdoesnotappreciablyalter1-integrinendocytosiswhenAMPKis activatedfor15minutes.Asdescribedabove,itisimportanttonotethelimitationofthe endocyticassaywithrespecttoA-769662treatmentandtime.1-integrininternalization measurementwaslimitedto15minutes,asafterthistime-pointtheassaydetection becomesconvolutedbythemeasurementofrecyclingof1-integrinaswell.Therefore,I canconcludethatA-769662treatmentselectivelyregulates1-integrinrecyclingbutnot thatofTfR,andthatAMPKmayalsoregulatecertainaspectsofendocytosisaswell.  HowmightAMPKcontroltherecyclingof1-integrinaswellaspossiblycontrol1integrinendocytosis?ThemechanismthatencompassesthiscouldpotentiallyinvolveArf6 62

GTPases.Arf6isaknownregulatorof1-integrinrecycling,1-integrinendocytosisand Arfsregulateclathrinmediatedendocytosis.   

63

A

Cell surface 1-integrin
Control (t=0) Control (t=15m) A-769662 (t=15m)

B

100

Amount of 1-integrin at cell surface before 15 min internalization

% 1-integrin internalized (in 15 min)

80

Fig 10. Acute AMPK activation (15 min) does not affect 1-integrin endocytosis

60

n.s.

40

20

0
AMPK activation

-

+

Endocytosis at t=15 min

(A) Cells were labeled with an antibody speciic for an exofacial epitope on  1-integrin. Following that, cells were treated with 100 M A-769662 for 15 minutes or not (control). Shown are representative luorescence micrographs depicting cell surface  1-integrin luorescence. Cells treated with 100 M A-769662 for 15 minutes displayed no signiicant difference of  1-integrin on the cell surface compared to control. Scale = 5 m. (B) Cell surface 1-integrin levels obtained by luorescence microscopy were quantiied. Shown is the % of 1-integrin internalized in 15 minutes. AMPK activation does not affect 1-integrin endocytosis (n =4 independent experiments).

64

A

Cell surface 1-integrin
Control A-769662

B
1.0

1-integrin recycling

1-integrin PM recycling

Fig 11. 1-integrin recycling is hindered by AMPK activation (A) Cells were treated with a solution of 100 M A-769662 +  1-integrin antibody or only the antibody (control) and incubated at speciic time points (15, 30, 60 minutes) to allow for recycling. Intact cells were labeled with a secondary antibody speciic for  1-integrin. Shown are representative luorescence micrographs depicting total  1-integrin luorescence in control and AMPK activated cells at 60 minutes. (B) Results were analyzed with a 2-day ANOVA followed by a Bonferroni post-test (* p<0.05). Scale = 5 m (n =3 independent experiments).

0.8 0.6

(normalized units)

*
control AMPK activated 20 40 60

0.4 0.2 0

0

time of recycling (min)

65

A

Cell surface Transferrin receptor
Control A-769662

B
Transferrin receptor recycling
1.0

Fig 12. Transferrin receptor recycling is unaffected by AMPK activation (A) Cells were treated with a solution of 100 M A-769662 + TfR antibody or only the antibody (control) and incubated at speciic time points (15, 30, 60 minutes) to allow for recycling. Intact cells were labeled with a secondary antibody speciic for TfR. Shown are representative luorescence micrographs depicting total TfR luorescence in control and AMPK activated cells at 60 minutes. Scale = 5 m (n =3 independent experiments). (B) Graph depicts the three time-points measured.

TfR PM recycling

(normalized units)

0.8 0.6 0.4 0.2 0

control AMPK activated
0 20 40 60

time of recycling (min)

66

Results part III: Regulation of Arf6 GTPase by AMPK
 With1-integrinrecyclingspecificallyaffected,thenextstepwastodetermine

whichtraffickingproteinregulatesthisprocesswithAMPK.Asmentioned,Arf6proteins havearoleinbothrecyclingandendocytosisof1-integrinandregulateclathrin-mediated endocytosis.WhatisalsonotableisthatweobservedthatAMPKactivationbytreatment withA-769662resultedinthedepletionofspecificArfGAPsfromthecellsurfacefraction, asdeterminedbythemassspectrometryscreen(Rossetal.2015).TheArfGAPsthat exhibitreducedcellsurfaceabundanceuponAMPKactivation,asdetectedbymass spectrometry,arelistedinTable1.Interestingly,analysisofthesequenceoftheseArfGAPs revealsanumberofpredictedAMPKphosphorylationsites,asdeterminedbymatchingto theAMPKconsensusphosphorylationmotifusingProSite(ProSitematch,2016)(Table1).

Table1­ArfGAPsremovedfromthecellsurfaceupontreatmentwithA-769662.PossibleAMPK phosphorylationsitesaspredictedbyProSite.Sequenceblasted:[MLIFV]-[RKH]-[RKH]-X-X-[ST] (ProSitematch,2016). GeneSymbol
ASAP1

ProteinDescription ArfGAPwithSH3domain,ankyrin repeatandPHdomain1

AMPKphosphorylationsit S733,T1074,

AGAP5

ArfGAPwithGTPasedomain,ankyrin repeatandPHdomain5

T408,S533

ARAP2

ArfGAPwithRhoGAPdomain, ankyrinrepeatandPHdomain2

S360,T1350

ARFGAP3

ADP-ribosylationfactorGTPase activatingprotein3

S18

67

A-769662 regulates Arf6 GTP binding and subsequently its cellular localization
WithevidencethatA-769662treatment,andthusAMPK,mayregulateArf6ArfGAPs (Table1),andgiventheimportantroleofArf6incontrolling1-integrinmembranetraffic (Dunphyetal.2006;Powelkaetal.2004;Oh&Santy2010),IsoughttotestwhetherA769662controlsArf6localizationandfunction.RPEcellsweretransfectedwitheitherwild typeArf6-GFPplasmid(GFP-Arf6-WThenceforth)oranArf6mutantthatisconstitutively boundtoGTP("GFP-Arf6-GTP-locked"henceforth),asitunabletoundergoGTPhydrolysis (referredtointheliteratureasconstitutivelyactiveArf6-Q67L,or"GTP-locked").Basedon theobservationthat"GTP-locked"Arf6exhibitsamostlyuniformlocalizationthroughout theplasmamembraneandthatamutantofArf6thatcanonlybindtoGDPexhibits punctatelocalization,ithasbeenproposedthatArf6localizationtopunctatemembrane structuresvs.uniformmembranedistributionmayreflectArf6GTP/GDPbindingstatus (Pasqualatoetal.2001;Schweitzer&D'Souza-Schorey2002;Hattulaetal.2006).  FollowingtransfectionwithvariousArf6­GFPconstructs,cellsweretreatedwithA769662toactivateAMPK,orleftuntreated(basal),sampleswerefixed,processedfor fluorescencemicroscopyandimagedusingaspinningdiscconfocalmicroscope(Fig13). UsinganautomatedsoftwareasinAguetetal.(2013)specialisedfordetectionandanalysis ofdiffraction-limitedstructureswithincells(e.g.CCPs),butmodifiedfordetectionofArf6 punctae,werevealedasignificantincreaseofArf6punctaeintheGFP-Arf6-WTcells treatedwithA-769662(Fig13).ThisconsistentwithA-769662treatmentelicitinga changefromapredominantlyuniformplasmamembraneArf6localization(andthusGTP-

68

boundArf6)toGDP-boundArf6(whichissaidtobelocalizedtopunctatestructures,such asonintracellularmembranecompartments).ThissuggeststhatA-769662treatment regulatesArf6GTPbindingornucleotidecycling.Furtheringthisidea,cellsexpressingGFPArf6-GTP-lockeddonotexhibitanincreaseinArf6punctaestructureupontreatmentwith A-769662(Fig13).GiventhatA-769662treatmentaltersArf6localizationinamanner thatrequiresGTPhydrolysisofArf6,itispossiblethatA-769662treatment,andthus AMPK,mayberegulatingmembranetrafficprocesses(e.g.1-integrinrecyclingand endocytosis)throughregulationofArf6.Consistentwiththisinterpretation,Arf6isa knownregulatorof1-integrintraffickingandspecificallyendocytosis(Oh&Santy2010). 

Acute perturbation of Arf6 GTP/GDP cycling regulates 1-integrin endocytosis
WhileitwasnotstraightforwardtomeasurehowA-769662treatmentmaycontrol 1-integrinendocytosis,InonethelessrevisitedtheideathatA-769662couldregulate1integrinendocytosis,viaArf6,withtheknowledgethatA-769662regulatesArf6-GTP loading.Thistime,IdecidedtoacutelyperturbArf6usingQS11,becauseitismoreacute thanothermethods,suchasexpressionofArf6mutantsorsiRNAgenesilencingofArf6or Arf6regulators.QS11isanArfGAPinhibitorwithbroadspecificityforanumberof ArfGAPs,suchthattreatmentofcellswithQS11willelicitanincreaseinArf6GTPlevels. First,IexaminedtheeffectofQS11oncellsurfacelevelsof1-integrin,byusingsimilar methodsasdetailedabove(Fig5).ThiswasdoneincellstreatedwithQS11oruntreated cells(control).Theresultingmicrographsrevealedanobservabledecreaseincellsurface 1-integrinintheQS11treatedcellscomparedtocontrol,whichwasconfirmedby 69

quantificationofcellsurface1-integrinlevels(Fig14).Thissuggeststhatinhibitionof ArfGAPsbyQS11hasasimilareffectoncellsurface1-integrinlevelsasA-769662 treatment.  Next,IrevisitedtheeffectofQS11on1-integrinendocytosis,tocomparetheeffect ofQS11tothatofA-769662treatment,usingthe1-integrinendocytosisaspreviously described(Fig10),withtheonlydifferencebeinga30-minutepre-incubationofQS11 before1-integrinlabellingonice.Thistime,theendocyticassayrevealedavirtually completeblockageof1-integrininternalizationinQS11treatedcellscomparedtocontrol cells(Fig15).ThisshowsthatArf6-GTP/GDPcyclingisanimportantaspectof1-integrin trafficking.  Thus,collectivelytheseexperimentsrevealthatAMPKactivationregulatesboth recyclingof1-integrinandcyclingofArf6-GTP/GDP(Fig11;Fig13).Therefore,theeffect ofinhibitingArfGAPswithQS11phenocopiestheeffectofA-769662treatmenton1integrintraffic.ThisisalsoconsistentwiththeideaofA-769662treatmentactsvia regulationofArfGAPstocontrolthismechanism.IfA-769662controlsArf6orArfGAPsto controlendocytosis,andgiventheobservationinpreviousstudiesthatArfGAPsandArf6 controlassemblyofclathrin-coatedpits(CCPs),IhypothesizethatAMPKmaycontrolArf6 withinCCPsandthusCCPassembly. 

A-769662 regulates Arf6 recruitment to clathrin coated pits
MyworksuggestsafunctionallinkbetweenAMPKandArf6in1-integrin 70

membranetraffic.InextsoughttodetermineifAMPKmayregulateArf6orArfGAPsto controlclathrin-coatedpitassembly.Todoso,ItransfectedinGFP-Arf6-WTorGFP-Arf6GTP-lockedplasmidintoRPEcellsstablyexpressingRFP-clathrinlightchain(CLC)(RPERFPhenceforth).Usingtotalinternalreflectionfluorescencemicroscopytoselectively imagethecellsurface(andthusCCPs),IexaminedArf6recruitmentinCCPsincellstreated withA-769662toactivateAMPKfor15minutes,oruntreated(control).  Themicrographswereanalyzedusingsoftwaredesignedtoautomaticallydetect diffraction-limitedCCPs(Aguetetal.2013),whichIpreviouslyusedtoquantifyArf6 punctae(Fig13).Thissoftwareusesa2-DGaussianmodelapproachasanapproximation ofthePSF.TheamplitudeoftheGaussianmodelofthePSFisproportionaltotheamountof clathrinorArf6withineachstructure,suchthatthehigherthepoint-sourceintensity,the moreofthespecificproteinispresentwithinthatspecificstructure.  ThisanalysisrevealedthatA-769662altersGFP-Arf6-WTrecruitmenttoCCPs(Fig 16).Specifically,inthecontrolcondition,Arf6localizationwithinCCPsishigherthanthat oftheA-769662treatedcondition.However,intheGFP-Arf6-GTP-lockedcells,A-769662 treatmentdoesnotdecreaseArf6recruitmentcomparedtothecontrol(Fig17).Overall, Arf6recruitmentismuchhigherinGFP-Arf6-GTP-lockedcellsthanGFP-Arf6-WTcells.This isconsistentwiththeideathatGTP-lockingArf6hindersitsmovementbetween compartmentsandcausesittobeboundontheplasmamembrane.Inthismodel,cells expressingArf6-lockedtotheplasmamembranewillbefoundinCCPsinmuchhigher abundancethanArf6thatisabletocycleitsGTP/GDP,andthereforeitslocalization.

71

A

GFP-Arf6 WT

Control

A-769662

Normalized Arf6 puncta density index

B

n.s

2.0

p<0.05

p<0.05

Fig 13. AMPK activation by A-769662 regulates Arf6 GTP binding (A) Cells expressing GFP-Arf6-WT and GFP-Arf6-GTP locked were stimulated with A-769662 for 60 min (AMPK activated) or 0.1% FBS (control). AMPK activation alters GFP-Arf6 from a uniform distribution to punctate structures, consistent with a reduction in GTP-bound Arf6 at the cell surface. Scale = 10 m. (B) Quantiication of Arf6 punctae using an automated detection software modiied for Arf6 punctae structures were detected and quantiied; shown are means ± SEM. (n=3 independent experiments)

1.5

1.0

0.5

0.0
Arf6-WT basal Arf6-WT A-769662 Arf6-CA basal Arf6-CA A-769662

72

A

Cell surface 1-integrin
Control QS11

B
1.0 0.8 0.6 0.4 0.2 0.0
Cell Surface 1-integrin (relative units)

p<0.01
Fig 14. QS11 treatment reduces the abundance of cell surface 1-integrin (A) Cells were treated with 5 M QS11 for 30 minutes. Cells were labeled with an antibody speciic for an exofacial epitope on 1-integrin. Shown are representative luorescence micrographs depicting cell surface 1-integrin luorescence levels. Cells treated with 5 M QS11 for 30 display a signiicant decrease of 1-integrin on the cell surface compared to control. Scale = 5 m. (B) Cell surface 1-integrin levels obtained by luorescence microscopy were quantiied. Shown is the cell surface levels of 1-integrin (relative units) (n=3 independent experiments)

Control QS11
73

A

Cell surface 1-integrin
Control QS11

B

p<0.05
100
% 1-integrin internalized (in 15 min)
no internalization
Fig 15. QS11 treatment hinders 1-integrin endocytosis (A) Cells were pretreated with 5 M QS11 (or not), followed by labelling of with an antibody speciic for an exofacial epitope on 1-integrin. Following that, cells were treated with 5 M QS11 (or not). Shown are representative luorescence micrographs depicting cell surface  1-integrin luorescence. Cells treated with QS11 show a hindered 1-integrin endocytosis Scale = 5 m. (B) Cell surface 1-integrin levels obtained by luorescence microscopy were quantiied. Shown is the % of 1-integrin internalized in 15 minutes. QS11 treatment hinders 1-integrin endocytosis (n =3 independent experiments)

80 60 40 20

0.0

Endocytosis at t=15 min
74

Control

QS11

A
Control

RFP-CLC

GFP-Arf6-WT

Merge

Normalized Arf6 puncta density index

B

A-769662
4

p<0.05

Fig 16. AMPK activation by A-769662 treatment decreases GFP-Arf6-WT recruitment to CCPs (A) RPE-RFP cells were transfected with GFP-Arf6-WT. The cells were treated with 100 M A-769662 (or not) for 15 minutes. Shown are TIRFM micrographs of RFP-CLC, GFP-Arf6-WT and the merge. Scale = 5 m (B) Analysis is performed by an automated detection software for clathrin and modiied for Arf6 (Aguet et al., 2013). Control condition shows a higher level of Arf6 recruitment to CCPs compared to the A-769662 condition. Arf6-WT basal scramble is the control,showing no bias in the automated detection software (n=3 independent experiments)

3

2

1

0
Arf6-WT basal Arf6-WT A-769662 Arf6-WT basal scram

75

A
Control

RFP-CLC

GFP-Arf6-GTP locked

Merge

A-769662
Normalized Arf6 puncta density index

B

15

n.s.

Fig 17. AMPK activation by A-769662 does not affect GFP-Arf6-GTP locked mutant recruitment to CCPs (A) RPE-RFP cells were transfected with GFP-Arf6-GTP locked mutant. The cells were treated with 100 M A-769662 (or not) for 15 minutes. Shown are TIRFM micrographs of RFP-CLC, GFP-Arf6-GTP locked and the merge. Scale = 5 m (B) Analysis is performed by an automated detection software for clathrin and modiied for Arf6 (Aguet et al., 2013). A-769662 treatment does not affect the mutant GTP locked Arf6 recruitment to CCPs. (n=3 independent experiments)

10

5

0
Arf6-CA basal Arf6-CA A-769662

76

Arf6 controls clathrin assembly
UsingtheautomateddetectionsoftwareforclathrincoatedpitsandArf6,Ilookedat howArf6expressionaffectsclathrinassembly.CCPsareheterogeneousinmanyaspectsof theirpropertiesandfunction,includingintheircomposition(Mettlenetal.2010;Banerjee etal.2012;Loerkeetal.2009;Antonescuetal.2011).Assuch,Arf6maynotbelocalizedto allCCPs,andinstead,maybecontrollingthefunctionofasubsetofCCPstowhichitis recruited.ExaminingtheroleofArf6incontrollingCCPassemblyrequiresmethodsin whichCCPspositiveforArf6canbeanalyzedseparatelyfromthoselackingArf6.Tothis end,IsortedthedetectedCCPobjectsintoCCPsthatcontainArf6andCCPsthatlackArf6.I firstexaminedattheCCPsthatlackedArf6recruitment(Arf6negativeCCPs).Imeasured CLCfluorescenceintensity:therecruitmentofclathrintoCCPs­thehigherthe fluorescenceintensity,themoreclathrinthatwasrecruitedtothestructuresinquestion, andthusthelargersizeofthesediffraction-limitedCCPs.IfoundthatinCCPslackingArf6 (WTorlocked),therewasnodifferenceofclathrinrecruitmenttoCCPsacrossall conditionsexamined(Fig18A).Next,IexaminedallCCPswithArf6recruitment(Arf6 positiveCCPs)(Fig18B).A-769662didnotaffectclathrinrecruitmentcomparedtothe controlinbothGFP-Arf6-WTandGFP-Arf6-GTP-lockedconditions.However,therewasa significantdifferenceofclathrinrecruitmentwhencomparingGFP-Arf6-WTandGFP-Arf6GTP-lockedconditions,whichsuggeststhatArf6enhancestherateorlevelsofclathrin recruitmenttoCCPs,andthattheGTP-bindingbyArf6furtherpromotesclathrin recruitment.  TodetermineifthealterationofCCPsizebyArf6occurredonlyasaresultofGTP

77

bindingbyArf6(evincedbycomparisonoftheGFP-Arf6-WTandGFP-Arf6-GTP-locked conditions),orwhetherArf6recruitmentitselfelicitedachangeinCCPsize(relativeto CCPsthatdonotrecruitArf6),IexaminedtheGFP-Arf6-WTcellsmoreclosely,lookingonly atthecontrolcondition(i.e.basal,nottreatedwithA-769662).Withinthecontrol condition,IfocusedonArf6positiveCCPsandArf6negativeCCPs.Thisanalysisrevealed thatArf6positiveCCPshadhigherlevelsofclathrinrecruitmentthanArf6negativeCCPs (Fig18C).Thisisconsistentwiththepreviousresults(Fig18A,B)whichshowthatGTPlockingArf6ontheplasmamembraneregulatestheformationofCCPsbyenhancingthe recruitmentofclathrintherein.TheseresultsdemonstratethatnotonlydoesGTPbinding byArf6enhanceCCPrecruitmentofArf6,butthatthesubsetofCCPsthatrecruitwild-type Arf6alsoexhibitlargersizerelativetoCCPsthatdonotrecruitArf6.Collectively,these resultsindicatethatArf6regulatesasubsetofCCPsandthatcontrolofArf6(e.g.bylongtermAMPKactivation),mayregulatetheendocytosisofspecificcargoreceptors(e.g. integrins),butnotothers(e.g.transferrinreceptor).  Therefore,A-769662treatmentdoesaltercertainaspectsofCCPs,specificallyArf6 recruitmenttoCCPs.I'vealsoshownthatArf6controlsclathrinassembly,althoughthe detailsandmechanismsbehindthatgobeyondthescopeofthisproject.Thisdatais consistentwiththemodelthatAMPKregulatesArfGAPstoeffectArf6regulation,which effectsclathrinmediatedendocytosis,toregulate1-integrinonthecellsurface.  

78

A
1.50 eGFP-CLC fluo. int. within CCPs eGFP-CLC fluo. int. within CCPs 1.25 1.00 0.75 0.50 0.25 0.00
Basal Arf6-WT (-) A-769662 Arf6-WT (-) Basal Arf6-GTP locked (-) A-769662 Arf6-GTP locked (-)

B
1.50 1.25 1.00 0.75 0.50 0.25 0.00
Basal Arf6-WT (+)

p<0.05

n.s across all comparisons

C
1.50 eGFP-CLC fluo. int. within CCPs 1.25 1.00 0.75 0.50 0.25 0.00

A-769662 Basal A-769662 Arf6-WT Arf6-GTP Arf6-GTP (+) locked (+) locked (+)

Fig 18. Arf6 regulates clathrin assembly in clathrin coated pits

p< 0.05

Basal Arf6-WT (+)

Basal Arf6-WT (-)

Analysis is performed by an automated detection software speciically for clathrin and modiied for Arf6 (Aguet et al., 2013). Cells expressing GFP-Arf6 and GFP-Arf6 (GTP locked) were stimulated with A-769662 for 15 min (AMPK activated) or 0.1% FBS (basal). (A) no difference is seen in CCPs negative for Arf6 in all four conditions. (B) No difference is seen in CCPs positive for Arf6 within conditions, however, comparing GFP-Arf6-WT to GFP-Arf6-GTP-locked shows a signiicant increase of CCP size in Arf6-GTP locked cells. (C) In the basal condition, examining only Arf6-WT positive CCPs and Arf6-WT negative CCPs. CCPs with Arf6-WT are larger than CCPs without Arf6 present.

79

Discussion
Tounderstandhowcellsareabletoadapttochangesinenvironmentalconditions, theinfluenceofthecellsurfaceproteomemustbeattheforefrontofthediscussion.Itis establishedthattheabundanceofcertainproteinscanbealteredfromthecellsurfaceupon energeticstress.ThisincludesthefacilitativeglucosetransportersGLUT1andGLUT4, whichexhibitincreasedabundanceontheplasmamembraneuponenergeticstress(Wuet al.2013;Chenetal.2008;Pehmolleretal.2009),andtheNA+/K+ATPasepump,which exhibitsreducedlevelsatthecellsurfaceuponAMPKactivation(Gusarovaetal.2009). AMPKisknownasthecell's"energysensor,"asitistheprimaryrespondertoenergetic shortagesandothertypesofstress.Itsactivationleadstoacascadeofchangesthat ultimatelypromotescatabolicpathwaysanddownplaysanabolicpathways.Althoughsome foundationhasbeenlaidtounderstandtheconnectionbetweenmetabolismandthecell surfaceproteome,theunderstandingofhowAMPKmayregulateandremodelthecell surfaceproteomeisstillinitsinfancy(Rossetal.2015;Klausetal.2012)  Arecentpublicationfromourlabhasdemonstratedanovelmethodtoidentifycell surfaceproteinswhichexhibitalteredabundanceatthecellsurfaceuponAMPKactivation (Rossetal.2015).ThefractionenrichedonthecellsurfaceuponAMPKactivationinclude proteinsinvolvedintheimmuneresponse(i.e.inflammatoryresponse),proteolyticand woundhealingproteins(Rossetal.2015).Cytoskeletalproteins,cellmigrationandcell adhesionproteinswereamongthemanythatweredepletedfromthecellsurfaceupon AMPKactivation(Rossetal.2015).Thispreviousworkwasdonebyacolleagueinthe Antonesculab,Ms.EdenRoss,whofocusedoncelladhesionproteinsduetotheirrolesin 80

cellmigration,woundhealing,butalsodiseasessuchascancerandmetastasisoftumours. Specifically,integrinshavebeenshowntobeheavilyinvolvedintumourcellmetastasis­ changesintheirexpressionorrecyclinghaveimpactsontumourcellmetastasis (Desgrosellier&Cheresh2010).Integrinsv3,51,andV6arehighlyupregulatedin sometumours,whereastheirnormalexpressionprofileislow(Desgrosellier&Cheresh 2010).InMs.Ross'study,shestudiedtherelationshipbetweenAMPKand1-integrin.She foundthatusingpharmacologicalactivatorsAICARandA-769662decreased1-integrins fromthecellsurface,butlefttransferrinreceptorunaffected(Rossetal.2015).  Inthispresentstudy,IvalidatedtheconnectionbetweenAMPKand1-integrin.I thendelvedintothemechanismbehindthisregulatorypathway,askingwhetherAMPK regulatingcellsurface1-integrinbyregulationof1-integrinendocytosis,decreasingthe rateofrecycling,orbothtoreducetheoveralllevelsofcellsurface1-integrin.Ishowed thatAMPKactivationdoesnotappreciablyaffect1-integrinendocytosis(albeitthatthisis withinthelimitationsoftheexperiment),buthasamarketedeffecton1-integrin recycling.IfollowedthatbyestablishingaconnectionbetweenAMPKandaknown regulatorof1-integrintrafficking,Arf6.IalsodemonstratedthatAMPKactivation correlateswithchangesinArf6localization,andthatArf6controlsaspectsofclathrin assemblyinCCPs. 

Regulation of 1-integrin by AMP-activated protein kinase (AMPK)
AsshowninVincentetal.(2015),offtargetandAMPKindependenteffectsare

81

possiblewithavarietyofAMPKagonists.Infact,A-769662mostcloselymimicsAMPK activation,asitlimitsofftargetandAMPKindependenteffects,however,withany pharmacologicalagent,confirmingthephenomenonthroughdifferentmeansisalways beneficial.Inourcase,itwasusingsiRNAagainstAMPK1/2subunit.Iachieved69.6± 2.6%knockdownefficiency,whichiscomparabletowhatothersreport(Fig5A) (Tangemanetal.2012).Thelackofinternalizationof1-integrinintheAMPK1/2 deficientcellstreatedwithA-769662confirmsthelinkbetweenAMPKand1-integrin(Fig 5BC).Importantly,Ialsoshowthatthereductionofcellsurface1-integrinisnotdueto degradationnorisitduetoachangeincellsizeinfluencingtheanalysis,butsimplya reductionin1-integrinabundanceatthecellsurfaceasitredistributestointracellular membranecompartments(Fig6,7).Thishassomeparallelstowhatothershavereported, inthatAMPKactivationfor24hourswiththebenzylisoquinolinealkaloidBerberine reduces1-integrinexpression(Tang&Lee2015).However,ourfindingsthat1-integrin expressionisunaffectedbyAMPKforupto3hoursshowsaverydifferentaspectof regulationof1-integrinbyAMPK,suchthatareductionincellsurfacespecific1-integrin occursinitiallyuponAMPKactivation.  I'vealsodemonstratedAMPKactivationleadstoaseverelyreducedcellmigration. Cellmigrationisanhighlyintegratedmultifacetedprocessthathelpsdrivemorphogenesis, tissuerepair,butcanalsodrivediseaseprogressionincancer,andatherosclerosisamong others(Ridleyetal.2003).Theprocessitselfisveryenergyintensive,asitrequires membraneprotrusionsattheleadingedgewiththehelpofintegrins(Ridleyetal.2003). Alongsidethisisavarietyofsignalingthatoccursthroughintegrins,whichareclustered 82

togetherandlinkedtotheactincytoskeletontocoordinatecellmigration.Assuch, integrinsareveryintimatelyinvolvedwithcellmigration(Ridleyetal.2003).Itisclear then,whyAMPKactivationdecreasescellmigration(Fig8)­cellmigrationcannotoccur withoutpropercyclingofintegrins,andthatisexactlywhatAMPKactivationappearstobe affecting,asseeninmy1-integrinrecyclingexperiments(Fig11).Othershavelookedat otheraspectsbywhichAMPKmayregulatecellmigration.Themicrotubuleplus-end protein,CLIP-170,whichbindsendocyticvesiclestomicrotubules,isinvolvedinthis process(Nakanoetal.2010).AMPKphosphorylatesCLIP-170onSer113tocontrol directionalcellmigrationandspeedofmicrotubulepolymerization(Nakanoetal.2010). Interestingly,AMPKdepletionbycompoundCorsiRNAresultedinimpairedmicrotubule stabilization,tubulinpolymerizationanddirectionalcellmigration(Nakanoetal.2010).On theoppositespectrum,AMPKactivationalsoinhibitscellmigration,whichisreflectedin theclinicalbenefitsoftenseenwithpharmacologicalAMPKactivators­preventionof atherosclerosis,andcancermetastasis(Yanetal.2015).Inthismechanism,Pdlim5is phosphorylatedbyAMPKatSer177whichinhibitscellmigrationbysupressingtheRac1Arp2/3signalingpathway(Yanetal.2015).ItappearsbothAMPKactivationand inhibitioncanimpaircellmigration­suggestingthatAMPKhasaroleoffinetuning processesratherthanbluntimpairment.  ToensurethatcellmigrationreductionwasduetoAMPKactivation,andnotcell deathduetoprolongedAMPKactivation(24hours),Iperformedacellviabilityassayusing PIstaining(Fig9).Asexpected,celldeathwasnotthecauseforreducedcellmigration,but AMPKactivationitself.PIisausefulmarkerofcellviability,asitismembraneimpermeable

83

andcannotenterviablecells(Yehetal.1981).ItwillonlystainDNAinnon-viablecells,as theintegrityoftheirplasmamembraneistypicallylostupondeath(Yehetal.1981). Interestingly,incertainconditionsAMPKmightprotectagainstcelldeath.AMPKactivation byresveratrolcanprotectagainstreactiveoxidativespecies,toinhibittheoccurrenceof celldeath(Hwangetal.2008).However,AMPKappearstohavecontext-specificcontrolof cellphysiology,withrespecttocontrolofcellviability:inchronicmyelogenusleukemia cells,resveratrolpromotescelldeathbyactivatingAMPK(Puissantetal.2010). 

AMPK regulation of 1-integrin endocytosis
DeterminingwhetherAMPKactivationregulatedendocytosisorrecyclingof1integrinwasatwo-tieredtask:measuringendocyticrateswithA-769662treatmentand measuringrecyclingrateswithA-769662treatment.I'veshownthatendocytosisof1integrinisnotaffectedintheearlytime-pointofAMPKactivation,specificallyinthefirst15 minutes.Imeasuredthataround44%of1-integrinundergoesendocytosisin15minutes inthecontrolconditionand40%of1-integrinundergoesundergoesendocytosisinthe AMPKactivatedconditionduringthesametime(Fig10).Thesevaluesatthe15-minute time-pointarecomparabletootherreportedendocyticratesof1-integrin(Teckchandani etal.2009).Interestingly,Arjonenetal.(2012)reporteddistinctendocyticratesforactive, inactiveandtotal1-integrins.Theirdatashowsactive1-integrinendocytosedatahigher ratewhencomparedtoinactiveortotal1-integrin,at15minutes(Arjonenetal.2012). Theendocyticratesreportedintheirstudywerearound25-35%dependingonthecellline fortotal1-integrin­lowerthanwhatmydatareports(Arjonenetal.2012).Itis

84

noteworthythattheyusedthreedifferentcancercelllinesfortheirmeasurements(PC-3, MDA-MB-231,andNCI-H460cells),allthreeofwhichyieldeddifferentvaluesof endocytosed1-integrinat15minutes(Arjonenetal.2012).Thedifferentcelllinescould explainthediscrepancy,asintegrinsareoftenmisregulatedincancercells(Desgrosellier& Cheresh2010).AnotherpossiblereasonisthelimitationoftheendocyticassaythatIused tomeasureendocytosis.Itrequireslabellingof1-integrinat4°Cforonehour,followedby rewarmingat37°CwithandwithoutA-769662.Duetothis,therewarmingperiodis limited,asusinglongertimepointsbeginstoinclude1-integrinrecyclingbacktothecell surface,whichwouldbedetectedas1-integrinthatdidnotundergoendocytosis.Itisstill possiblethatAMPKactivationaffectsendocytosis,especiallyifalonger30-minute endpointisused,asitwasusedininotherstudies(Arjonenetal.2012).Infact,themost strikingdifferencesinendocyticratesbetweenvariouscelllinesandbetweenintegrin activationstatesisseenat30minutesinArjonenetal.(2012).  TocomplementmystudiesandfurtherstudywhetherandhowAMPKactivation maycontrol1-integrinendocytosis,othermethodsmaybeused.Suchmethodsinclude theantibodyandquenchingbasedassaywhichcandirectlymeasureintegrinendocytosis (Arjonenetal.2012).ThismethodisbasedonquenchingthefluorescentsignalofAlexa Fluor488-conjugatedanti-1-integrinantibodiesontheplasmamembraneusinga particularanti-AlexaFluor488antibody.Thisallowsforquenchingofall1-integrin labelledonthecellsurface,andmeasuringonlythefluorescenceoftheendocytosed1integrin(Arjonenetal.2012).Thismethodhasbeenshowntoyieldcomparableendocytic kineticsof1-integrin(Arjonenetal.2012),andwouldallowmeasurementof 85

internalizationof1-integrinforlongertime-points.Anothermethodtomeasure1integrinendocytosisisabiotin-immunoprecipitationbasedassayorareversible biotinylationassay(Gabrieletal.2009),whichmayalsohaveadvantagestomeasure longertimesof1-integrininternalization. 

AMPK regulates 1-integrin recycling but not Transferrin receptor recycling
Withthedatashowingthat1-integrinendocytosisisnotaffectedbyAMPK activation(following15minutesAMPKactivationand15minutes1-integrin internalization),Ishiftedtomeasuring1-integrinrecycling.Idemonstratedthat1integrinrecyclingisslowedby40%withAMPKactivationcomparedtothecontrol,after1 hourofrecycling(Fig11).WithAMPKregulating1-integrinrecycling,Iquestioned whetherotherreceptorsarealsoregulated.MeasuringTfRrecyclingshowednosignificant differenceincontrolandAMPKactivatedconditions(Fig12).  Determiningwhichcompartment1-integrinisrecyclingtoisadifficulttaskas therearemanydifferentendosomesinvolved.Integrinrecyclingbacktotheplasma membraneoccursthroughtwospatiallyandtemporallydistinctpathways,dubbedthe shortloopandthelonglooppathways(DeFranceschietal.2015).Recyclingthroughthe shortlooppathwayisaquickdeliverybacktotheplasmamembrane,andoccursthrough theRab4endosomes.Thelonglooppathwayinvolvesslowerrecyclingtotheplasma membrane,asitconnectswiththeRab11-positiveperinuclearrecyclingcompartments

86

(PNRC)beforeintegrinsareroutedtothecellsurface.Integrinactivationstatemustalsobe takenintoconsideration,asinactiveandactive1-integrinsaretraffickedtodifferent compartments(DeFranceschietal.2015).Bothbegintheirrecyclingjourneyattheearly endosomesandtheRab5/Rab21-positiveendosomes.Fromhere,activeandinactive1integrinsseparate­active1-integrinsaretargetedtoRab11,andinactive1-integrinsare recyclingtoRab4endosomes(DeFranceschietal.2015).ThroughanF-actindependent mechanism,inactive1-integrinaretraffickedtoArf6-positiveprotrusionsontheplasma membrane(DeFranceschietal.2015).Inactiveintegrinsarealsolikelytobefoundonthe plasmamembraneandactiveintegrinsinthecytoplasm­thisbuildsonthefactthat inactiveintegrinsusetheshortloopandactiveintegrinsthelongloop(DeFranceschietal. 2015).  Repeatingendocyticandrecyclingassayswithantibodiesthatselectivelyrecognize inactiveoractiveconformationsof1-integrinwouldbeaninterestingavenuetoexplore, todetermineiftheregulationofcellsurface1-integrinbyAMPKmaybeselectivefora particularactivationstateof1-integrin.Moreimportanceisbeingplacedonintegrin activationstatesanditsconsequencesontheirbehaviour(Bazzonietal.1995;Byronetal. 2009).We'vealreadyseenthedifferencesinlocalizationandkineticsofactiveandinactive integrins(Arjonenetal.2012;Byronetal.2009).ThepossibilitythatAMPKisregulatinga specificpopulationof1-integrins,beitactiveorinactive,isdefinitelynoteworthyto addressmovingforward.  Lastly,GTPasesarealsoinvolvedinregulating1-integrinrecycling.Arf6promotes 87

1-integrinrecyclingwhereasRab35negativelyregulates1-integrinrecycling.Rab35 doesthisbyinhibitingArf6byrecruitmentofACAP2(Dozynkiewiczetal.2012).ACAP2is aArf6GAPbutisalsoaRab35effector.Rab35recruitsACAP2toArf6-positiveendosomes whereitdeactivatesArf6(Dozynkiewiczetal.2012).AsArf6promotes1-integrin recycling,deactivatingitleadstoadecreasedrateofrecycling(Dozynkiewiczetal.2012). 

AMPK regulation of Arf6 to control 1-integrin trafficking
Arf6regulatestheendocytosisandrecyclingofavarietyofproteinsbetweenthe plasmamembranetoendosomalsystems,including1-integrin(Oh&Santy2010).Here, weshowthatAMPKactivationaffectsArf6localization(Fig13A,B).Ahighernumberof Arf6punctatestructuresarefoundinAMPKactivatedcellscomparedtocontrol.Arf6-GTP istypicallyfoundatthecellperiphery(i.e.theplasmamembrane),whereasArf6-GDPis foundonendosomalcompartments(Gaschet&Hsu1999).Withoutdirectlyquantifying levelsofArf6-GTPandArf6-GDP,itishardtosaywhetherAMPKactivationisfavouringone formovertheotherbyandlarge.However,whatcanbeconcludedfromtheseresultsis thatAMPKappearsbetoregulatingArf6localizationinamannerthatrequiresArf6 GTP/GDPcycling.IntheArf6-GTP-lockedmutant,thenumberofpunctatestructuresdonot increaseintheAMPKactivatedconditionincomparisontothecontrolArf6-GTP-locked condition(Fig13B).Thus,whenArf6,inconjunctionwithArfGAPscannothydrolyzeGTP toGDP,AMPKactivationisnotabletoinfluenceArf6GTP/GDPcyclingandalsoappearsto beunabletoshiftlocalizationofArf6topunctatestructures.IthasbeenreportedthatArf6 bindingtostructurallydistinctGAPscanfine-tuneArf6-dependentintegrintrafficking pathways(DeFranceschietal.2015).AdemonstrationofthisistheArfGAPsACAP1and 88

ARAP2exhibitingdifferentialandoppositeeffectsonfocaladhesionmorphology,basedon theirlocalizationtospatiallydistinctArf6-positiveendosomes(DeFranceschietal.2015).  TofurthertestthefunctionofArf6GTP/GDPcycling,IusedanArfGAPinhibitor QS11.QS11inhibitsanumberofArfGAPs,whichincreasesthelevelsofArf6-GTP.Ifound thatcellsurfacelevelsof1-integrindecreasedafteronly30minutesofQS11treatment (Fig14).ThismimicstheeffectofAMPKactivationon1-integrinandhighlightsthe importanceofArf6GTP/GDPcyclingontrafficking.AsQS11treatmentonlyneeded30 minutesofactivationtoelicitasimilareffectthatA-769662doesin60minutes,itis possiblethatQS11isactingdownstreamofAMPKactivation,andthereforeneedslesstime toproduceaneffect.WithalimitationoftheendocyticassaywithrespecttoA-769662 treatmentsuchthatthiscouldbedoneforonly15minutes,Irevisitedthe1-integrin internalizationassaynowwithQS11.Importantly,pre-treatmentfor30minwithQS11 treatmenthinders1-integrinendocytosissignificantlycomparedtothecontrolcondition (Fig15).  AsArf6isconsidered"active"initsGTPform,itisestablishedthatArf6activation enhances1-integrinrecycling(Arjonenetal.2012).IobservedthatinhibitionofArfGAPs withQS11(toenhanceArf6-GTPlevels)hadthesameeffectasAMPKactivationon1integrinmembranetraffic.Typically,smallGTPaseproteinshavebeenthoughtas molecularswitchesthatshiftbeenaGTP-boundactivestateandaGDP-boundinactive state.FromthissimplisticinterpretationarisesthenotionthataGTP-lockedactiveArf6 mutantwouldreproduceormagnifythefunctionsofanactivewild-typeArf6.However,in

89

thisstudyaswellasothersthatlookat1-integrinrecycling,thisisnotthecase(Kleinet al.2006;Radhakrishna&Donaldson1997;Naslavskyetal.2003).Infact,completionofthe GTPhydrolysiscycleisanecessarycomponentofsmallGTPases,toelicitthecomplete biologicalresponse.Therearesomeexamplesoftheimportanceofnucleotidecyclingfor normalfunctionofArfsandotherGTPases.ForRabandRanfamiliesofsmallGTPases, completionofthenucleotidecyclingisnecessaryforthetransportofvesiclesandshifting inandoutofthenucleus,respectively(Chavrier&Goud1999;Kuerstenetal.2001). FormationofthecoatcomplexproteinIalsorequiresnucleotidecyclingofArf1(Yangetal. 2002).ItisthenpossiblethatArf6nucleotidecycling,andnotsimplytherelativelevelsof Arf6-GTPorArf6-GDP,playsamoresignificantroleinregulationofmembranetrafficthan whatwasthoughtbefore.  TheimportanceofGTP/GDPcyclingforArf6hasbeenpreviouslydemonstrated withmajorhistocompatibilitycomplexclassI(MHCI)(Kleinetal.2006).Theyshowthat Arf6regulatesitsbiologicalfunctionsbycyclingthroughitsGTPandGDPboundforms (Kleinetal.2006).ForMHCI,GTPhydrolysisofArf6isnecessaryforefficientrecycling. Here,ArfGAPswereshowntohaveagreaterroleforArf6ratherthansimplyanendpoint fordeactivatingArf6.  ArfGAPscomprisethelargestbindingpartnersofArf6(Randazzo&Hirsch2004). TheArfGAPACAP1isaneffectorforArf6,necessaryformembraneprotrusionformation (Kleinetal.2006).ArfGAPsarealsoheavilyimplicatedasregulatorsoftheactin cytoskeleton(Inoue&Randazzo2007).ArfGAPsarecomprisedoftwomaingroups

90

dependingontheirstructure:ArfGAP1type,whichhaveanArfGAPdomainattheN terminal,andAZAPtype,ArfGAPswithANKrepeatsandaPHdomain(Inoue&Randazzo 2007).MembersofArfGAP1typeincludeArfGAP1/3,SMAP1/2,andGIT1/2;membersof theAZAPtypeconsistofASAP1/2/3,ACAP1/2/3,ARAP1/2/3andAGAP1/2/3(Inoue& Randazzo2007).Ourmassspectrometryscreenwhichdetailedproteinsdepletedfromthe cellsurfaceuponAMPKactivationincludedtheArfGAPsASAP1,AGAP5,ARAP2and ArfGAP3(Table1).ThispointstothepossibilitythatAMPKisregulatingArfGAPswhich regulateArf6,tocontrol1-integrinrecycling.Itisnotonlytheidentificationofthese specificArfGAPsinourmassspectrometryassayasputativeproteinsregulatedbyAMPK thathintsattheconnectionbetweenAMPKandArf6:theseArfGAPsalsohavemultiple potentialAMPKconsensusphosphorylationsites(Table1).Iperformedthisanalysisfor AMPKconsensusphosphorylationmotifsusingaProSitefeaturewhichsearchessequences forspecificproteinmotifs.Inthiscase,ArfGAPsaminoacidsequenceswereusedtosearch fortheAMPKconsensusphosphorylationsite:XXXS/TXXX,wherehydrophobic () =M,L,I,F,orV;basic () = R,K,orH;X=anyaminoacid,andS/T=phosphorylationsite (Marinetal.2015).VariabilityalsoexistsinthesequencethatAMPKphosphorylates,asit isabletophosphorylatesiteslackingthe-4/-6basicresidue(Marinetal.2015).Insome cases,AMPKcanalsophosphorylatesiteswiththe-5hydrophobicresidueshiftedto-4 position(Xuetal.2014).SeveralphosphorylationsitesweredetectedonallfourArfGAPs, butthisdoesnotnecessarilyconfirmthemastargetsbyAMPK.Furthertestingneedstobe donetodeterminewhetherAMPKregulatesArf6viaArfGAPphosphorylation.  Someofthepossibleexperimentalapproachestomoredirectlytesttheregulationof

91

Arf6byAMPKandArf6beginswithusinganArf6pull-downactivationassay,which measuresthelevelsofArf6-GTPandArf6-GDPinacell.Thisinvolvesusingcovalently conjugatedGGA3-PBDbeads.ThebeadsutilizeaproteinbindingdomainoftheArf6 effectorGGA3,whichspecificallybindstheArf6-GTPboundform(Takatsuetal.2002; Balasubramanianetal.2007).Usingthesebeadsallowsustopull-downonlytheArf6-GTP inalysatefractionandquantifyitviaimmunoblotting.ThiswouldletusseewhetherAMPK activationchangestheratioofArf6-GTPandArf6-GDP.Iperformedthistypeofanalysis usingacommercialkit(CytoskeletonInc,Denver,CO),butwasunabletoobservepulldownofGTP-boundArf6,evenfromthepositivecontrolfractionprovidedbythe manufacturer.Futureexperimentswithin-housepurifiedGGA3effectordomainsofArf6,to allowscalingupofcellularmaterialfromwhichGTP-boundArf6maybeprecipitated,may allowsuccessfuldetectionofArf6-GTPlevelsincontrolvsAMPK-activatedcells.Certainly, thespinningdiskconfocalimagesdosuggestaroleforAMPKinregulatingArf6cycling,but thiswouldhelpconfirmthephenomenon(Fig13).  TodeterminewhetherAMPKregulatesArf6cyclingtocontrol1-integrintraffic, previoustoanyexperimentslookingatspecificArfGAPsfoundinthemassspectrometry screen,anArf6fast-cyclingmutant(Arf6-T157N)canbeused.Thismutantisableto quicklycyclebetweenGTPandGDPstates,regardlessofanyoutsidesignalinginput(Klein etal.2006).Forthis,cellswouldbetransfectedwiththeGFP-Arf6-T157N,andthecell surface1-integrinmeasurementwouldbemeasuredviatheimmunofluorescenceassays usedinthisthesis,withandwithoutA-769662treatment.IfAMPKactivationcontrols1integrintrafficbyregulatingArf6nucleotidecycling,thenweshouldseethesamelevelof

92

1-integrincellsurfacelevelsincontrolandAMPKactivatedconditionsincellsexpressing theArf6-T157N.ThiswouldverynicelyshowtheimportanceofArf6nucleotidecyclingon 1-integrinmembranetrafficbutalsoconfirmifAMPKregulatesthisprocessthroughArf6. 

AMPK and Arfs regulation of CCPs and endocytosis
BuildingontheideathatAMPKregulates1-integrintraffickingviaArf6,Ihave discoveredthatAMPKactivationdecreasesArf6recruitmenttoCCPs(Fig16).However,in Arf6-GTP-lockedcells,AMPKactivationdoesnotinfluenceArf6recruitmentatall,having similarlevelsofCCPsasthecontrolcondition(Fig17).TheconnectionbetweenArf6and AMPKhasbeenimplicatedbeforeinayeastmodel,inwhichSnf1p(theyeasthomologueof AMPK)actsasaGEFtoactivateArf3p(yeasthomologueofArf6)(Hsuetal.2015).Itshould benotedthatthisfunctionofSnf1pasanArfGEFmaybeuniquetotheyeastproteinand doesnotappeartooccurinmammalianAMPK(Hsuetal.2015).Nonetheless,thissuggests theexistenceofevolutionarilyconservedrequirementsforregulationofArfGTPasesby AMPKduringmetabolicstress,evenifthisregulationmayoccurbydistinctmolecular mechanisms.Further,therehavebeenpreviousreportsoftheregulationofclathrinand CCPsbyArf6.Arf6hasbeenshowntoregulateCMEfromapicalandbasolateral membranesofpolarizedMDCKcells(Altschuleretal.1999;Palaciosetal.2002).Arfs enhanceAP-2bindingtomembraneclathrinassembly,whereusingtheArf6-GTP-locked mutantenhancedclathrinandAP-2recruitmenttoisolatedmembranevesicles,similarto whatmydatashowswithrespecttoCCPformationatthecellsurfaceinlivingcells, assayedbyTIRFmicroscopy(Fig17)(Kraussetal.2003).ArfGAPsforArf6alsohavethe abilitytocontrolclathrinmediatedendocytosis:SMAP1bindsdirectlytotheclathrinheavy

93

chainviaaclathrin-boxtoregulateCME(Tanabeetal.2005).Lastly,AP-1,theclathrin adaptorcomplexresponsibleforsortingcargobetweenthetrans-golginetworkand endosomesrequiresactivationbyArf1,whichissimilartoArf6(Renetal.2013).Arf1 unlockstheabilityforAP-1tobindcargo,whenitisactivatedbyGTPbinding.Thestudy demonstratesdirectbindingofAP-1byArf1atthreeinteractionsiteswhichareimportant forrecruitment,activation,orboth(Renetal.2013).Theseauthorssuggestamodelwhere Arf1isresponsiblefortherecruitmentandactivationofAP-1atmembranes(Renetal. 2013).ThelaststudydemonstratesarelationshipbetweenArf1andAP-1,whichcouldbea similarmodelwithArf6andclathrin/AP-2.Iproposeamodelherewhichinvolves reciprocalregulation,inwhichArf6regulatesCCPassemblyandinwhichsomecomponent ofCCPsenhancesArf6binding.AsAP-2isrequiredforthenucleationofclathrinassembly, itislikelythatAP-2ispresentonthemembranefirst.AP-2bindingandnucleationthen likelyrecruitsArf6tothemembrane,andpresenceofArf6onthemembraneenhancesAP2bindingtoclathrin(Antonescuetal.,2011),thusmakingthisreciprocalregulationofArf6 andAP-2/clathrinoneinvolvingpositivefeedbackthatpromotesCCPformation.AsArf6is onlyfoundinasubsetofCCPs,thismechanismappearstofunctiontocontroltheformation ofasubsetofCCPs,perhapsthoseharboring1-integrin.  Consistentwiththismodel,IhavealsodemonstratedthatpresenceofArf6(WT)or Arf6(GTP-locked)resultsinlargerclathrinstructurescomparedtostructureslackingArf6 (Fig18BC).Importantly,thesizeofCCPwithArf6-WTcomparedtoCCPwithArf6-GTPlockedmutantaresignificantlysmaller.ThissuggeststhatArf6nucleotidecyclingisapart ofclathrinassembly.Infact,apreviousstudyhasdemonstratedtheroleofcompletingthe

94

Arf6nucleotidecycleingyrating-clathrin(G-clathrin)regulation(Yietal.2013).Briefly,Gclathrincomplexesarestructurallyandfunctionallydistinct,astheircomplexesdonot haveAP-1orAP-2recruitment(Yietal.2013).Theyarealsoprimarilyfoundbelowthe plasmamembraneatsortingendosomes(Yietal.2013).  TodeterminewhetherArf6nucleotidecyclingisnecessarytoregulateclathrin assembly,itisnecessarytofirstusetheArf6-fastcyclingmutantasdescribedabove. Followingthat,itisnecessarytodeterminewhetheroneoftheArfGAPsinthemass spectrometryscreen(Table1)maybephosphorylatedbyAMPKandthusinturncontrol Arf6function.Forthis,aPhosphogelenrichmentkitcanbeused.Inshort,Phosphogeluses immobilizedmetalionchromatography(IMAC)toseparatephosphorylatedproteins.It involvesFe3+,whichbindstophosphorylatedproteinsmuchstrongerduetothecharge interaction(Andersson&Porath1986).Thekitusesagarosetoseparatethe phosphorylatedformoftheproteinfromthenon-phosphorylatedform.Thesearethen immunoblottedfor­aphosphorylatedproteinwillappeartoexhibithighermolecular weightduetotheimpedimentcausedbytheFe3+-phosphorylationinteraction.In conjunctionwithantibodiesthatselectivelyrecognizespecificArfGAPssuchasArfGAP3, thismethodcanbeappliedtoidentifywhethertheArfGAPsinTable1arephosphorylated byAMPKactivation.Ifthisisthecase,thenpointmutationsatlikelyphosphorylationsites wouldbethenextlogicalstep,toseeiftheknockoutreversestheeffectofAMPKactivation ofcellsurface1-integrinlevels.

95

AMPK

Fig 19. Proposed model for AMPK and Arf6 on 1-integrin regulation The model proposed for AMPK regulation of 1-integrin membrane trafic. AMPK affects Arf6 via ArfGAPs, which inturn regulates 1-integrin membrane trafic.





ArfGAPs

Arf6

1-integrin membrane traffic
96

Conclusion
Insummary,IhaveestablishedthatAMPKactivationselectivelyregulates1integrinmembranetrafficbysiRNAknockdownofAMPK1/2.Withthis,Iexploredhow AMPKactivationregulates1-integrintraffic.IhaveshownthatAMPKactivationmassively reducesRPEcellmigration,withoutaffectingthecellviability,possiblyduetoitsregulation of1-integrin.Ofinterestwaswhetherendocytosisorrecyclingof1-integrinwasaffected. Idemonstratedthat1-integrinendocytosisbyAMPKactivationwasnotappreciably affected,althoughthatcouldpotentiallybealimitationoftheassayused.Ifollowedthisby measuring1-integrinandTfRrecycling,inwhich1-integrinbutnotTfRrecyclingwas affectedbyAMPKactivation.Thisdemonstratedaspecificregulationof1-integrinandnot TfRbyAMPK,whichwasalsoseenwithcellsurfacemeasurementsofbothreceptors(Ross etal.,2015).Asdatafromthemassspectrometryscreensuggested,ArfGAPsweredepleted fromthecellsurfaceuponAMPKactivation(Rossetal.,2015).  DuetotheestablishedroleofArf6in1-integrinmembranetraffic,Ihypothesized AMPKcouldbeactingonsomecomponentofArfstoregulate1-integrinmembranetraffic. Thiswasevincedbyspinningdiskconfocalmicrographs,depictinganincreaseofArf6 punctatestructuresinAMPKactivatedcells,butnochangeinArf6-GTP-lockedmutantcells byAMPKactivation.ThisdatahintedatAMPKregulatingArf6nucleotidecycling;I discoveredthatArfGAPinhibitionbyQS11treatmentmimickedAMPKactivationoncell surface1-integrinlevels.RevisitingendocytosiswithArfGAPinhibitionrevealeda reductionof1-integrininternalization.Ifollowedthisbymeasuringclathrinassembly

97

dynamicsandArf6,whichrevealedthatAMPKactivationreducedcolocalizationofArf6WTinCCPs,andthatthisdidnotoccurinArf6-GTPlockedmutantcells.Ialso demonstratedthatCCPsarelargerinstructuresthatcontainArf6-WT,andthatpresenceof Arf6-GTP-lockedmutantinCCPincreasestheirsizecomparedtoArf-WTCCPs.Thisdata revealsthatAMPKregulatesArf6localizationtoCCPs.Italsosuggestsareciprocal regulationofArf6onCCPassembly,anddemonstratesthatcontrolofArf6nucleotide cyclingmaybepartofamechanismbywhichAMPKcanregulateclathrin/CCPassembly. DiscoveringwhichcomponentofArf6isregulatedbyAMPKisthenextstepinabroader studytounderstandhowAMPKcontrolscellsurfacemembranetrafficandthecellsurface proteome.WhetherAMPKactsdirectlyonArf6orthroughanArfGAPtoregulate nucleotidecyclingremainstobeanswered.Understandingthisnewpathwaywillleadto betterunderstandingofhowAMPKregulatesthecellsurfaceproteome,andhowselective orbroaditscontrolis.Overall,thisresearchmaybelayingthegroundworkforthe developmentoffuturetherapeutictargets,specificallyagainsttumourigenesisand metastasisgiventheheavyinvolvementofintegrins.      

98

References

Abram,C.L.&Lowell,C.A.,2009.Theinsandoutsofleukocyteintegrinsignaling.Annual reviewofimmunology,27,pp.339­362. Abu-elheiga,L.etal.,1997.HumanAcetyl-CoACarboxylase2.JBiolChem,272(16), pp.10669­10677. Abu-Elheiga,L.etal.,1995.Humanacetyl-CoAcarboxylase:characterization,molecular cloning,andevidencefortwoisoforms.ProceedingsoftheNationalAcademyof SciencesoftheUnitedStatesofAmerica,92(9),pp.4011­5.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=42092&tool=pmcentrez &rendertype=abstract. Abu-Elheiga,L.etal.,2005.Mutantmicelackingacetyl-CoAcarboxylase1are embryonicallylethal.ProceedingsoftheNationalAcademyofSciencesoftheUnited StatesofAmerica,102(34),pp.12011­6.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1189351&tool=pmcentr ez&rendertype=abstract. Abu-Elheiga,L.etal.,2000.Thesubcellularlocalizationofacetyl-CoAcarboxylase2. ProceedingsoftheNationalAcademyofSciencesoftheUnitedStatesofAmerica,97(4), pp.1444­1449. Aguet,F.etal.,2013.Advancesinanalysisoflowsignal-to-noiseimageslinkdynaminand AP2tothefunctionsofanendocyticcheckpoint.Developmentalcell,26(3),pp.279­91. Availableat:http://www.cell.com/article/S1534580713003821/fulltext[Accessed May2,2015]. Akram,M.,2014.Citricacidcycleandroleofitsintermediatesinmetabolism.Cell biochemistryandbiophysics,68(3),pp.475­478. Al-Fageeh,M.B.&Smales,C.M.,2006.Controlandregulationofthecellularresponsesto coldshock:theresponsesinyeastandmammaliansystems.TheBiochemicaljournal, 397(2),pp.247­259. Altschuler,Y.etal.,1999.ADP-ribosylationfactor6andendocytosisattheapicalsurfaceof Madin-Darbycaninekidneycells.JCellBiol,147(1),pp.7­12.Availableat: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Ci tation&list_uids=10508850. Andersson,L.&Porath,J.,1986.Isolationofphosphoproteinsbyimmobilizedmetal(Fe3+) affinitychromatography.Analyticalbiochemistry,154(1),pp.250­254.

99

Andrews,Z.B.,2011.Centralmechanismsinvolvedintheorexigenicactionsofghrelin. Peptides,32(11),pp.2248­2255.Availableat: http://dx.doi.org/10.1016/j.peptides.2011.05.014. Antonescu,C.N.etal.,2011.Phosphatidylinositol-(4,5)-bisphosphateregulatesclathrincoatedpitinitiation,stabilization,andsize.Molecularbiologyofthecell,22(14), pp.2588­2600. Antonescu,C.N.,McGraw,T.E.&Klip,A.,2014.Reciprocalregulationofendocytosisand metabolism.ColdSpringHarborperspectivesinbiology,6(7),p.a016964.Availableat: http://www.ncbi.nlm.nih.gov/pubmed/24984778[AccessedApril27,2015]. Antonny,B.etal.,1997.N-terminalhydrophobicresiduesoftheG-proteinADP-ribosylation factor-1insertintomembranephospholipidsuponGDPtoGTPexchange. Biochemistry,36(15),pp.4675­4684. Aponte,Y.,Atasoy,D.&Sternson,S.M.,2011.AGRPneuronsaresufficienttoorchestrate feedingbehaviorrapidlyandwithouttraining.Natureneuroscience,14(3),pp.351­ 355.Availableat:http://dx.doi.org/10.1038/nn.2739. Arjonen,A.etal.,2012.DistinctRecyclingofActiveandInactive1Integrins.Traffic,13(4), pp.610­625.Availableat:http://dx.doi.org/10.1111/j.1600-0854.2012.01327.x. Artavanis-tsakonas,S.,Rand,M.D.&Lake,R.J.,1999.NotchSignaling:CellFateControland SignalIntegrationinDevelopment.,284(April),pp.770­777. Bai,M.etal.,2011.ARFGAP1promotesendocytosisregulatedbyAP-2.Naturecellbiology, 13(5),pp.559­567.Availableat: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087831/. Balasubramanian,N.etal.,2007.Arf6andmicrotubulesinadhesion-dependenttrafficking oflipidrafts.Naturecellbiology,9(12),pp.1381­1391. Ballestrem,C.etal.,2000.Actin-dependentlamellipodiaformationandmicrotubuledependenttailretractioncontrol-directedcellmigration.Molecularbiologyofthecell, 11(9),pp.2999­3012. Banerjee,A.,Berezhkovskii,A.&Nossal,R.,2012.StochasticModelofClathrin-CoatedPit Assembly.BiophysicalJournal,102(12),pp.2725­2730.Availableat: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379625/. Bazzoni,G.etal.,1995.MonoclonalAntibody9EG7DefinesaNovelbeta1IntegrinEpitope InducedbySolubleLigandandManganese,butInhibitedbyCalcium.,270(43), pp.25570­25577. Behnia,R.&Munro,S.,2005.Organelleidentityandthesignpostsformembranetraffic. Nature,438(7068),pp.597­604.Availableat:

100

http://www.ncbi.nlm.nih.gov/pubmed/16319879. Bianchi,A.etal.,1990.Identificationofanisozymicformofacetyl-CoAcarboxylase.Journal ofBiologicalChemistry,265(3),pp.1502­1509. Blümer,J.etal.,2013.RabGEFsareamajordeterminantforspecificRabmembrane targeting.JournalofCellBiology,200(3),pp.287­300. Bonen,A.etal.,1999.Musclecontractileactivityincreasesfattyacidmetabolismand transportandFAT/CD36.AmJPhysiol,276(4Pt1),pp.E642­9.Availableat: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Ci tation&list_uids=10198299. Browne,G.J.,Finn,S.G.&Proud,C.G.,2004.StimulationoftheAMP-activatedProteinKinase LeadstoActivationofEukaryoticElongationFactor2KinaseandtoIts PhosphorylationataNovelSite,Serine398.JournalofBiologicalChemistry,279(13), pp.12220­12231. Byron,A.etal.,2009.Anti-integrinmonoclonalantibodies.Journalofcellscience,122(Pt 22),pp.4009­4011. Caswell,P.&Norman,J.,2008.Endocytictransportofintegrinsduringcellmigrationand invasion.TrendsinCellBiology,18(6),pp.257­263.Availableat: http://www.sciencedirect.com/science/article/pii/S0962892408001074. Caswell,P.T.&Norman,J.C.,2006.IntegrinTraffickingandtheControlofCellMigration. Traffic,7(1),pp.14­21.Availableat:http://dx.doi.org/10.1111/j.16000854.2005.00362.x. Caswell,P.T.,Vadrevu,S.&Norman,J.C.,2009.Integrins:mastersandslavesofendocytic transport.Naturereviews.Molecularcellbiology,10(12),pp.843­53.Availableat: http://www.ncbi.nlm.nih.gov/pubmed/19904298[AccessedJanuary12,2015]. Ceresa,B.P.,2006.RegulationofEGFRendocytictraffickingbyrabproteins.Histologyand Histopathology,21(7-9),pp.987­993. Chavrier,P.&Goud,B.,1999.TheroleofARFandRabGTPasesinmembranetransport. CurrentOpinioninCellBiology,11(4),pp.466­475. Chen,S.etal.,2008.ComplementaryregulationofTBC1D1andAS160bygrowthfactors, insulinandAMPKactivators.TheBiochemicaljournal,409(2),pp.449­59.Availableat: http://www.ncbi.nlm.nih.gov/pubmed/17995453. Chidambaram,S.,Zimmermann,J.&vonMollard,G.F.,2008.ENTHdomainproteinsare cargoadaptorsformultipleSNAREproteinsattheTGNendosome.Journalofcell science,121(Pt3),pp.329­338.

101

Claret,M.etal.,2007.AMPKisessentialforenergyhomeostasisregulationandglucose sensingbyPOMCandAgRPneurons.JournalofClinicalInvestigation,117(8),pp.2325­ 2336. Cocucci,E.etal.,2012.Thefirstfivesecondsinthelifeofaclathrin-coatedpit.Cell,150(3), pp.495­507. Conaway,R.C.&Conaway,J.W.,1988.ATPactivatestranscriptioninitiationfrompromoters byRNApolymeraseIIinareversiblesteppriortoRNAsynthesis.JournalofBiological Chemistry,263(6),pp.2962­2968. Corton,J.M.etal.,1995.5-aminoimidazole-4-carboxamideribonucleoside.Aspecific methodforactivatingAMP-activatedproteinkinaseinintactcells?Europeanjournalof biochemistry/FEBS,229(2),pp.558­565. Cremona,O.etal.,1999.Essentialroleofphosphoinositidemetabolisminsynapticvesicle recycling.Cell,99(2),pp.179­188. Dai,J.etal.,2004.ACAP1promotesendocyticrecyclingbyrecognizingrecyclingsorting signals.Developmentalcell,7(5),pp.771­6.Availableat: http://www.cell.com/article/S1534580704003624/fulltext[AccessedMay2,2015]. Davies,S.P.etal.,1995.5'-AMPinhibitsdephosphorylation,aswellaspromoting phosphorylation,oftheAMP-activatedproteinkinase.Studiesusingbacterially expressedhumanproteinphosphatase-2C??andnativebovineproteinphosphatase2Ac.FEBSLetters,377(3),pp.421­425. Demetriades,C.,Doumpas,N.&Teleman,A.A.,2014.RegulationofTORC1inresponseto aminoacidstarvationvialysosomalrecruitmentofTSC2.Cell,156(4),pp.786­799. Desgrosellier,J.S.&Cheresh,D.A.,2010.Integrinsincancer:biologicalimplicationsand therapeuticopportunities.Naturereviews.Cancer,10(1),pp.9­22. Dittman,J.S.&Kaplan,J.M.,2006.Factorsregulatingtheabundanceandlocalizationof synaptobrevinintheplasmamembrane.ProceedingsoftheNationalAcademyof SciencesoftheUnitedStatesofAmerica,103(30),pp.11399­11404. Dozynkiewicz,M.A.etal.,2012.Rab25andCLIC3CollaboratetoPromoteIntegrin RecyclingfromLateEndosomes/LysosomesandDriveCancerProgression. DevelopmentalCell,22(1),pp.131­145.Availableat: http://dx.doi.org/10.1016/j.devcel.2011.11.008. Dunphy,J.L.etal.,2006.TheArf6GEFGEP100/BRAG2regulatescelladhesionby controllingendocytosisofbeta1integrins.CurrentBiology,16(3),pp.315­320. Erdmann,K.S.etal.,2007.AroleoftheLowesyndromeproteinOCRLinearlystepsofthe endocyticpathway.Developmentalcell,13(3),pp.377­390.

102

Evans,J.M.M.etal.,2005.Metforminandreducedriskofcancerindiabeticpatients.BMJ (Clinicalresearched.),330(7503),pp.1304­1305. FCheung,P.C.etal.,2000.CharacterizationofAMP-activatedproteinkinase-subunit isoformsandtheirroleinAMPbinding.Biochem.J,346,pp.659­669. Faubert,B.etal.,2013.AMPKIsaNegativeRegulatoroftheWarburgEffectandSuppresses TumorGrowthIn&#xa0;Vivo.CellMetabolism,17(1),pp.113­124.Availableat: http://dx.doi.org/10.1016/j.cmet.2012.12.001. Faubert,B.etal.,2014.LossofthetumorsuppressorLKB1promotesmetabolic reprogrammingofcancercellsviaHIF-1alpha.ProceedingsoftheNationalAcademyof SciencesoftheUnitedStatesofAmerica,111(7),pp.2554­2559. Faubert,B.etal.,2015.TheAMP-activatedproteinkinase(AMPK)andcancer:Manyfaces ofametabolicregulator.CancerLetters,356(2),pp.165­170.Availableat: http://dx.doi.org/10.1016/j.canlet.2014.01.018. Ford,M.G.etal.,2001.SimultaneousbindingofPtdIns(4,5)P2andclathrinbyAP180inthe nucleationofclathrinlatticesonmembranes.Science(NewYork,N.Y.),291(5506), pp.1051­1055. Ford,M.G.J.etal.,2002.Curvatureofclathrin-coatedpitsdrivenbyepsin.Nature, 419(6905),pp.361­366. DeFranceschi,N.etal.,2015.Integrintraffic-theupdate.Journalofcellscience,pp.1­14. Availableat:http://www.ncbi.nlm.nih.gov/pubmed/25663697[AccessedFebruary 11,2015]. Gabriel,L.,Stevens,Z.&Melikian,H.,2009.Measuringplasmamembraneproteinendocytic ratesbyreversiblebiotinylation.Journalofvisualizedexperiments:JoVE,(34),pp.2­5. Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3152245&tool=pmcentr ez&rendertype=abstract. Gaschet,J.&Hsu,V.W.,1999.DistributionofARF6betweenmembraneandcytosolis regulatedbyitsGTPasecycle.JournalofBiologicalChemistry,274(28),pp.20040­ 20045. Giugliano,D.,Ceriello,A.&Esposito,K.,2008.Glucosemetabolismandhyperglycemia.In AmericanJournalofClinicalNutrition.pp.217­222. Grant,B.D.&Donaldson,J.G.,2009.Pathwaysandmechanismsofendocytoticrecycling. MolecularCellBiology,10(9),pp.597­604. Gusarova,G.A.etal.,2009.Alpha1-AMP-activatedproteinkinaseregulateshypoxia-induced Na,K-ATPaseendocytosisviadirectphosphorylationofproteinkinaseCzeta.

103

Molecularandcellularbiology,29(13),pp.3455­64.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2698765&tool=pmcentr ez&rendertype=abstract. Gwinn,D.M.etal.,2008.AMPKPhosphorylationofRaptorMediatesaMetabolic Checkpoint.MolecularCell,30(2),pp.214­226. terHaar,E.etal.,1998.AtomicStructureofClathrin:APropellerTerminalDomainJoins anZigzagLinker.Cell,95(4),pp.563­573.Availableat: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428171/. terHaar,E.,Harrison,S.C.&Kirchhausen,T.,2000.Peptide-in-grooveinteractionslink targetproteinstothebeta-propellerofclathrin.ProceedingsoftheNationalAcademy ofSciencesoftheUnitedStatesofAmerica,97(3),pp.1096­100.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15533&tool=pmcentrez &rendertype=abstract. Hardie,D.G.,Ross,F.a.&Hawley,S.a.,2012.AMPK:anutrientandenergysensorthat maintainsenergyhomeostasis.NatureReviewsMolecularCellBiology,13(4),pp.251­ 262.Availableat:http://dx.doi.org/10.1038/nrm3311. Harms,U.etal.,2014.EIF4B,eIF4GandRNAregulateeIF4Aactivityintranslationinitiation bymodulatingtheeIF4Aconformationalcycle.NucleicAcidsResearch,42(12), pp.7911­7922. Hattula,K.etal.,2006.CharacterizationoftheRab8-specificmembranetrafficroutelinked toprotrusionformation.Journalofcellscience,119(Pt23),pp.4866­77.Availableat: http://jcs.biologists.org/content/119/23/4866.short\nhttp://www.ncbi.nlm.nih.gov/ pubmed/17105768. Hawley,S.aetal.,2003.ComplexesbetweentheLKB1tumorsuppressor,STRAD alpha/betaandMO25alpha/betaareupstreamkinasesintheAMP-activatedprotein kinasecascade.Journalofbiology,2(4),p.28. Hawley,S.a.etal.,1995.5`-AMPActivatestheAMP-activatedProteinKinaseCascade,and Ca+2/CalmodulinActivatestheCalmodulin-dependentProteinKinaseICascade,via ThreeIndependentMechanisms.JournalofBiologicalChemistry,270(45),pp.27186­ 27191. Hawley,S.a.etal.,2005.Calmodulin-dependentproteinkinasekinase-betaisanalternative upstreamkinaseforAMP-activatedproteinkinase.CellMetabolism,2(1),pp.9­19. VanderHeiden,M.G.,Cantley,L.C.&Thompson,C.B.,2009.UnderstandingtheWarburg effect:themetabolicrequirementsofcellproliferation.Science(NewYork,N.Y.), 324(5930),pp.1029­1033. Honing,S.etal.,2005.Phosphatidylinositol-(4,5)-bisphosphateregulatessortingsignal

104

recognitionbytheclathrin-associatedadaptorcomplexAP2.MolecularCell,18(5), pp.519­531. Hoppe,S.etal.,2009.AMP-activatedproteinkinaseadaptsrRNAsynthesistocellular energysupply.ProceedingsoftheNationalAcademyofSciencesoftheUnitedStatesof America,106(42),pp.17781­17786. Houten,S.M.&Wanders,R.J.A.,2010.Ageneralintroductiontothebiochemistryof mitochondrialfattyacid-oxidation.JournalofInheritedMetabolicDisease,33(5), pp.469­477. Hsu,J.,Chen,K.&Lee,F.S.,2015.Snf1/AMP-activatedproteinkinaseactivatesArf3pto promoteinvasiveyeastgrowthviaanon-canonicalGEFdomain.Nature Communications,6,p.7840.Availableat: http://www.nature.com/doifinder/10.1038/ncomms8840. Huang,X.etal.,2008.ImportantroleoftheLKB1-AMPKpathwayinsuppressing tumorigenesisinPTEN-deficientmice.TheBiochemicaljournal,412(2),pp.211­221. Hurley,R.L.etal.,2005.TheCa2+/calmodulin-dependentproteinkinasekinasesareAMPactivatedproteinkinasekinases.TheJournalofbiologicalchemistry,280(32), pp.29060­29066. Huttenlocher,A.&Horwitz,A.R.,2011.IntegrinsinCellMigration.Availableat: http://linkinghub.elsevier.com/retrieve/pii/S0076687907260033. Huveneers,S.&Danen,E.H.J.,2009.Adhesionsignaling-crosstalkbetweenintegrins,Src andRho.Journalofcellscience,122(Pt8),pp.1059­1069. Hwang,J.T.etal.,2008.ResveratrolprotectsROS-inducedcelldeathbyactivatingAMPKin H9c2cardiacmusclecells.GenesandNutrition,2(4),pp.323­326. Hyman,T.,Shmuel,M.&Altschuler,Y.,2006.ActinIsRequiredforEndocytosisattheApical SurfaceofMadin-DarbyCanineKidneyCellswhereARF6andClathrinRegulatethe ActinCytoskeleton.MolecularBiologyoftheCell. Hynes,R.O.,2002.IntegrinsBidirectional,AllostericSignalingMachines.Cell,110(6), pp.673­687.Availableat:http://www.cell.com/article/S0092867402009716/fulltext [AccessedFebruary6,2015]. Imamura,K.etal.,2001.Cellcycleregulationviap53phosphorylationbya5'-AMP activatedproteinkinaseactivator,5-aminoimidazole-4-carboxamide-1-beta-Dribofuranoside,inahumanhepatocellularcarcinomacellline.Biochemicaland biophysicalresearchcommunications,287(2),pp.562­567. Inoki,K.,Zhu,T.&Guan,K.-L.,2003.TSC2mediatescellularenergyresponsetocontrolcell growthandsurvival.Cell,115(5),pp.577­590.

105

Inoue,H.&Randazzo,P.A.,2007.ArfGAPsandtheirinteractingproteins.Traffic,8(11), pp.1465­1475. Iverson,A.J.etal.,1990.Immunologicalanalysisofacetyl-CoAcarboxylasemass,tissue distributionandsubunitcomposition.TheBiochemicaljournal,269(2),pp.365­71. Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1131586&tool=pmcentr ez&rendertype=abstract. Jackson,L.P.etal.,2010.Alarge-scaleconformationalchangecouplesmembrane recruitmenttocargobindingintheAP2clathrinadaptorcomplex.Cell,141(7), pp.1220­1229. Jimenez-Soto,L.F.etal.,2009.HelicobacterpyloritypeIVsecretionapparatusexploitsbeta 1integrininanovelRGD-independentmanner.PLoSPathogens,5(12). Jones,M.C.,Caswell,P.T.&Norman,J.C.,2006.Endocyticrecyclingpathways:emerging regulatorsofcellmigration.CurrentOpinioninCellBiology,18(5),pp.549­557. Availableat: http://www.sciencedirect.com/science/article/pii/S095506740600113X. Jones,R.G.etal.,2005.AMP-activatedproteinkinaseinducesap53-dependentmetabolic checkpoint.MolecularCell,18(3),pp.283­293. Kanno,E.etal.,2010.Comprehensivescreeningfornovelrab-bindingproteinsbyGSTpulldownassayusing60differentmammalianRabs.Traffic(Copenhagen,Denmark), 11(4),pp.491­507. Kelly,B.T.etal.,2014.Clathrinadaptors.AP2controlsclathrinpolymerizationwitha membrane-activatedswitch.Science(NewYork,N.Y.),345(6195),pp.459­463. Kiens,B.,2006.SkeletalMuscleLipidMetabolisminExerciseandInsulinResistance.Physiol Rev,pp.205­243. Kim,E.,2009.MechanismsofaminoacidsensinginmTORsignalingpathway.Nutrition researchandpractice,3(1),pp.64­71. Kim,J.etal.,2016.AMPKactivators:mechanismsofactionandphysiologicalactivities. Experimental&MolecularMedicine,48(4),p.e224.Availableat: http://dx.doi.org/10.1038/emm.2016.16. Kirchhausen,T.,Owen,D.&Harrison,S.C.,2014.Molecularstructure,function,and dynamicsofclathrin-mediatedmembranetraffic.ColdSpringHarborPerspectivesin Biology,6(5). Klaus,A.etal.,2012.Atwo-dimensionalscreenforAMPKsubstratesidentifiestumor suppressorfumaratehydrataseasapreferentialAMPK2substrate.Journalof

106

Proteomics,75(11),pp.3304­3313.Availableat: http://dx.doi.org/10.1016/j.jprot.2012.03.040. Klein,S.etal.,2006.RoleoftheArf6GDP/GTPcycleandArf6GTPase-activatingproteinsin actinremodelingandintracellulartransport.JournalofBiologicalChemistry,281(18), pp.12352­12361. Koronakis,V.etal.,2011.WAVEregulatorycomplexactivationbycooperatingGTPasesArf andRac1.ProceedingsoftheNationalAcademyofSciencesoftheUnitedStatesof America,108(35),pp.14449­54.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3167530&tool=pmcentr ez&rendertype=abstract. Krauss,M.etal.,2003.ARF6stimulatesclathrin/AP-2recruitmenttosynapticmembranes byactivatingphosphatidylinositolphosphatekinasetypeIy.JournalofCellBiology, 162(1),pp.113­124. Kuersten,S.,Ohno,M.&Mattaj,I.W.,2001.Nucleocytoplasmictransport:Ran,betaand beyond.Trendsincellbiology,11(12),pp.497­503. Li,X.-B.,Gu,J.-D.&Zhou,Q.-H.,2015.Reviewofaerobicglycolysisanditskeyenzymes- newtargetsforlungcancertherapy.Thoraciccancer,6(1),pp.17­24.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4448463&tool=pmcentr ez&rendertype=abstract. Lim,C.J.etal.,2008.Integrin-mediatedProteinKinaseAActivationattheLeadingEdgeof MigratingCellsJ.E.Schwarzbauer,ed.MolecularBiologyoftheCell,19(11),pp.4930­ 4941.Availableat:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575143/. Loerke,D.etal.,2009.CargoandDynaminRegulateClathrin-CoatedPitMaturationF. Hughson,ed.PLoSBiology,7(3),p.e1000057.Availableat: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656549/. Luiken,J.J.F.P.etal.,2003.TranslocationinRatCardiacMyocytesIsMediatedThrough AMP-ActivatedProteinKinaseSignaling.Diabetes,52,pp.1627­1634. Mai,A.etal.,2011.CompetitivebindingofRab21andp120RasGAPtointegrinsregulates receptortrafficandmigration.TheJournalofcellbiology,194(2),pp.291­306. Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3144408&tool=pmcentr ez&rendertype=abstract[AccessedApril27,2015]. Marin,T.L.etal.,2015.IdentificationofAMP-activatedproteinkinasetargetsbya consensussequencesearchoftheproteome.BMCSystemsBiology,9(1),pp.1­12. Availableat:http://www.biomedcentral.com/1752-0509/9/13. Mcmahon,H.T.&Boucrot,E.,2011.Molecularmechanismandphysiologicalfunctionsof

107

clathrin-mediatedendocytosis.NaturePublishingGroup,12(8),pp.517­533.Available at:http://dx.doi.org/10.1038/nrm3151. Mettlen,M.etal.,2010.Cargo-andadaptor-specificmechanismsregulateclathrinmediatedendocytosis.JournalofCellBiology,188(6),pp.919­933. Miaczynska,M.etal.,2004.APPLproteinslinkRab5tonuclearsignaltransductionviaan endosomalcompartment.Cell,116(3),pp.445­456. Mim,C.&Unger,V.M.,2012.MembranecurvatureanditsgenerationbyBARproteins. Trendsinbiochemicalsciences,37(12),pp.526­533.Availableat: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508348/. Munday,M.R.,2002.Regulationofmammalianacetyl-CoAcarboxylase.BiochemicalSociety transactions,30(Pt6),pp.1059­1064. Nakano,A.etal.,2010.AMPKcontrolsthespeedofmicrotubulepolymerizationand directionalcellmigrationthroughCLIP-170phosphorylation.Naturecellbiology, 12(6),pp.583­590.Availableat:http://dx.doi.org/10.1038/ncb2060. Naslavsky,N.,Weigert,R.&Donaldson,J.G.,2003.Convergenceofnon-clathrin-and clathrin-derivedendosomesinvolvesArf6inactivationandchangesin phosphoinositides.Molecularbiologyofthecell,14(2),pp.417­431. Newsholme,E.A.,Crabtree,B.&Ardawi,M.S.,1985.Theroleofhighratesofglycolysisand glutamineutilizationinrapidlydividingcells.Biosciencereports,5(5),pp.393­400. Oakhill,J.S.etal.,2011.AMPKIsaDirectAdenylateCharge-RegulatedProteinKinase. Science,332(6036),pp.1433­1435.Availableat: http://science.sciencemag.org/content/332/6036/1433.abstract. Oh,S.J.&Santy,L.C.,2010.Differentialeffectsofcytohesins2and3onbeta1integrin recycling.TheJournalofbiologicalchemistry,285(19),pp.14610­6.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2863229&tool=pmcentr ez&rendertype=abstract. Palacios,F.etal.,2002.ARF6-GTPrecruitsNm23-H1tofacilitatedynamin-mediated endocytosisduringadherensjunctionsdisassembly.Naturecellbiology,4(12), pp.929­936. Partridge,A.W.etal.,2005.Transmembranedomainhelixpackingstabilizesintegrin IIb3inthelowaffinitystate.JournalofBiologicalChemistry,280(8),pp.7294­7300. Pasqualato,S.etal.,2001.ThestructuralGDP/GTPcycleofhumanArf6.MolecularBiology, 2(3),pp.234­238. Pasqualato,S.,Renault,L.&Cherfils,J.,2002.Arf,Arl,ArpandSarproteins:afamilyofGTP-

108

bindingproteinswithastructuraldevicefor"front-back"communication.EMBO reports,3(11),pp.1035­1041. Pehmoller,C.etal.,2009.GeneticdisruptionofAMPKsignalingabolishesbothcontraction- andinsulin-stimulatedTBC1D1phosphorylationand14-3-3bindinginmouseskeletal muscle.AmJPhysiolEndocrinolMetab,297(3),pp.E665­75.Availableat: http://www.ncbi.nlm.nih.gov/pubmed/19531644\nhttp://ajpendo.physiology.org/co ntent/ajpendo/297/3/E665.full.pdf. Pellinen,T.,2006.SmallGTPaseRab21regulatescelladhesionandcontrolsendosomal trafficof1-integrins.TheJournalofCellBiology,173(5),pp.767­780.Availableat: http://www.jcb.org/cgi/doi/10.1083/jcb.200509019[AccessedMarch14,2015]. Pellinen,T.&Ivaska,J.,2006.Integrintraffic.Journalofcellscience,119(Pt18),pp.3723­ 3731. Pinter,K.etal.,2013.LocalisationofAMPKsubunitsincardiacandskeletalmuscles. JournalofMuscleResearchandCellMotility,34(5-6),pp.369­378. Powelka,A.M.etal.,2004.Stimulation-DependentRecyclingofIntegrinb1Regulatedby ARF6andRab11.,pp.1­18. Puissant,A.etal.,2010.Resveratrolpromotesautophagiccelldeathinchronic myelogenousleukemiacellsviaJNK-mediatedp62/SQSTM1expressionandAMPK activation.CancerResearch,70(3),pp.1042­1052. Radhakrishna,H.&Donaldson,J.G.,1997.ADP-ribosylationfactor6regulatesanovel plasmamembranerecyclingpathway.TheJournalofcellbiology,139(1),pp.49­61. Randazzo,P.A.&Hirsch,D.S.,2004.ArfGAPs:multifunctionalproteinsthatregulate membranetrafficandactinremodelling.Cellularsignalling,16(4),pp.401­413. Rapoport,I.etal.,2008.AmotifintheclathrinheavychainrequiredfortheHsc70/auxilin uncoatingreaction.Molecularbiologyofthecell,19(1),pp.405­413. Regen,C.M.&Horwitz,A.F.,1992.Dynamicsofbeta1integrin-mediatedadhesivecontacts inmotilefibroblasts.TheJournalofcellbiology,119(5),pp.1347­1359. Ren,X.etal.,2013.StructuralbasisforrecruitmentandactivationoftheAP-1clathrin adaptorcomplexbyArf1.Cell,152(4),pp.755­767. Ridley,A.J.etal.,2003.Cellmigration:integratingsignalsfromfronttoback.Science(New York,N.Y.),302(5651),pp.1704­9.Availableat: http://classic.sciencemag.org/content/302/5651/1704.full. Ross,E.etal.,2015.AMP-activatedproteinkinaseregulatesthecellsurfaceproteomeand integrinmembranetraffic.PloSone.

109

Sakamoto,K.etal.,2006.DeficiencyofLKB1inheartpreventsischemia-mediated activationofAMPK2butnotAMPK1.Americanjournalofphysiology.Endocrinology andmetabolism,290(5),pp.E780­E788.Availableat: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2128705/. Sakamoto,K.etal.,2005.DeficiencyofLKB1inskeletalmusclepreventsAMPKactivation andglucoseuptakeduringcontraction.TheEMBOjournal,24(10),pp.1810­1820. Sakamoto,K.&Holman,G.D.,2008.EmergingroleforAS160/TBC1D4andTBC1D1inthe regulationofGLUT4traffic.Americanjournalofphysiology.Endocrinologyand metabolism,295(1),pp.E29­37.Availableat: http://ajpendo.physiology.org/content/295/1/E29.long\nhttp://www.ncbi.nlm.nih.g ov/pubmed/18477703\nhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid =PMC2493596. Sakurai,A.etal.,2011.Phosphatidylinositol-4-phosphate5-kinaseandGEP100/Brag2 proteinmediateantiangiogenicsignalingbysemaphorin3E-plexin-D1throughArf6 protein.TheJournalofbiologicalchemistry,286(39),pp.34335­45.Availableat: http://www.jbc.org/cgi/content/long/286/39/34335[AccessedMay2,2015]. Salt,I.etal.,1998.AMP-activatedproteinkinase:greaterAMPdependence,and preferentialnuclearlocalization,ofcomplexescontainingthealpha2isoform.The Biochemicaljournal,334(Pt1,pp.177­87.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1219677&tool=pmcentr ez&rendertype=abstract. Samovski,D.etal.,2012.InsulinandAMPKregulateFAtranslocase/CD36plasma membranerecruitmentincardiomyocytesviaRabGAPAS160andRab8aRabGTPase. Journaloflipidresearch,53(4),pp.709­717. Sazanov,L.A.,2015.Agiantmolecularprotonpump:structureandmechanismof respiratorycomplexI.NatRevMolCellBiol,16(6),pp.375­388.Availableat: http://dx.doi.org/10.1038/nrm3997. Schweitzer,J.K.&D'Souza-Schorey,C.,2002.LocalizationandactivationoftheARF6 GTPaseduringcleavagefurrowingressionandcytokinesis.JournalofBiological Chemistry,277(30),pp.27210­27216. Scott,J.W.etal.,2004.CBSdomainsformenergy-sensingmoduleswhosebindingof adenosineligandsisdisruptedbydiseasemutations.JournalofClinicalInvestigation, 113(2),pp.274­284. Shattil,S.,Kim,C.&Ginsberg,M.,2010.Thefinalstepsofintegrinactivation:theendgame. Shaw,R.J.etal.,2016.TheLKB1tumorsuppressornegativelyregulatesmTORsignaling. CancerCell,6(1),pp.91­99.Availableat:http://dx.doi.org/10.1016/j.ccr.2004.06.007.

110

Shaw,R.J.etal.,2004.ThetumorsuppressorLKB1kinasedirectlyactivatesAMP-activated kinaseandregulatesapoptosisinresponsetoenergystress.Proceedingsofthe NationalAcademyofSciencesoftheUnitedStatesofAmerica,101(10),pp.3329­3335. Shearer,J.etal.,2004.AMPKinase-InducedSkeletalMuscleGlucoseButNotLong-Chain FattyAcidUptakeIsDependentonNitricOxide.Diabetes,53(6),pp.1429­1435. Shearer,J.etal.,2005.Heart-typefattyacid-bindingproteinreciprocallyregulatesglucose andfattyacidutilizationduringexercise.Americanjournalofphysiology. Endocrinologyandmetabolism,288(2),pp.E292­E297. Smilenov,L.B.etal.,1999.Focaladhesionmotilityrevealedinstationaryfibroblasts. Science(NewYork,N.Y.),286(5442),pp.1172­1174. Steinberg,G.R.etal.,2004.AMP-activatedproteinkinaseisnotdown-regulatedinhuman skeletalmuscleofobesefemales.JournalofClinicalEndocrinologyandMetabolism, 89(9),pp.4575­4580. Steinberg,G.R.&Kemp,B.E.,2009.AMPKinHealthandDisease.Physiologicalreviews, 89(3),pp.1025­1078. Steven,aC.etal.,1983.Massdistributionsofcoatedvesiclesisolatedfromliverandbrain: analysisbyscanningtransmissionelectronmicroscopy.TheJournalofcellbiology, 97(6),pp.1714­23.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2112720&tool=pmcentr ez&rendertype=abstract. Suter,M.etal.,2006.Dissectingtheroleof5'-AMPforallostericstimulation,activation,and deactivationofAMP-activatedproteinkinase.JournalofBiologicalChemistry,281(43), pp.32207­32216. Swiatecka-Urban,A.,2013.Membranetraffickinginpodocytehealthanddisease.Pediatric Nephrology(Berlin,Germany),28(9),pp.1723­1737.Availableat: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578983/. Takatsu,H.etal.,2002.GGAproteinsassociatewithGolgimembranesthroughinteraction betweentheirGGAHdomainsandADP-ribosylationfactors.BiochemJ,365(Pt2), pp.369­378.Availableat:http://www.ncbi.nlm.nih.gov/pubmed/11950392. Tanabe,K.etal.,2005.AnovelGTPase-activatingproteinforARF6directlyinteractswith clathrinandregulatesclathrin-dependentendocytosis.Molecularbiologyofthecell, 16(4),pp.1617­28.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1073646&tool=pmcentr ez&rendertype=abstract. Tang,W.&Lee,K.,2015.InhibitoryeffectsofBerberineonthemigratoryandinvasive abilitiesofcancercells.,pp.8­11.

111

Tangeman,L.,Wyatt,C.N.&Brown,T.L.,2012.KnockdownofAMP-activatedproteinkinase alpha1andalpha2catalyticsubunits.JournalofRNAiandgenesilencing:an internationaljournalofRNAandgenetargetingresearch,8,pp.470­8.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3542724&tool=pmcentr ez&rendertype=abstract. Teckchandani,A.etal.,2009.QuantitativeproteomicsidentifiesaDab2/integrinmodule regulatingcellmigration.,186(1),pp.99­111. Toker,A.,1998.Thesynthesisandcellularrolesofphosphatidylinositol4,5-bisphosphate. CurrentOpinioninCellBiology,10(2),pp.254­261. Traub,L.M.,2009.Ticketstoride:selectingcargoforclathrin-regulatedinternalization. Naturereviews.Molecularcellbiology,10(9),pp.583­96.Availableat: http://www.ncbi.nlm.nih.gov/pubmed/19696796. Uni,T.,1981.ATPRequirementHeLafortheProcessesCellNuclei1ofDNAReplicationin IsolatedTheATPrequirementfortwostepsofDNAreplication,thesynthesisand subsequentjoiningofOkazakifragments,wasinvestigatedbyusingisolatedHeLacell nuclei.Am.,89(3),pp.801­807. Urbanska,A.etal.,2011.BiochemicalcharacterizationofAPPLEndosomes:Theroleof annexinA2inAPPLmembranerecruitment.Traffic,12(9),pp.1227­1241. Vincent,E.E.etal.,2014.DifferentialeffectsofAMPKagonistsoncellgrowthand metabolism.Oncogene,(January),pp.1­13.Availableat: http://www.nature.com/doifinder/10.1038/onc.2014.301[AccessedMarch17, 2015]. Viollet,B.etal.,2006.ActivationofAMP-activatedproteinkinaseintheliver:anew strategyforthemanagementofmetabolichepaticdisorders.TheJournalofphysiology, 574(Pt1),pp.41­53.Availableat: http://www.ncbi.nlm.nih.gov/pubmed/16644802\nhttp://www.pubmedcentral.nih.g ov/articlerender.fcgi?artid=PMC1817784. Warburg,O.,1956.Ontheoriginofcancercells.Science(NewYork,N.Y.),123(3191), pp.309­314. Webb,D.J.etal.,2004.FAK-Srcsignallingthroughpaxillin,ERKandMLCKregulates adhesiondisassembly.Naturecellbiology,6(2),pp.154­161. Woods,A.etal.,2005.Ca2+/calmodulin-dependentproteinkinasekinase-betaacts upstreamofAMP-activatedproteinkinaseinmammaliancells.Cellmetabolism,2(1), pp.21­33. Woods,A.etal.,2003.LKB1IstheUpstreamKinaseintheAMP-ActivatedProteinKinase Cascade.CurrentBiology,13(22),pp.2004­2008.

112

Wraith,D.C.&Chesterton,C.J.,1982.Cell-surfaceremodellingduringmammalian erythropoiesis.BiochemJ,208(1),pp.239­242.Availableat: http://www.ncbi.nlm.nih.gov/pubmed/7159394. Wu,N.etal.,2013.AMPK-DependentDegradationofTXNIPuponEnergyStressLeadsto EnhancedGlucoseUptakeviaGLUT1.MolecularCell,49(6),pp.1167­1175.Available at:http://dx.doi.org/10.1016/j.molcel.2013.01.035. Xiao,B.etal.,2011.StructureofmammalianAMPKanditsregulationbyADP.Nature, 472(7342),pp.230­3.Availableat:http://dx.doi.org/10.1038/nature09932. Xing,Y.etal.,2010.StructureofclathrincoatwithboundHsc70andauxilin:mechanismof Hsc70-facilitateddisassembly.TheEMBOjournal,29(3),pp.655­665. Xu,Q.etal.,2014.AMPKregulateshistoneH2BO-GlcNAcylation.Nucleicacidsresearch, 42(9),pp.5594­5604. Yan,D.etal.,2010.Thecell-surfaceproteinsDally-likeandIhogdifferentiallyregulate Hedgehogsignalingstrengthandrangeduringdevelopment.Development(Cambridge, England),137,pp.2033­2044. Yan,Y.etal.,2015.AugmentedAMPKactivityinhibitscellmigrationbyphosphorylating thenovelsubstratePdlim5.Naturecommunications,6,p.6137.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4317497&tool=pmcentr ez&rendertype=abstract[AccessedMarch17,2015]. Yang,J.-S.etal.,2002.ARFGAP1promotestheformationofCOPIvesicles,suggesting functionasacomponentofthecoat.TheJournalofcellbiology,159(1),pp.69­78. Yang,Y.etal.,2011.Hungerstatesswitchaflip-flopmemorycircuitviaasynapticAMPKdependentpositivefeedbackloop.Cell,146(6),pp.992­1003.Availableat: http://dx.doi.org/10.1016/j.cell.2011.07.039. Yeh,C.J.G.,Hsi,B.L.&PageFaulk,W.,1981.Propidiumiodideasanuclearmarkerin immunofluorescence.II.Usewithcellularidentificationandviabilitystudies.Journalof ImmunologicalMethods,43(3),pp.269­275. Yi,L.,Yi,Zhan&Keen,J.H.,2013.Arf6RegulationofGyrating-Clathrin. Yue,J.etal.,2014.MicrotubulesregulatefocaladhesiondynamicsthroughMAP4K4. Developmentalcell,31(5),pp.572­85.Availableat: http://www.cell.com/article/S1534580714006911/fulltext[AccessedMay2,2015]. Zheng,B.&Cantley,L.C.,2007.Regulationofepithelialtightjunctionassemblyand disassemblybyAMP-activatedproteinkinase.ProceedingsoftheNationalAcademyof SciencesoftheUnitedStatesofAmerica,104(3),pp.819­22.Availableat: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1783397&tool=pmcentr

113

ez&rendertype=abstract. Zoncu,R.etal.,2009.Aphosphoinositideswitchcontrolsthematurationandsignaling propertiesofAPPLendosomes.Cell,136(6),pp.1110­1121.    

114

